Product Name | CAS | MF | MW | Synonyms |
---|---|---|---|---|
Oxacillin Sodium Salt | 1173-88-2 | C19H18N3NaO5S | 423.42 | 3,3-Dimethyl-6-(5-methyl-3-phenyl-4-isoxazolecarboxamido)-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid Monosodium Salt; (2S,5R,6R)-3,3-Dimethyl-6-[[(5-methyl-3-phenyl-4-isoxazolyl)carbonyl]amino]-7-oxo-4-Thia-1-azabicyclo[3.2.0]heptane-2-carb |
Oxacillin Sodium Salt Monohydrate | 7240-38-2 | C19H18N3NaO5S.H2O | 441.43 | (2S,5R,6R)-3,3-Dimethyl-6-[[(5-methyl-3-phenyl-4-isoxazolyl)carbonyl]amino]-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid Sodium Salt Hydrate; Penicillin P-12 Hydrate; Sodium Oxacillin Hydrate; BRL-1400 Hydrate; Bactocill Hydrate; Bristopen Hy |
Oxacillin Impurity F (Thioxacillin) | 5053-35-0 | C19H19N3O4S2 | 417.5 | 3,3-Dimethyl-6-(5-methyl-3-phenyl-4-isoxazolecarboxamido)-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carbothioic Acid |
Oxacillin Impurity D | 1642559-63-4 | C18H21N3O4S | 375.45 | |
Oxacillin | 66-79-5 | C19H19N3O5S | 401.44 | [2S-(2,5,6)]-3,3-dimethyl-6-(methyl-3-phenylisoxaz-4-ole-carboxamide-7-oxy-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid;(2S,5R,6R)-3,3-Dimethyl-6-[(5-methyl-3-phenylisoxazol-4-yl)carbonylamino]-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic a |
Oxacephem Nucleus | 67977-91-7 | C28H24N2O5 | 468.50 | |
OXA-01 | 936889-68-8 | C21H20ClN5O2 | 409.9 | 4-[8-amino-1-(7-chloro-1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexane-1-carboxylic acid |
OXA (17-33) | 343268-91-7 | C79H125N23O22 | 1749 | |
OX BILE | 75302-04-4 | 0 | OX BILE; OX BILE DRIED; OXBILE POWDER; OXGALL; OXGALL EXTRACT | |
Ovalicin | 19683-98-8 | C16H24O5 | 296.363 | Graphinone; (3S,4R,5S)-4-hydroxy-5-methoxy-4-[(2S,3R)-2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl]-1-oxaspiro[2.5]octan-6-one |
Ovalene | 190-26-1 | C32H14 | 398.45 | OVALENE; phenanthro[3,4,5,6-qrabc]coronene; 1,14:3,4:7,8:10,11-Tetraethenodibenzo[fg,op]naphthacene |
Ovalbumin (323-339) (chicken, japanese quail) | 92915-79-2 | C74H120N26O25 | 1773.9 | OVALBUMIN CHICKEN (323-339); OVALBUMIN (323-339) (CHICKEN, JAPANESE QUAIL); OVA (323-339); OVA (323-339) (CHICKEN, JAPANESE QUAIL); H2N-ISQAVHAAHAEINEAGR-OH; ILE-SER-GLN-ALA-VAL-HIS-ALA-ALA-HIS-ALA-GLU-ILE-ASN-GLU-ALA-GLY-ARG; H-ILE-SER-GLN-ALA-VAL-HIS-AL |
OUP16 | 1038917-11-1 | C11H16N6O | 248.29 | OUP-16;Guanidine, N-cyano-N''-methyl-N'-[[(2R,5R)-tetrahydro-5-(1H-imidazol-5-yl)-2-furanyl]methyl]-, rel- |
OUL 35 | 6336-34-1 | C14H12N2O3 | 256.26 | 4,4'-Oxybis[benzamide];4-(4-Carbamoylphenoxy)benzamide |
OU749 | 519170-13-9 | C16H15N3O3S2 | 361.4 | N-[5-(4-methoxybenzyl)-1,3,4-thiadiazol-2-yl]benzenesulfonamide |
OTX015 | 202590-98-5 | C25H22ClN5O2S | 492 | OTX-015; OTX 015 |
OTX008 | 928213-43-8 | OTX 008; OTX-008; PTX-008; calixarene 0118; N-(2-dimethylamino)ethyl)acetamidyl calix[4]arene | ||
OTS-514 | 1338540-63-8 | C21H20N2O2S | 364.46 | OTS514 |
OT-R antagonist 2 | 364071-16-9 | C28H29N3O4 | 471.54 | (4E)-N-[(2S)-2-Hydroxy-2-phenylethyl]-4-(methoxyimino)-1-[(2'-methyl-4-biphenylyl)carbonyl]-L-prolinamide; |
OT-R antagonist 1 | 364071-17-0 | C28H29N3O4 | 471.54 | (4Z)-N-[(2S)-2-Hydroxy-2-phenylethyl]-4-(methoxyimino)-1-[(2'-methyl-4-biphenylyl)carbonyl]-L-prolinamide |
o-Topolin-9-glucoside | 160299-96-7 | C18H21N5O6 | 403.39 | 6-(2-hydroxybenzylamino)-9-b-D-glucopyranosylpurine |
Otophylloside T | 1642306-14-6 | C48H70O18 | 935.073 | |
Otophylloside O | 1326583-08-7 | C56H84O20 | 1077.27 | |
Otophylloside F | 250217-73-3 | C48H76O16 | 909.12 | |
O-TOLUIDINE-D9 | 194423-47-7 | C7D9N | 116.21 | O-TOLUIDINE-D9; 1-Amino-2-methylbenzene-d9; 2-Amino-1-methylbenzene-d9; 2-Aminotoluene-d9; 2-Methyl-1-aminobenzene-d9; 2-Methylaniline-d9; 2-Methylbenzenamine-d9; 2-Methylphenylamine-d9 |
o-Toluenesulfonicacid | 88-20-0 | C7H8O3S | 172.20200 | |
Otilonium bromide | 26095-59-0 | C29H43BrN2O4 | 563.57 | Otilonium Bromide |
O-TERPHENYL (D14) | 5142-67-6 | C18D14 | 244.39 | O-TERPHENYL (D14) |
Otenabant HCl | 686347-12-6 | C22H18N4O2S3 | 466.6 | 1-(8-(2-chlorophenyl)-9-(4-chlorophenyl)-9H-purin-6-yl)-4-(ethylamino)piperidine-4-carboxamide hydrochloride; CP945598; CP-945598; CP 945598; CP945,598; CP-945,598; CP 945,598; Otenabant HCl |
Otenabant (CP-945,598) | 686344-29-6 | C25H25Cl2N7O | 510.423 | Otenabant; CP-945,598; CP-945598. |
Otamixaban | 193153-04-7 | C25H26N4O4 | 446.50 | XRP0673; XRP-0673; XRP 0673; Otamixaban; methyl (2R,3R)-2-[(3-carbamimidoylphenyl)methyl]-3-[[4-(1-oxidopyridin-1-ium-4-yl)benzoyl]amino]butanoate2-(3-carbamimidoylbenzyl)-3-(4-(1-oxypyridin-4-yl)benzoylamino)butyric acid methyl ester2-(R)-(3-carbamimidoy |
OSU-03012 | 1471979-81-3 | C26H19F3N4O | 460.46 | OSU-03012; AR-12; OSU 03012; OSU03012; PDK1 inhibitor AR-12; 2-amino-N-[4-[5-phenanthren-2-yl-3-(trifluoromethyl)pyrazol-1-yl]phenyl]acetamide |
OSU 6162 hydrochloride | 156907-84-5 | C15H23NO2S.HCl | 317.87 | (3S)-3-[3-(Methylsulfonyl)phenyl]-1-propylpiperidine hydrochloride |
OSU 03012 | 742112-33-0 | C26H19F3N4O | 460.46 | AR-12; OSU-03012; 2-amino-N-[4-[5-phenanthren-2-yl-3-(trifluoromethyl)pyrazol-1-yl]phenyl]acetamide |
Osthol hydrate | 69219-24-5 | C15H18O4 | 262.301 | 8-(3-Hydroxy-3-methylbutyl)-7-methoxy-2H-1-benzopyran-2-one |
Osthole | 484-12-8 | C15H16O3 | 244.29 | Osthol; 7-methoxy-8-(3-methylbut-2-en-1-yl)-2H-chromen-2-one |
Osilodrostat | 928134-65-0 | C13H10FN3 | 227.24 | 4-[(5R)-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl]-3-fluorobenzonitrile; LCI699 |
Ospemifene E-Isomer | 238089-02-6 | C24H23ClO2 | 378.9 | 2-[4-[(1E)-4-chloro-1,2-diphenyl-1-buten-1-yl]phenoxy]ethanol; 2-[4-[(1E)-4-chloro-1,2-diphenyl-1-butenyl]phenoxy]ethanol |
Osmundacetone | 37079-84-8 | C10H10O3 | 178.18 | 3,4-Dihydroxybenzalacetone; (E)-3,4-DIHYDROXYBENZYLIDENEACETONE; (E)-4-(3,4-dihydroxyphenyl)but-3-en-2-one |
OSMIUM CARBONYL | 15696-40-9 | C12O12Os3 | 906.81 | Dodecacarbonyl-triangulo-triosmium; Os3(CO)12; Osmium carbonyl (Os3(CO)12); Osmium dodecacarbonyl; DODECACARBONYLTRIOSMIUM; OSMIUM CARBONYL |
OSMI-1 | 1681056-61-0 | C28H25N3O6S2 | 563.6 | (2R)-N-(2-furylmethyl)-2-(2-methoxyphenyl)-2-{[(2-oxo-1,2-dihydroquinolin-6-yl)sulfonyl]amino}-N-(2-thienylmethyl)acetamide |
Osmanthuside B | 94492-23-6 | C29H36O13 | 592.59 | |
Osmanthus Absolute | 68917-05-5 | 0 | OSMANTHUS OIL, ABSOLUTE FROM OSMANTHUS F RAGRANS LOUR.; exOsmanthusfragrans; OSMANTHUSABSOULTE; Osmanthus oil from Osmanthus fragrans Lour.; Osmanthus Concrete; Osmanthus Absolute | |
OSI-930 | 728033-96-3 | C22H16F3N3O2S | 443.444 | OSI 930; OSI930 |
OSI-7904L | 139987-54-5 | C27H24N4O6 | 500.511 | GS7904L; GW1843; 1843U89; OVI-237 |
OSI-413 | 183365-34-6 | C21H22ClN3O4 | 415.87 | |
OSI-027 | 936890-98-1 | C21H22N6O3 | 406.446 | OSI-027 |
Oseltamivir-d3 | 1093851-61-6 | C16H25N2O4D3 | 315.43 | (3R,4R,5S)-4-(Acetylamino-d3)-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylic Acid Ethyl Ester; |
Oseltamivir | 196618-13-0 | C16H28N2O4 | 312.40 | (-)-Oseltamivir; Enfluvir; Ethyl (3R,4R,5S)-5-amino-4-acetamido-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate; GOP-A-Flu; GS 4104; Oseltamivir; Tamiflu-Free; Tamvir |
Oseltamivir Phosphate | 204255-11-8 | C16H31N2O8P | 410.40 | (3R,4R,5S)-4-(Acetylamino)-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylic Acid Ethyl Ester Phosphate; Oseltamir Phosphate; Ro 64-0796/002; Tamiflu |
Oseltamivir Methyl Ester HCl | 208720-78-9 | C15H26N2O4. HCl | 336.2 | (3R,4R,5S)-methyl 4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-enecarboxylate HCl; |
Oseltamivir Impurity G | 956267-10-0 | C16H28N2O4 | 312.41 | 4-N-Desacetyl-5-N-acetyl Oseltamivir; (3R,4R,5S)-5-(Acetylamino)-4-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylic Acid Ethyl Ester; |
Oseltamivir impurity F | 1052063-37-2 | C15H26N2O4 | 298.38 | 3-Des(1-ethylpropoxy)-3-(1-methylpropoxy) Oseltamivir; (3R,4R,5S)-4-(Acetylamino)-5-amino-3-(1-methylpropoxy)-1-cyclohexene-1-carboxylic Acid Ethyl Ester; |
Oseltamivir Impurity D | 1346604-18-9 | C11H13NO4 | 223.23 | 4-Acetylamino-3-hydroxybenzoic Acid Ethyl Ester; |
Oseltamivir Impurity A | 1391047-93-0 | C14H24N2O4 | 284.36 | 4-N-Desacetyl-5-N-acetyl Oseltamivir Acid; (3R,4R,5S)-5-(Acetylamino)-4-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylic Acid; Oseltamivir EP Impurity A; |
Oseltamivir HCl | 204255-09-4 | C16H28N2O4.HCl | 349.41 | (3R,4R,5S)-4-(Acetylamino)-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylic Acid Ethyl Ester Hydrochloride; Oseltamir Hydrochloride; Ro 64-0796/002; |
Oseltamivir Carboxylic Acid | 187227-45-8 | C14H24N2O4 | 284.35 | (3R,4R,5S)-4-acetamido-5-amino-3-pentan-3-yloxycyclohexene-1-carboxylic acid Oseltamivir acid Oseltamivir carboxylate 187227-45-8 Oseltamivir (acid) (3R,4R,5S)-4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylic acid |
Osanetant | 160492-56-8 | C35H41Cl2N3O2 | 606.62 | SR-142801; N-[1-[3-[(3R)-1-benzoyl-3-(3,4-dichlorophenyl)piperidin-3-yl]propyl]-4-phenylpiperidin-4-yl]-N-methylacetamide |
Orvepitant maleate | 579475-24-4 | C31H35F7N4O2.C4H4O4 | 744.7 | (2R,4S)-4-[(8aS)-6-oxo-1,3,4,7,8,8a-hexahydropyrrolo[1,2-a]pyrazin-2-yl]-N-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethyl]-2-(4-fluoro-2-methylphenyl)-N-methylpiperidine-1-carboxamide (Z)-but-2-enedioic acid |
Orvepitant | 579475-18-6 | C31H35F7N4O2 | 628.63 | (2R,4S)-4-[(8aS)-6-oxo-1,3,4,7,8,8a-hexahydropyrrolo[1,2-a]pyrazin-2-yl]-N-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethyl]-2-(4-fluoro-2-methylphenyl)-N-methylpiperidine-1-carboxamide;GW-823296;GW823296 |
Orthosulfamuron | 213464-77-8 | C16H20N6O6S | 424.44 | ORTHOSULFAMURON; 1-(4,6-Dimethoxypyrimidin-2-yl)-3-[2-(dimethylcarbamoyl)phenylsulfamoyl]urea; |
OrthosilicicAcid | 62647-18-1 | H4O4Si | 96.11486 | OrthosilicicAcid; Einecs 233-477-0; Silicic acid (ortho); Silicic acid (si(OH)4) |
Orteronel | 566939-85-3 | C18H17N3O2 | 307.353 | TAK-700 |
Ortataxel | 186348-23-2 | C44H57NO17 | 871.93 | Bay-59-8862, IDN-5109, SB-T-101131 |
Orsellinic acid | 480-64-8 | C8H8O4 | 168.15 | 2,4-dihydroxy-6-methylbenzoic acid |
ORRISOL | 76649-25-7 | C9H16O | 140.23 | (* Alt. CAS #) CAS: 56805-23-3; e,z-3,6-Nonadienol, 3,6-Nonadien-1-ol, 3,6-NONADIEN-1-OL BRI, 3,6-Nonadienol, e,z-3,6-Nonadienol, FEMA CAS: 56805-23-3, ORRISOL, trans,cis-3,6-Nonadienol |
Orphenadrine-d3 Citrate Salt | 1185011-75-9 | C18H20D3NO | 272.41 | N,N-Dimethyl-2-[(2-methylphenyl)phenylmethoxy]ethanamine-d3 Citrate Salt |
Orphenadrine Citrate | 4682-36-4 | C18H23NO.C6H8O7 | 461.5 | N,N-Dimethyl-2-[(2-methylphenyl)phenylmethoxy]ethanamine Citrate Salt; |
Orphenadrine | 83-98-7 | C18H23NO | 269.39 | N,N-Dimethyl-2-[(2-methylphenyl)phenylmethoxy]ethanamine; |
Orphanin FQ (1-11) | 178249-41-7 | C49H75N15O14 | 1098.2 | FGGFTGARKSA |
Oroxylin A 7-O-glucuronide | 36948-76-2 | C22H20O11 | 460.39 | Oroxyloside |
Oroxylin A 7-O-beta-D-glucuronide methyl ester | 82475-01-2 | C23H22O11 | 474.4 | Wogonin 7-O-beta-D-glucuronide methyl ester; Wogonoside methyl ester; 5-Hydroxy-6-methoxyflavone-7-yl beta-D-glucopyranosiduronic acid methyl ester |
Oroxin B | 114482-86-9 | C27H30O15 | Baicalein7-O-b-gentiobioside; Baicalein-7-O-diglucoside | |
Oroxin A | 31567-75-6 | C21H20O10 | 5,6-dihydroxyflavone-7-glucoside; baicalein-7-O-glucoside; Borepane, 1-ethyl-; B-Aethyl-boracycloheptan; 1-ethyl-borepane; | |
Orotidine 5'-monophosphate trisodium salt | 68244-58-6 | C10H10N2O11PNa3 | 434.14 | Orotidylic acid; OMP; 3-[3,4-dihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]-2,6-dioxopyrimidine-4-carboxylic acid,sodium; sodium 3-((2R,3R,4S,5R)-3,4-dihydroxy-5-(phosphonatooxymethyl)tetrahydrofuran-2-yl)-2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxylat |
Orotidine | 314-50-1 | C10H12N2O8 | 288.21 | 6-Carboxyuridine; 3-Ribofuranosylorotic acid; Uridin-6-carboxylic acid |
Orotic acid | 65-86-1 | C5H4N2O4 | 156.1 | UK-20349 |
Orobol | 480-23-9 | C15H10O6 | 286.2 | 3',4',5,7-TETRAHYDROXYISOFLAVONE |
Orobanchyl acetate | 1413843-71-6 | C21H24O7 | 388.416 | [(3E,3aS,4S,8bS)-8,8-dimethyl-3-[[(2R)-4-methyl-5-oxo-2H-furan-2-yl]oxymethylidene]-2-oxo-3a,4,5,6,7,8b-hexahydroindeno[1,2-b]furan-4-yl] acetate |
Ophiopogonoside A | 791849-22-4 | C21H38O8 | 418.52 | |
Ornidazole Related Compound | 31876-69-4 | C7H9N3O3 | 183.17 | 1-(2-Methyl-5-nitro-1H-imidazol-1-yl)acetone; |
Ornidazole Levo- | 166734-83-4 | C7H10ClN3O3 | 219.63 | (2S)-1-chloro-3-(2-methyl-5-nitroimidazol-1-yl)propan-2-ol Ornidazole (Levo-) NCGC00016723-01 CAS-16773-42-5 ZINC563 AC1O71N3 CHEMBL1742294 SCHEMBL15158378 |
Ornidazole Impurity B | 696-23-1 | C4H5N3O2 | 127.1 | 2-Methyl-4(5)-nitroimidazole; |
Ornidazole Impurity 1 | 1384752-15-1 | C7H8ClN3O2 | 201.61 | (E)-1-(3-chloroallyl)-2-methyl-5-nitro-1H-imidazole; |
Oprozomib | 935888-69-0 | C25H32N4O7S | 532.60918 | ONX0912; ONX-0912; ONX 0912; PR047; PR-047; PR 047. |
Orlistat | 96829-58-2 | C29H53NO5 | 495.745 | Ro 18-0647; Ro18-0647; Ro-18-0647; Ro 180647; Ro180647; Ro-180647; Ro 18-0647/002; Orlistat, Alli, Tetrahydrolipastatin, Tetrahydrolipstatin, THLP, Xenical |
Oritavancin | 171099-57-3 | C86H97Cl3N10O26 | ||
origanum oil | 8007-11-2 | 0 | thymus capitatis; ORIGANUM OIL; ORIGANUM OIL CRETIC; ORIGANUM OIL, SPANISH TYPE; OREGANO OIL; OIL, ORIGANUM; OIL OF ORIGANUM; Oils,origanum | |
Orientin-2''-O-p-trans-coumarate | 1229437-75-5 | C30H26O13 | 594.525 | [(2S,3R,4S,5S,6R)-2-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxochromen-8-yl]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl] (E)-3-(4-hydroxyphenyl)prop-2-enoate |
Orientin-2''-O-p-trans-coumarate | 73815-15-3 | C30H26O13 | 594.52 | Orientin 2''-O-p-trans-coumarate |
Orientin | 28608-75-5 | C21H20O11 | 448.38 | 8-b-D-Glucopyranosyl-3,4,7-tetrahydroxyflavone; Luteolin 8-C-b-D-glucopyranoside; Lutexin |
Orientanol A | 190381-82-9 | C21H24O7 | 388.4 | [6aS-[6aalpha,10(R*),11aalpha]]-10-(2,3-Dihydroxy-3-methylbutyl)-9-methoxy-6H-benzofuro[3,2-c][1]benzopyran-3,6a(11aH)-diol |
Oridonin | 28957-04-2 | C20H28O6 | 364.43 | Isodonol, Rubescenin |
Org30958 | 99957-90-1 | C21H30O2S2 | 378.59 | (8S,9S,10S,13S,14S)-10-[(ethyldisulfanyl)methyl]-13-methyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17-dione; 19-(ethyldithio)androst-4-ene-3,17-dione; ORG 30958; ORG-30958 |
ORG-27569 | 868273-06-7 | C24H28ClN3O | 409.95 | ORG-27569; ORG-27569; ORG-27569. |
Org OD 02-0 | 13258-85-0 | C22H30O2 | 326.47 | 19-Norpregn-4-ene-3,20-dione, 10-vinyl-; 10-Vinyl-19-norprogesterone |
Org 48762-0 | 755753-89-0 | C24H16F2N4 | 398.41 | 4,6-Bis(4-fluorophenyl)-2-methyl-5-(4-pyridyl)-2H-pyrazolo[3,4-b]pyridine; Org 48762-0; UR 13870 |
Org 37684 | 213007-95-5 | C14H19NO2.HCl | 269.77 | (3S)-3-[(2,3--Dihydro-5-methoxy-1H-inden-4-yl)oxy]pyrrolidine hydrochloride |
ORG 25935 hydrochloride | 949588-40-3 | C21H25NO3.HCl | 375.89 | SCH-900435; rel-N-Methyl-N-[[(1R,2S)-1,2,3,4-tetrahydro-6-methoxy-1-phenyl-2-naphthalenyl]methyl]glycine hydrochloride |
Org 25543 hydrochloride | 495076-64-7 | C24H32lN2O4.HCl | 448.98 | N-[[1-(Dimethylamino)cyclopentyl]methyl]-3,5-dimethoxy-4-(phenylmethoxy)benzamide hydrochloride |
Org 24598 lithium salt | 722456-08-8 | C19H19F3LiNO3 | 373.3 | N-Methyl-N-[(3R)-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propyl]-glycine lithium salt |
Org 24598 | 372198-97-5 | C19H20F3NO3 | 367.36 | N-Methyl-N-[(3R)-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propyl]-glycine |
Org 12962 hydrochloride | 210821-63-9 | C10H11ClF3N3.HCl | 302.12 | 1-[6-Chloro-5-trifluoromethyl)-2-pyridinyl]-piperazine hydrochloride |
Orfamide B | 939960-35-7 | C63H112N10O17 | 1281.6 | |
Orfamide A | 939960-34-6 | C64H114N10O17 | 1295.7 | |
Orexin B (mouse) | 202801-92-1 | C126H215N45O34S | 2936.43 | |
O-Propargyl-puromycin | 1416561-90-4 | C24H29N7O5 (free acid) | 495.53 (free acid) | |
Opipramol-d4 | 1215716-70-3 | C23H25D4N3O | 367.53 | 4-[3-(5H-Dibenz[b,f]azepin-5-yl)propyl]-1-piperazineethanol-d4; N-[3-[4-(2-Hydroxyethyl)piperazino]propyl]iminostilbene-d4 |
Opicapone | 923287-50-7 | C15H10Cl2N4O6 | 413.17 | BIA 9-1067 |
Ophiopogonin D' | 65604-80-0 | C44H70O16 | Diosgenin 3-O-[alpha-L-rhamnopyranosyl-(1-2)][beta-D-xylopyranosyl-(1-3)]-beta-D-glucopyranoside | |
Ophiopogonin C | 911819-08-4 | (3beta,25R)-14,17-Dihydroxyspirost-5-en-3-yl O-6-deoxy-alpha-L-mannopyranosyl-(1-2)-O-[beta-D-xylopyranosyl-(1-4)]-beta-D-glucopyranoside | ||
Ophiopogonin A | 11054-24-3 | C41H64O13 | 764.94 | b-D-Galactopyranoside |
Ophiopogonanone F | 588706-67-6 | C20H22O7 | 374.38 | 7,2'-Dihydroxy-5,8,4'-trimethoxy-6-methylhomoisoflavanone; 7-Hydroxy-5,8-dimethoxy-6-methyl-3-(2'-hydroxy-4'-methoxybenzyl)chroman-4-one |
Ophiopogonanone E | 588706-66-5 | C19H20O7 | 360.36 | RubiadinOphiopogonanone E; 5,7-Dihydroxy-3-[(2-hydroxy-4-methoxyphenyl)methyl]-8-methoxy-6-methyl-2,3-dihydrochromen-4-one |
Ophiopogonanone C | 477336-75-7 | C19H16O7 | 356.33 | (R)-Ophiopogonanone C;8-Formylophiopogonanone A; (R)-3-(benzo[d][1,3]dioxol-5-ylmethyl)-5,7-dihydroxy-6-methyl-4-oxochromane-8-carbaldehyde |
Ophiopogonanone A | 75239-63-3 | C18H16O6 | 328.32 | (-)-3-(1,3-Benzodioxol-5-ylmethyl)-2,3-dihydro-5,7-dihydroxy-6-methyl-4H-1-benzopyran-4-one |
Ophiobolin C | 19022-51-6 | C25H38O3 | 386.6 | Zizanin A |
Ophiobolin B | 5601-74-1 | C25H38O4 | 402.6 | Cochliobolin B, Zizanin B, Ophiobolsin A |
Ophiobolin A | 4611-05-6 | C25H36O4 | 400.6 | |
OPC-3930: 6-[3-(1-cyclohexyl-1H-tetrazol-5-yl)propoxy]-2(1H)-Quinolinone | 73963-46-9 | C19H23N5O2 | 353.42 | |
OPC 31260 hydrochloride | 138470-70-9 | C27H30ClN3O2 | 464.01 | N-(4-(5-(dimethylamino)-2,3,4,5-tetrahydro-1H-benzo[b]azepine-1-carbonyl)phenyl)-2-methylbenzamide hydrochloride;OPC31260; |
OPC 21268 | 131631-89-5 | C26H31N3O4 | 449.54 | N-[3-[4-[[4-(3,4-Dihydro-2-oxo-1(2H)quinolinyl)-1-piperidinyl]carbonyl]phenoxy]propyl]-acetamide |
OPC 14714 | 203395-84-0 | C23H28BrN3O2 | 0 | 7-[4-[4-(2-Bromophenyl)-1-piperazinyl]butoxy]-3,4-dihydro-2(1H)-quinolinone; OPC-14714 |
OPC 13463 | 73372-63-1 | C16H13N2O6- | 329.29 | 5-methoxycarbonyl-2,6-dimethyl-4-(2-nitrophenyl)pyridine-3-carboxylate;MP-2689 |
Opalmon | 88852-12-4 | |||
ONX-0914 | 960374-59-8 | C31H40N4O7 | 580.6719 | ONX 0914; ONX0914; PR-957; PR957; PR 957. |
ONT-093 | 216227-54-2 | C32H38N4O | 494.683 | OC144-093; OC-144-093 |
Ono-RS-347 | 103176-67-6 | C26H25N5O4 | 471.51 | 8-(4-(4-Phenylbutoxy)benzoyl)amino-2-(tetrazol-5'-yl)benzo-1,4-dioxane;4-(4-Phenylbutoxy)-N-[3-(2H-tetrazol-5-yl)-2,3-dihydro-1,4-benzodioxin-5-yl]benzamide;N-(3-(1H-tetrazol-5-yl)-2,3-dihydrobenzo[b][1,4]dioxin-5-yl)-4-(4-phenylbutoxy)benzamide |
ONO-RS-082 | 99754-06-0 | C21H22ClNO3 | 371.9 | 2-(4-amylcinnamoyl)amino-4-chlorobenzoic acid |
O-Nornuciferine | 3153-55-7 | C18H19NO2 | 281.35 | N-Methylasimilobine |
Ononetin | 487-49-0 | C15H14O4 | 258.27 | 1-(2,4-Dihydroxyphenyl)-2-(4-methoxyphenyl)ethanone |
ONO-DI 004 | 250605-97-1 | C24H38O6 | 422.55492;g/mol | ONO-DI-004; 4-[2-[(1R,2R,3R)-3-hydroxy-2-[(E,3S,5S)-3-hydroxy-5-methylnon-1-enyl]-5-oxocyclopentyl]acetyl]cyclohexane-1-carboxylicacid; AC1NSK98; GTPL1914; SCHEMBL1273561; 250605-97-1 |
ONO-AE3-208 | 402473-54-5 | C24H21FN2O3 | 404.43 | AE 3-208; ONO AE3 208; 4-Cyano-2-[[2-(4-fluoro-1-naphthalenyl)-1-oxopropyl]amino]benzenebutanoic acid; 4-[4-cyano-2-[2-(4-fluoronaphthalen-1-yl)propanoylamino]phenyl]butanoic acid |
ONO-8711 | 216158-34-8 | C22H30ClNO4S | 440 | ONO 8711; ONO8711; GTPL1920; (Z)-6-[(2R,3S)-3-[[(4-chloro-2-methylphenyl)sulfonylamino]methyl]-2-bicyclo[2.2.2]octanyl]hex-5-enoic acid |
Ondansetron Impurity I | 15128-52-6 | C12H11NO | 185.23 | 1,2,3,4-Tetrahydrocarbazol-4-one; |
ONO 8130 | 459841-96-4 | C25H28N2O5S2 | 500.63 | 4-[[[2,3-Dihydro-6-[(2-methylpropyl)[(4-methyl-2-thiazolyl)sulfonyl]amino]-1H-indene-5yl]oxy]methyl]benzoic acid |
ONO 4817 | 223472-31-9 | C22H28N2O6 | 416.47 | N-[(1S,3S)-1-[(Ethoxymethoxy)methyl]-4-(hydroxyamino)-3-methyl-4-oxobutyl]-4-phenoxybenzamide |
Ono 3403 | 181586-07-2 | C2H31N3O8S | 545.60 | (4-carbamimidoylphenyl) 4-[(E)-3-[(2-ethoxy-2-oxoethyl)-prop-2-enylamino]-2-methyl-3-oxoprop-1-enyl]benzoate;methanesulfonic acid; ethyl N-allyl-N-(2-methyl-3-(4-(4-amidinophenoxycarbonyl)phenyl)propenoyl)aminoacetate methanesulfonate; ONO 3403; ONO-3403 |
Onjixanthone II | 136083-93-7 | C15H12O7 | 304.254 | 1,3,6-Trihydroxy-2,7-dimethoxyxanthone; 1,3,6-trihydroxy-2,7-dimethoxyxanthen-9-one |
Onjisaponin Z | 1078708-72-1 | C71H106O32 | 1471.59 | |
Onjisaponin O | 1009314-38-8 | C77H116O37 | 1633.74 | |
Onjisaponin J | 873334-98-6 | C85H126O42 | 1819.9 | |
Onjisaponin B | 35906-36-6 | C75H112O35 | Senegin III; Sinegin 3 | |
Onjisaponin A | 82410-33-1 | C80H120O39 | 1705.8 | |
Onitisin 2'-O-glucoside | 62043-53-2 | C21H30O9 | 426.5 | Onitisin 2'-O-glucoside |
Onitisin | 53823-03-3 | C15H20O4 | 264.3 | Hydroxypterosin A |
Onitin 2'-O-glucoside | 76947-60-9 | C21H30O8 | 410.5 | Onitin 2'-O-glucoside |
Onitin | 53823-02-2 | C15H20O3 | 248.3 | 2,3-Dihydro-4-hydroxy-6-(2-hydroxyethyl)-2,2,5,7-tetramethyl-1H-inden-1-one;1H-Inden-1-one,2,3-dihydro-4-hydroxy-6-(2-hydroxyethyl)-2,2,5,7-tetraMethyl-; 4-hydroxy-6-(2-hydroxyethyl)-2,2,5,7-tetramethyl-3H-inden-1-one |
o-Nicotine | 23950-04-1 | C10H14N2 | 162.23 | 2-(1-Methyl-2-pyrrolidinyl)pyridine; ortho-Nicotine |
Ondansetron-d5 | 1219798-86-3 | C18H16N3OD5 | 300.42 | (±)-ONDANSETRON-D5 (METHYLIMIDAZOLE-D5); 1,2,3,9-Tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-one-d5; |
Ondansetron Impurity H | 99614-14-9 | C17H17N3O | 279.34 | N-Demethyl Ondansetron; 1,2,3,9-Tetrahydro-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-one; |
Ondansetron Impurity C | 27387-31-1 | C13H13NO | 199.25 | 1,2,3,9-Tetrahydro-9-methyl-4H-carbazol-4-one; 2,3-Dihydro-9-methylcarbazol-4(1H)-one; USP Ondansetron Related Compound C; |
Ondansetron Impurity B | 1076198-52-1 | C37H38N6O2 | 598.75 | 6,6'-Methylenebis[(3RS)-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-1,2,3,9-tetrahydro-4H-carbazol-4-one; |
Ondansetron Hydrochloride Dihydrate | 103639-04-9 | C18H19N3O.HCl.2H2O | 365.85 | Zofran; GR 38032F; Ondansetron (hydrochloride dihydrate) |
Ondansetron HCl | 99614-01-4 | C18H19N3O·HCl | 329.82 | GR 38032F; GR38032F; GR-38032F; |
Ondansetron 8-D-glucuronide (mixture of isomers) | 126671-72-5 | C24H27N3O8 | 485.49 | |
Ondansetron 7-D-glucuronide (mixture of isomers) | 126671-74-7 | |||
Ondansetron | 99614-02-5 | C18H19N3O | 293.36 | GR 38032F, GR-C507/75 |
ONC 201 | 1616632-77-9 | C24H26N4O | 386.499 | TIC 10; TIC10; ONC201; ONC 201; ONC-201; NSC350625; TRAIL-inducing compound 10 |
Onalespib | 912999-49-6 | C24H31N3O3 | 409.52 | Onalespib lactate; AT-13387 lactate; UNII-66226JUH2I; ATI-13387AU; ATI-13387A; AT13387; AT-13387; AT 13387. |
ON123300 | 1357470-29-1 | C24H27N7O | 429.52 | UNII-QJ8RO3296G; QJ8RO3296G; CHEMBL3115681; ON123300; SCHEMBL10050883; BDBM50447512 |
ON1231320 | 131247-39-8 | C22H15F2N5O3S | 467.45 | 2-((1H-indol-5-yl)amino)-6-((2,4-difluorophenyl)sulfonyl)-8-methylpyrido[2,3-d]pyrimidin-7(8H)-one; ON1231320; ON-1231320; ON 1231320; GBO-006; GBO006; GBO 006. |
ON-013100 | 865783-95-5 | C19H22O7S | 394.43 | (E)-5-(((2,4,6-Trimethoxystyryl)sulfonyl)methyl)-2-methoxyphenol; ON-013100; ON 013100; ON013100. |
ON 146040 | 1404231-34-0 | C24H23N7O3S | 489.55 | ON-146040; ON146040 |
Omipalisib | 1086062-66-9 | C25H17F2N5O3S | 505.5 | GSK-2126458; GSK2126458; GSK 2126458; Omipalisib |
Omidenepag | 1187451-41-7 | C23H22N6O4S | 478.53 | (6-((N-(4-(1H-pyrazol-1-yl)benzyl)pyridine-3-sulfonamido)methyl)pyridin-2-yl)glycine |
O-Methylviridicatin | 6152-51-4 | C16H13NO2 | 251.3 | AIDS-089094, 3-Methoxy-4-phenyl-1H-quinolin-2-one |
O-Methylviridicatin | 6152-57-4 | C16H13NO2 | 251.3 | AIDS-089094; 3-methoxy-4-phenyl-Carbostyril; Viridicatin methyl ester; 3-O-Methylviridicatin; 3-Methoxy-4-phenyl-1H-quinolin-2-one |
O-Methylsterigmatocystin | 17878-69-2 | C19H14O6 | 338.3 | |
O-Methylpallidine | 27510-33-4 | C20H23NO4 | 341.407 | Fissistigine C; Sebiferine |
o-Methylhydroxylamine | 67-62-9 | CH5NO | 47.0565 | |
O-Methyldauricine | 2202-17-7 | C39H46N2O6 | 638.79 | O,O-Dimethylcuspidaline; O,O-Dimethyldauricinoline |
O-methyl atovaquone | 129700-41-0 | C23H21ClO3 | 380.88 | Trans-2-[4-(4-Chlorophenyl)cyclohexyl]-3-methoxy-1,4-naphthalenedione; 2-((1r,4r)-4-(4-Chlorophenyl)cyclohexyl)-3-methoxynaphthalene-1,4-dione |
o-Methoxytopolin-9-glucoside | 1226978-27-7 | C19H23N5O6 | 417.42 | [6-(2-Methoxybenzylamino)-9-b-Dglucopyranosylpurine |
o-Methoxybenzyl bromide | 52289-93-7 | C8H9BrO | 201.06 | 1-(bromomethyl)-2-methoxybenzene; o-Methoxybenzylbromide; 2-Methoxy benzyl bromide; O-(bromomethyl)anisole |
o-Mesitylenesulfonylhydroxylamine | 36016-40-7 | C9H13NO3S | 215.27 | O-(MESITYLSULFONYL)HYDROXYLAMINE; O-mesitylenesulphonylhydroxylamine; O-Mesitylenesulfonylhydroxylamine; 2-[(Aminooxy)sulfonyl]-1,3,5-trimethylbenzene; O-(2,4,6-Trimethylphenyl)sulfonylhydroxylamine; N-hydroxy-2,4,6-trimethylbenzenesulfonamide |
o-Mercapto-N,N-dimethylbenzamide | 20877-02-5 | C9H11NOS | 181.255 g/mol | N,N-dimethyl-2-sulfanylbenzamide; o-Mercapto-N,N-dimethylbenzamide; 20877-02-5; n,n-dimethyl-2-sulfanylbenzamide; N,N-DIMETHYL-2-SULFANYL-BENZAMIDE; 2-mercapto-n,n-dimethylbenzamide |
Omeprazole-D3 Sulfone | 1189891-71-1 | C17H16D3N3O4S | 364.43 | 6-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfonyl]-1H-benzimidazole-d3; 2-[[(3,5-Dimethyl-4-methoxy-2-pyridyl)methyl]sulfonyl]-5-methoxybenzimidazole-d3; |
Omeprazole-d3 | 922731-01-9 | C17H16D3N3O3S | 348.43 | OMEP-d3; OMP-d3; OMZ-d3; 6-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole-4,5,7-d3 |
Oltipraz | 64224-21-1 | C8H6N2S3 | 226.33 | CD1400 |
Omeprazole-13C,D3 Sulfone | 1261393-28-5 | C1613CH16D3N3O4S | 365.43 | 6-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfonyl]-1H-benzimidazole-13c, d3; 2-[[(3,5-Dimethyl-4-methoxy-2-pyridyl)methyl]sulfonyl]-5-methoxybenzimidazole-13c, d3 |
Omeprazole-13C,D3 | 1261395-28-1 | C1613CH16D3N3O3S | 349.43 | 6-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole-13C,D3;5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole-13C,D3; ( - plusmn;)-Omeprazole-13C,D3; Antra-13C,D3; Gastrogard-13C,D3; Gastrol |
Omeprazole Sulfone N-Oxide | 158812-85-2 | C17H19N3O5S | 377.42 | 5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-1-oxido-2-pyridinyl)methyl]sulfonyl]- 1H-benzimidazole; Esomeprazole Impurity Impurity I; Omeprazole EP Impurity I; |
Omeprazole Sulfone | 88546-55-8 | C17H19N3O4S | 361.42 | 5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfonyl]- 1H-benzimidazol;6-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfonyl]-1H-benzimidazole;OMeprazole Related CoMpound A;Omeprazole sulfone;6-methoxy-2-[(4-methoxy-3,5-dimethylpy |
Omeprazole Sulfide (Ufiprazole) | 73590-85-9 | C17H19N3O2S | 329.42 | Esomeprazole related substance C; Omeprazole Sulfide;6-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]thio]-1H-benzimidazole; 2-[[(3,5-Dimethyl-4-methoxy-2-pyridyl)methyl]thio]-5-methoxybenzimidazole; Pyrmetazole; Ufiprazole; 2-{[(3,5-dimethyl-4-m |
Omeprazole sodium | 95510-70-6 | C17H18N3NaO3S | 367.4 | Sodium 5-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]benzimidazol-3-ide |
Omeprazole Related Compound 2 | 109371-19-9 | C9H13NO | 151.21 | 4-Methoxy-2, 3, 5-Trimethylpyridine; |
Omeprazole N-Oxide | 176219-04-8 | C17H19N3O4S | 361.42 | 6-Methoxy-2-[[(4-methoxy-3,5-dimethyl-1-oxido-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole; |
Omeprazole Impurity H | 863029-89-4 | C16H16ClN3O2S | 349.84 | 4-Desmethoxy-4-chloro Omeprazole; 2-[[(4-Chloro-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-5-methoxy-1H-benzimidazole; |
Omeprazole Impurity G | 125656-83-9 | C16H13N3O2S | 311.36 | 9-Methoxy-1,3-dimethyl-12-thioxopyrido[1',2':3,4]imidazo[1,2-a]benzimidazol-2-(12H)-one |
Omeprazole Impurity F | 125656-82-8 | C16H13N3O2S | 311.36 | 8-Methoxy-1,3-dimethyl-12-thioxopyrido[1',2':3,4]imidazo[1,2-a]benzimidazol-2-(12H)-one (Mixture of Regioisomers) |
Omeprazole Impurity B | 110374-16-8 | C16H17N3O2S | 315.4 | 4-Desmethoxy Omeprazole; 2-[(RS)-[(3,5-Dimethylpyridin-2-yl)methyl]sulphinyl]-5-Methoxy-1H-Benzimidazole; |
Omeprazole Impurity A (5-Methoxy-1H-Benzimidazole-2-Thiol) | 37052-78-1 | C8H8N2OS | 180.23 | 5-Methoxy-2-mercaptobenzimidazole; Esomeprazol EP Impurity A |
Omeprazole Impurity | 1227380-90-6 | C16H15N3O4 | 313.32 | 1,4-Dihydro-1-(5-methoxy-1H-benzimidazol-2-yl)-3,5-dimethyl-4-oxo-2-pyridinecarboxylic Acid; |
Omeprazole Acid Impurity | 120003-72-7 | C17H16N3O5S | 375.41 | 3-Pyridinecarboxylicacid, 4-methoxy-6-[[(6-methoxy-1H-benzimidazol-2-yl)sulfinyl]methyl]-5-methyl-; |
Omeprazole 4'-O-Demethyl Impurity | 301669-82-9 | C16H17N3O3S | 331.4 | 4-Hydroxy Omeprazole; 2-[[(5-Methoxy-1H-benzimidazol-2-yl)sulfinyl]methyl]-3,5-dimethyl-4-pyridinol; |
Omeprazole | 73590-58-6 | C17H19N3O3S | 345.42 | OPC-13013; OPC 13013; OPC13013; Losec; Prilosec; Antra; Omeprazon |
OMEGA-TRANSAMINASE VF, VIBRIO FLUVIALIS, RECOMBINANT | 9030-47-1 | |||
omega-3 Arachidonic Acid ethyl ester | 123940-93-2 | C22H36O2 | 332.5 | |
Omecamtiv mecarbil | 873697-71-3 | C20H24FN5O3 | 401.43 | CK-1827452 |
OMDM-2 | 616884-63-0 | C27H45NO3 | 431.66 | (9Z)-N-[1-((R)-4-Hydroxbenzyl)-2-hydroxyethyl]-9-octadecenamide |
Omapatrilat | 167305-00-2 | C19H24N2O4S2 | 408.53 | Omapatrilat; BMS-186716; Vanlev; Bms 186716; UNII-36NLI90E7T; CHEMBL289556; (4S,7S,10aS)-5-oxo-4-[[(2S)-3-phenyl-2-sulfanylpropanoyl]amino]-2,3,4,7,8,9,10,10a-octahydropyrido[2,1-b][1,3]thiazepine-7-carboxylic acid |
OMALIZUMAB | 242138-07-4 | 0 | OMALIZUMAB | |
Omadacycline tosylate | 1075240-43-5 | C36H48N4O10S | 728.85 | |
Omadacycline mesylate | 1196800-40-4 | C30H44N4O10S | 652.76 | PTK 0796 mesylate; PTK-0796 mesylate; PTK0796 mesylate; Amadacycline mesylate |
Omadacycline hydrochloride | 1196800-39-1 | C29H40N4O7.HCl | 593.11 | (4S,4aS,5aR,12aR)-4,7-bis(dimethylamino)-9-[(2,2-dimethylpropylamino)methyl]-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide;hydrochloride; Omadacycline (hydrochloride) |
Omadacycline | 389139-89-3 | C29H40N4O7 | 556.65 | PTK 0796; Amadacycline |
Omaciclovir | 124265-89-0 | C10H15N5O3 | 253.26 | 2-HMHBG; UNII-C9H909GLI3; Omaciclovir [USAN:INN]; C9H909GLI3; H 2G;2-amino-9-[(2R)-4-hydroxy-2-(hydroxymethyl)butyl]-3H-purin-6-one |
OM99-2 | 314266-76-7 | C41H64N8O14 | 892.99 | OM99-2; H-GLU-VAL-ASN-[(2R,4S,5S)-5-AMINO-4-HYDROXY-2,7-DIMETHYL-OCTANOYL]-ALA-GLU-PHE-OH; EVNL-PSI-AAEF; GLU-VAL-ASN-(2R,4S,5S)-5-AMINO-*4-HYDROXY-2,7-DIMET; [2-AMINOBENZOYL-GLY1]-GALANIN FRAGMENT (1-10)-LYS(RETRO-M-NITRO-TYR) AMIDE HUMAN; [2-aminobenzoy |
OM-137 | 292170-13-9 | C13H14N4O3S | 306.34 | OM-137; OM137; OM 137 |
Olvanil | 58493-49-5 | C26H43NO3 | 417.63 | N-Vanillyloleoylamide |
Olumacostat glasaretil | 1261491-89-7 | C26H43NO7 | 481.63 | 2-((2-ethoxy-2-oxoethyl)(methyl)amino)-2-oxoethyl 5-(tetradecyloxy)furan-2-carboxylate |
Olsalazine Sodium | 6054-98-4 | C14H8N2O6.2Na | 346.2 | |
Olsalazine | 15722-48-2 | C14H10N2O6 | 302.24 | OLSALAZINE;3,3'-azobis(6-hydroxy-benzoicaci;3,3'-azobis(6-hydroxybenzoicacid);5,5'-azobis(salicylicacid);azodisal;c.i.mordantyellow5;Ph-CJ-91B;4,4'-Dihydroxyazobenzene-3,3'-dicarboxylic acid |
Olprinone Hydrochloride | 119615-63-3 | C14H11ClN4O | 286.72 | 1,2-Dihydro-5-(imidazo[1,2-a]pyridin-6-yl)-6-methyl-2-oxo-3-pyridinecarbonitrile hydrochloride, Loprinone hydrochloride |
Olprinone | 106730-54-5 | C14H10N4O | 250.26 | |
Olpadronate sodium | 63132-39-8 | C5H15NO7P2 | 263.121 | Olpadronate Sodium; Olpadronate; Olpadronic; olpadronic acid |
Olmesartan Methyl Ketone | 1227626-45-0 | C25H28N6O2 | 444.54 | Olmesartan Methyl Ketone; 1-[4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazol-5-yl]ethanone; |
Olopatadine-d3 N-Oxide | 1246832-94-9 | C21H20NO4D3 | 356.44 | 11-[3-(Dimethyloxidoamino-d3)propylidene]-6,11-dihydrodibenz[b,e]oxepin-2-acetic Acid |
Olopatadine-d3 HCl | 1331635-21-2 | C21H20NO3D3·HCl | 376.9 | (11Z)-11-[3-(Dimethyl-d3-amino)propylidene]-6,11-dihydrodibenz[b,e]oxepin-2-acetic Acid Hydrochloride |
Olopatadine N-Oxide | 203188-31-2 | C21H23NO4 | 353.42 | 11-[3-(Dimethyloxidoamino)propylidene]-6,11-dihydrodibenz[b,e]oxepin-2-acetic Acid; |
Olopatadine hydrochloride | 140462-76-6 | C21H23NO3.HCl | 373.88 | Pataday; Allelock; 2-[(11Z)-11-[3-(dimethylamino)propylidene]-6H-benzo[c][1]benzoxepin-2-yl]acetic acid hydrochloride |
Olopatadine Acetaldehyde | 1376615-97-2 | C21H23NO2 | 321.42 | 2-[(11Z)-11-[3-(dimethylamino)propylidene]-6H-benzo[c][1]benzoxepin-2-yl]acetaldehyde; |
Olopatadine | 113806-05-6 | C21H23NO3 | 337.41 | (Z)-11-[3-(Dimethylamino)propylidene]-6,11-dihydrodibenz[b,e]oxepin-2-acetic Acid; 11-[(Z)-3-(Dimethylamino)propylidene]-6,11-dihydrodibenz[b,e]oxepin-2-acetic Acid; Opatanol; Pataday; Patanol; KW-4679, KW-4943A |
Olomoucine | 101622-51-9 | C15H18N6O | 298.35 | Olomoucine |
Olodaterol Hydrochloride | 869477-96-3 | C21H27ClN2O5 | 422.91 | (R)-6-hydroxy-8-(1-hydroxy-2-((1-(4-methoxyphenyl)-2-methylpropan-2-yl)amino)ethyl)-2H-benzo[b][1,4]oxazin-3(4H)-one hydrochloride; Olodaterol hydrochloride; Olodaterol HCl; BI-1744; BI 1744; BI1744; Olodaterol; Striverdi |
Olmutinib | 1353550-13-6 | C26H26N6O2S | 486.18 | N-(3-((2-((4-(4-methylpiperazin-1-yl)phenyl)amino)thieno[3,2-d]pyrimidin-4-yl)oxy)phenyl)acrylamide; HM61713; HM 61713; HM-61713; BI 1482694; BI-1482694; BI1482694; Olmutinib |
Olmesartan-d6 Acid | 1185144-74-4 | C24H20D6N6O3 | 452.54 | 4-(1-Hydroxy-1-methylethyl-d6)-2-propyl-1-[[2'-(1H-tetazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic Acid; CS 088-d6; RNH 6270-d6; |
Olmesartan-D4 | 1420880-41-6 | C24H22D4N6O3 | 450.53 | 4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2 - rsquo;-(1H-tetazol-5-yl)[1,1 - rsquo;-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic Acid-d4; CS 088-d4; RNH 6270-d4; |
Olmesartan Methyl Ester | 1347262-29-6 | C25H28N6O3 | 460.54 | 4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic Acid Methyl Ester; |
Olmesartan Medoxomil-d6 | 1127298-67-2 | C29H24N6O6D6 | 564.64 | 4-[1-Hydroxy-1-(methylethyl-d6)]-2-propyl-1-[[2'-(1H-tetazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic Acid (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl Ester |
Olmesartan Medoxomil Related Compound A | 849206-43-5 | C24H24N6O2 | 428.5 | Olmesartan Lactone Impurity; 3,6-Dihydro-6,6-dimethyl-2-propyl-3-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-4H-Furo[3,4-d]imidazol-4-one; Olmesartan EP Impurity B; |
Olmesartan Medoxomil Methyl Ether Impurity | 896419-17-3 | C30H32N6O6 | 572.63 | 4-(1-Methoxy-1-methylethyl)-2-propyl-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic Acid (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl Ester; |
Olmesartan Medoxomil Impurity C (Dehydro Impurity) | 879562-26-2 | C29H28N6O5 | 540.58 | Dehydro Olmesartan Medoxomil; 4-(1-Methylethenyl)-2-propyl-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic Acid (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl Ester; Olmesartan EP Impurity C; |
Olmesartan Medoxomil Impurity 4 | 95579-71-8 | C5H5ClO3 | 148.55 | 4-Chloro-4-methyl-5-methylene-1,3-dioxolan-2-one; |
Olmesartan Medoxomil Impurity 3 | 1092980-84-1 | C13H22N2O3 | 254.33 | 4-(1-Methoxy-1-methylethyl)-2-propyl-1H-imidazole-5-carboxylic Acid Ethyl Ester; Ethyl 4-(1-Methoxy-1-methylethyl)-2-propyl-1H-imidazole-5-carboxylate; |
Olmesartan Medoxomil Impurity 1 | 1392475-91-0 | C34H34N6O9 | 670.68 | (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(2-hydroxypropan-2-yl)-1-((2'-(1-((5-methyl-2-oxo-1,3-dioxol-4-yl)methyl)-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-propyl-1H-imidazole-5-carboxylate; |
Olmesartan Medoxomil Ethyl Methyl Analog | 1378863-74-1 | C30H32N6O6 | 572.63 | 4-(1-Hydroxy-1-methylpropyl)-2-propyl-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic Acid (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl Ester; |
Olmesartan medoxomil Butyl Impurity | 144689-78-1 | C30H32N6O6 | 572.63 | 2-Butyl-4-(1-hydroxy-1-methylethyl)-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic Acid (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl Ester; |
Olmesartan medoxomil | 144689-63-4 | C29H30N6O6 | 558.59 | Olmesartan medoxomil; CS 866; CS-866; Olmetec; Olsertain; Azor; Benicar; |
Olmesartan Impurity (N-(Triphenylmethyl)-5-(4'-bromomethylbiphenylyl)tetrazole) | 124750-51-2 | C33H25BrN4 | 557.498 | 5-(4'-(BROMOMETHYL)(1,1'-BIPHENYL)-2-YL)-1-TRITYL-1H-TETRAAZOLE |
Olmesartan Impurity (Ethyl 4-(1-Hydroxy-1-methylethyl)-2- Propyl-Imidazole-5-Carboxylate) | 144689-93-0 | C12H20N2O3 | 240.3 | 4-(1-Hydroxy-1-methylethyl)-2-propyl-1H-imidazole-5-carboxylic Acid Ethyl Ester; 2-Propyl-5-(1-hydroxy-1-methylethyl)-3H-imidazole-4-carboxylic Acid Ethyl Ester; Ethyl 4-(1-Hydroxy-1-methylethyl)-2-propyl-1H-imidazole-5-carboxylate; |
Olmesartan Ethyl Ester Trityl Impurity | 144690-33-5 | C45H44N6O3 | 716.89 | ethyl 5-(1-hydroxy-1-methylethyl)-2-propyl-3-[2'-(1-trityl-1H-tetrazol-5-yl)biphenyl-4-ylmethyl]-3H-imidazole-4-carboxylate; |
Olmesartan Ethyl Ester Impurity | 144689-23-6 | C26H30N6O3 | 474.57 | ethyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2'-[2-(triphenylmethyl)-2H-tetrazol-5-yl]biphenyl-4-yl]methyl]imidazole-5-carboxylate; |
Olmesartan Dimer Ester Impurity | 1040250-19-8 | C48H50N12O5 | 875.01 | OlMesartan DiMer Ester Impurity; 4-{2-[4-(2-hydroxypropan-2-yl)-2-propyl-1-({4-[2-(1H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1H-imidazole-5-carbonyloxy]propan-2-yl}-2-propyl-1-({4-[2-(1H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1H-imidazole-5-carb |
Olmesartan acid O-b-D-glucuronide | 369395-57-3 | C30H34N6O9 | 622.63 | |
Olmesartan | 144689-24-7 | C24H26N6O3 | 450.54 | Benicar; Olmetec; Votum; RNH-6270; RNH6270; RNH 6270; CS-866; CS866; CS 866; Olmesartan; 5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylic acid 4-(hydroxy-1-methylethyl)-2-propyl-1-((2'-(1H-tetrazol-5 |
Olivil monoacetate | 1016974-78-9 | C22H26O8 | 418.44 | 9-O-Acetylolivil, 1-O-Acetyl-2,6-dideoxy-D-arabino-hexopyranose |
Olivil 4'-O-glucoside | 76880-93-8 | C26H34O12 | 538.54 | (2S,3R,4S,5S,6R)-2-[4-[[(3S,4R,5S)-3-hydroxy-5-(4-hydroxy-3-methoxyphenyl)-4-(hydroxymethyl)oxolan-3-yl]methyl]-2-methoxyphenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol |
Olive Oil | 8001-25-0 | |||
Oleoyl serotonin | 1002100-44-8 | C28H44N2O2 | 440.7 | (9Z)-N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]octadec-9-enamide; N-(2-(5-Hydroxy-1H-indol-3-yl)ethyl)-9Z-octadecenamide |
Oleoyl-L-carnitine | 38677-66-6 | C25H47NO4 | 425.65 | C18:1 Carnitine; L-Carnitine oleoyl ester; L-Oleoylcarnitine; (3R)-3-[(Z)-octadec-9-enoyl]oxy-4-(trimethylazaniumyl)butanoate |
Oleoyl serinol | 72809-08-6 | C21H41NO3 | 355.6 | N-Oleoyl serinol; S-18; (Z)-N-(1,3-dihydroxypropan-2-yl)octadec-9-enamide |
Oleoyl oxazolopyridine | 288862-58-8 | C24H36N2O2 | 384.6 | CAY10400; (Z)-1-([1,3]oxazolo[4,5-b]pyridin-2-yl)octadec-9-en-1-one |
Oleoyl ethyl amide | 85075-82-7 | C20H39NO | 309.5 | OEtA; N-Ethyloleamide; (1Z)-N-Ethyloctadec-9-enimidate |
Oleoyl coenzyme A | 1716-06-9 | C39H68N7O17P3S | 1031.98 | cis-9-Octadecenoyl coenzyme A; oleoyl-CoA; cis-9-Octadecenoyl-CoA; S-octadec-9c-enoyl-coenzyme-A; Oleyl-CoA; |
Oleoyl 3-carbacyclic phosphatidic acid | 779333-58-3 | C22H41O5P | 416.5 | 3-ccPA 18:1; (2-Hydroxy-2-oxo-1,2lambda5-oxaphospholan-5-yl)methyl (Z)-octadec-9-enoate |
Oleoresin Paprika | 68917-78-2 | 0 | Oleoresin Paprika; Paprika oleoresin | |
Oleonuezhenide | 112693-21-7 | C48H64O27 | 1073 | methyl (5E,6S)-5-ethylidene-4-[2-[[(2R,3S,4S,5R,6R)-5-[2-[(2S,3E)-3-ethylidene-5-methoxycarbonyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4H-pyran-4-yl]acetyl]oxy-3,4-dihydroxy-6-[2-(4-hydroxyphenyl)ethoxy]oxan-2-yl]methoxy]-2-o |
Oleonitrile | 112-91-4 | C18H33N | ||
OLEIC-13C18 ACID 99 ATOM % 13C | 312623-86-2 | C18H34O2 | 300.62336 | |
Oleic acid-2,6-diisopropylanilide | 140112-65-8 | C30H51NO | 441.7 | (Z)-N-(2,6-Diisopropylphenyl)-9-octadecenamide |
Oleic acid-13C | 82005-44-5 | 13CC17H34O2 | 283.467 | (Z)-9-Octadecenoic Acid-13C; 9| currency-cis-Octadecenoic Acid-13C |
Oleaside A | 69686-84-6 | C30H44O7 | 516.7 | |
Oleanonic acid | 17990-42-0 | C30H46O3 | 454.695 | |
Oleanolic acid acrylate | 1975976-24-9 | C33H50O4 | 510.75 | |
Oleanolic acid | 508-02-1 | C30H48O3 | 456.7 | Caryophyllin |
Oleandrin | 465-16-7 | C32H48O9 | 576.72 | (3b,5b,16b)-16-(Acetyloxy)-3-[(2,6-dideoxy-3-O-methyl-a-L-arabino-hexopyranosyl)oxy]-14-hydroxycard-20(22)-enolide; Neriolin; Corrigen |
Oleandomycin triacetate | 2751-09-9 | |||
Oleandomycin Phosphate | 7060-74-4 | C35H64NO16P | 687.87 | 1,9-Dioxaspiro[2.13]hexadecane Oleandomycin Derivative; Matromycin |
Oleandomycin | 3922-90-5 | C35H61NO12 | 687.9 | Amimycin, Matromycin, PA 105 |
Olanzapine glucuronide | 186792-80-3 | C23H28N4O6S | 488.56 | OLANZAPINE GLUCURONIDE; 1-Deoxy-1-[2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepin-10-yl]-b-D-glucopyranuronic Acid; Olanzapine-b-D-glucuronide; 1-Deoxy-1-[2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepin-10- |
Olanzapine | 132539-06-1 | C17H20N4S | 312.43975 | LY170053 |
Olanexidine hydrochloride semihydrate | 218282-71-4 | C17H29Cl3N5O1/2 | 417.8 | OPB-2045; OPB-2045G; 1-[N'-[(3,4-dichlorophenyl)methyl]carbamimidoyl]-2-octylguanidine hydrate dihydrochloride |
Olamufloxacin | 167887-97-0 | C20H23FN4O3 | 386.43 | olamufloxacin; (s)-(-)-5-amino-7-(7-amino-5-azaspiro[2,4]hept-5-yl)-1-cyclopropyl-6-fluoro-1,4-dihydro-8-methyl-4-oxoquinoline-3-carboxylic acid; (s)-(-)-5-amino-7-(7-amino-5-azaspiro[2,4]hept-5-yl)-1-cyclopropyl-6-fluoro-1,4-dihydro-8-methyl-4-oxoquinoli |
Olaflur | 6818-37-7 | C27H60F2N2O3 | 498.77 | 2,2'-((3-((2-hydroxyethyl)octadecylamino)propyl)imino)bis-ethanodihydrof; 2,2'-((3-(n-(2-hydroxyethyl)-n-octadecylamino)propyl)imino)di-ethanodihydr; aminefluoride297; bis-hydroxyaethylaminopropyl-hydroxyaethyl-octadecylamindihydrofluorid; c-27-aminefluor |
OL135 | 681135-77-3 | C21H22N2O2 | 334.42 | OL-135;1-Oxo-1-[5-(2-pyridyl)oxazol-2-yl]-7-phenylheptane;7-Phenyl-1-[5-(2-pyridinyl)-2-oxazolyl]-1-heptanone;7-Phenyl-1-[5-(pyridin-2-yl)-1,3-oxazol-2-yl]heptan-1-one |
Okanin | 484-76-4 | C15H12O6 | 288.25 | OKANIN; 2',3',4',3,4,-PENTAHYDROXYCHALCONE; (E)-3-(3,4-Dihydroxyphenyl)-1-(2,3,4-trihydroxyphenyl)-2-propen-1-one; 2',3,3',4,4'-Pentahydroxychalcone |
Okadaic acid potassium salt | 209266-79-5 | C44H68O13.K | 843 | potassium;(2R)-3-[(2S,6R,8S,11R)-2-[(E,2R)-4-[(2S,2'R,4R,4aS,6R,8aR)-4-hydroxy-2-[(1S,3S)-1-hydroxy-3-[(2S,3R,6S)-3-methyl-1,7-dioxaspiro[5.5]undecan-2-yl]butyl]-3-methylidenespiro[4a,7,8,8a-tetrahydro-4H-pyrano[3,2-b]pyran-6,5'-oxolane]-2'-yl]but-3-en-2- |
OK-1035 | 98293-88-0 | C12H9N5O | 239.233 | OK-1035; OK 1035; OK1035. |
O-Isobutyl Phenol | 4167-75-3 | C10H14O | 150.21756;g/mol | 2-(2-methylpropyl)phenol; 2-Isobutylphenol; Isobutylphenol; o-Isobutylphenol; 2-(2-Methylpropyl)phenol; 4167-75-3 |
Oils, sesame | 8008-74-0 | gingillioil; oils,glyceridic,sesame; Oils,sesame; sesame; sextra; BENNE OIL; SESAME OIL; SESAME OIL, TOASTED | ||
Oils, cherry laurel | 8000-44-0 | |||
OIL YELLOW OB | 131-79-3 | C17H15N3 | 261.32 | 1-((2-methylphenyl)azo)-2-naphthalenamine; 1-(2-methylphenyl)azo-2-naphthalenamine; 1-(2-methylphenyl)azo-2-naphthylamine; 1-(2-o-tolylazo)-2-naphthylamine; 1-(o-tolylazo)-2-naphthylamin; 1-(o-tolylazo)-2-naphthylamine |
OICR 9429 | 1801787-56-3 | C29H32F3N5O3 | 555.59 | N-[2-(4-Methylpiperazin-1-yl)-5-[3-(morpholin-4-ylmethyl)phenyl]phenyl]-6-oxo-4-(trifluoromethyl)-1,6-dihydropyridine-3-carboxamide |
o-Hydroxycinnamaldehyde | 60125-23-7 | C9H8O2 | 148.2 | 3-(2-Hydroxyphenyl)acrylaldehyde; (E)-2-HYDROXYCINNAMALDEHYDE |
OH-EPCP | 62893-24-7 | C15H17N3O6 | 335.31 | |
Ohchinin acetate | 67023-81-8 | C38H44O9 | 644.8 | |
Ohchinin | 67023-80-7 | C36H42O8 | 602.73 | N2 -[(4,6-Dimethoxy-2-naphthyl)sulfonyl]-L-arginyl-N-cyclohexylglycine. |
OGT2378 | 441061-33-2 | C11H23NO4 | 233.305 | OGT2378; OGT-2378; OGT 2378 |
OGT 2115 | 853929-59-6 | C24H16BrFN2O4 | 495.3 | 2-[4-[[3-(4-Bromophenyl)-1-oxo-2-propenyl]amino]-3-fluorophenyl]-5-benzoxazoleacetic acid |
O-Glycidyl-O'-methylpolyethyleneglycol 5,000 | 40349-67-5 | C9H18O5 | ||
Oglufanide disodium | 122933-59-9 | C16H19N3O5 | 333.344 | NSC 334073; Oglufanide; Thymogen; Timogen; IM 862. |
Oglufanide | 38101-59-6 | C16H19N3O5 | 333.34 | Oglufanide; alpha-Glutamyltryptophan; L-a-Glutamyl-L-tryptophan; (4S)-4-amino-5-[[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]amino]-5-oxopentanoic acid; |
Oglemilast | 778576-62-8 | C20H13Cl2F2N3O5S | 516.3 | GRC 3886 |
OG-L002 hydrochloride | 1357298-75-9 | C15H15NO.HCl | 261.75 | OG-L002 HCl; 4-[(1R,2S)-2-Aminocyclopropyl]-[1,1-biphenyl]-3-ol Hydrochloride |
OG-L002 | 1357302-64-7 | C15H15NO | 225.29 | N/A |
Ogerin | 1309198-71-7 | C17H17N5O | 307.35 | 2-[4-Amino-6-[(phenylmethyl)amino]-1,3,5-triazin-2-yl]benzenemethanol |
O-Geranylconiferyl alcohol | 129350-09-0 | C20H28O3 | 316.4 | (2E)-3-[4-[[(2E)-3,7-Dimethyl-2,6-octadien-1-yl]oxy]-3-methoxyphenyl]-2-propen-1-ol;3-(4-((3,7-DiMethylocta-2,6-dien-1-yl)oxy)-3-Methoxyphenyl)prop-2-en-1-ol;Conifegrol |
O-DESMETHYL-CIS-TRAMADOL HCl (D6) | 1261393-87-6 | C15H17D6NO2·HCl | 291.8 | rel-3-[(1R,2R)-2-[(dimethyl-d3 amino)methyl]-1-hydroxycyclohexyl]-phenol, monohydrochloride |
O-Desmethylastemizole | 73736-50-2 | C27H29FN4O | 444.56 | 4-[2-[4-[[1-[(4-Fluorophenyl)methyl]-1H-benzimidazol-2-yl]amino]-1-piperidinyl]ethyl]phenol; Desmethylastemizole; |
O-Desmethyl-(+)-cis-Tramadol HCl | 148262-77-5 | C15H24ClNO2 | 285.81 | (+)-(1R,2R)-O-DESMETHYL TRAMADOL HCL;(+)-O-Desmethyl Tramadol hydrochloride;O-Desmethyl-cis-tramadol hydrochloride solution;3-[(1R,2R)-2-[(Dimethylamino)methyl]-1-hydroxycyclohexyl]phenol Hydrochloride;(1R-cis)-3-[2-[(Dimethylamino)methyl]-1-hydroxycycloh |
O-Desmethyl-(-)-cis-Tramadol HCl | 148218-19-3 | C15H24ClNO2 | 285.81 | 3-[(1S,2S)-2-[(Dimethylamino)methyl]-1-hydroxycyclohexyl]phenol Hydrochloride; (1S-cis)-3-[2-[(Dimethylamino)methyl]-1-hydroxycyclohexyl]phenol Hydrochloride |
O-Desmethyl Venlafaxine Glucuronide (Mixture of Isomers) | 1021933-98-1 | C22H33NO8 | 439.50 | 4-[2-(Dimethylamino)-1-(1-hydroxycyclohexyl)ethyl]phenol glucuronide; 4-[2-(Dimethylamino)-1-(1-hydroxycyclohexyl)ethyl]phenylb-D-glucopyranosiduronic acid |
O-Desmethyl Venlafaxine Cyclic Impurity | 1346601-55-5 | C16H23NO2 | 261.37 | 5-(4-Hydroxyphenyl)-3-methyl-1-oxa-3-azaspiro[5.5]undecane; 4-(3-Methyl-1-oxa-3-azaspiro[5.5]undecanyl)phenol |
O-Desmethyl Vandetanib | 910298-60-1 | C21H22BrFN4O2 | 461.34 | 4-[(4-Bromo-2-fluorophenyl)amino]-7-[(1-methyl-4-piperidinyl)methoxy]-6-quinazolinol |
O-Desmethyl Urapidil | 91453-03-1 | C19H27N5O3 | 373.46 | 6-[[3-[4-(2-Hydroxyphenyl)-1-piperazinyl]propyl]amino]-1,3-dimethyl-2,4(1H,3H)-pyrimidinedione |
O-Desmethyl Pantoprazole O-Sulfate | 1189856-53-8 | C15H13F2N3O7S2 | 449.41 | 2-[[[6-(Difluoromethoxy)-1H-benzimidazol-2-yl]sulfinyl]methyl]-3-methoxy-4-pyridinol 4-(Hydrogen Sulfate) |
O-Desmethyl Metoclopramide Hydrochloride | 38059-78-8 | C13H21Cl2N3O2 | 322.23 | 4-Amino-5-chloro-N-[2-(diethylamino)ethyl]-2-hydroxy-benzamide Hydrochloride |
O-Desmethyl Gefitinib | 847949-49-9 | C21H22ClFN4O3 | 432.89 | 7-Quinazolinol, 4-[(3-Chloro-4-Fluorophenyl)Amino]-6-[3-(4-Morpholinyl)Propoxy]-; 4-[(3-Chloro-4-Fluorophenyl)Amino]-6-[3-(4-Morpholinyl)Propoxy]-7-Quinazolinol; M523595 |
O-desmethyl Mebeverine alcohol hydrochloride | 856620-39-8 | C15H26ClNO2 | 287.83 | 4-[2-[ethyl(4-hydroxybutyl)amino]propyl]phenol;hydrochloride; O-desmethyl Mebeverine alcohol (hydrochloride) |
O-Desmethyl Mebeverine Acid | 586357-02-0 | C15H23NO3 | 265.35 | 4-[Ethyl[2-(4-hydroxyphenyl)-1-methylethyl]amino]butanoic Acid |
O-Desmethyl Ivabradine | 304462-60-0 | C26H34N2O5 | 454.57 | 3-[3-[[[(7S)-3,4-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl]methylamino]propyl]-1,3,4,5-tetrahydro-7-hydroxy-8-methoxy-H-3-benzazepin-2-one; 7-Demethyl Ivabradine |
O-Desmethyl Indomethacin | 2504-32-7 | C18H14ClNO4 | 343.77 | 1-(4-Chlorobenzoyl)-5-hydroxy-2-methyl-1H-indole-3-acetic Acid; 5-Hydroxyindomethacin; Demethylindomethacin; Desmethylindomethacin; |
O-Desmethyl galanthamine b-D-glucuronide | 464189-54-6 | C22H27NO9 | 449.45 | (4aS,6R,8aS)-4a,5,9,10,11,12-Hexahydro-6-hydroxy-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepin-3-yl b-D-glucopyranosiduronic acid |
O-Desmethyl carvedilol | 72956-44-6 | C23H24N2O4 | 392.46 | 2-[2-[[3-(9H-Carbazol-4-yloxy)-2-hydroxypropyl]amino]ethoxy]phenol; BM 14242; Desmethylcarvedilol; |
O-Desmethyl Apixaban Sulfate | 1118765-14-2 | C24H23N5O7S | 525.54 | |
O-Desmethyl Apixaban | 503612-76-8 | C24H23N5O4 | 445.48 | 4-Demethoxy-4-hydroxy apixaban |
O-Desmethyl Adapalene | 125316-60-1 | C27H26O3 | 398.49 | 6-(4-Hydroxy-3-tricyclo[3.3.1.13,7]dec-1-ylphenyl)-2-naphthalenecarboxylic Acid; 6-[3-(1-Adamantyl)-4-hydroxyphenyl]-2-naphthalenecarboxylic Acid |
O-Desethyl-O-propyl Methisosildenafil | 1391053-82-9 | C24H34N6O4S | 502.63 | rel-5-[5-[[(3R,5S)-3,5-Dimethyl-1-piperazinyl]sulfonyl]-2-propoxyphenyl]-1,6-dihydro-1-methyl-3-propyl-7H-pyrazolo[4,3-d]pyrimidin-7-one; |
O-Desethyl Sildenafil (Sildenafil Impurity C) | 139755-91-2 | C20H26N6O4S | 446.52 | 5-[2-Hydroxy-5-(4-methylpiperazinylsulphonyl)phenyl]1-methyl-3-n-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyramidin-7-one; 5-[2-Hydroxy-5-[[4-(methyl)-1-piperazinyl]sulfonyl]phenyl]-1,6-dihydro-1-methyl-3-propyl-7H-pyrazolo[4,3-d]pyrimidin-7-one; |
O-Desaryl Ranolazine | 172430-46-5 | C17H27N3O3 | 321.41 | 4-(2,3-Dihydroxypropyl)-N-(2,6-dimethylphenyl)-1-piperazineacetamide; RS 88640; CVT-2512; Ranolazine Impurity 4; CVT-2512; CVT 2512; CVT2512; RS 88640; RS-88640; UNII-04210SF62M |
O-Demethylstachartin C | 1219361-60-0 | C28H39NO6 | 485.62 | |
O-Demethylforbexanthone | 92609-77-3 | C18H14O6 | 326.3 | 7,9,12-trihydroxy-2,2-dimethylpyrano[3,2-b]xanthen-6-one |
Odelepran | 676501-25-0 | C20H24FN3O3 | 373.43 | Ondelopran;6-[2-Fluoro-4-[[2-(oxan-4-yl)ethylamino]methyl]phenoxy]pyridine-3-carboxamide;LY2196044;LY-2196044 |
Odapipam | 131796-63-9 | C19H20ClNO2 | 329.82 | NNC 756; (5S)-8-chloro-5-(2,3-dihydro-1-benzofuran-7-yl)-3-methyl-1,2,4,5-tetrahydro-3-benzazepin-7-ol |
Odanacatib | 603139-19-1 | C25H27F4N3O3S | 525.56 | MK-0822 |
OD-36 | 1638644-62-8 | C16H15ClN4O2 | 330.77 | OD36; OD-36; OD 36; 6-Chloro-10,11,14,17-tetrahydro-13H-1,16-etheno-4,8-metheno-1H-pyrazolo[3,4-g][1,14,4,6]dioxadiazacyclohexadecine |
OCTYLTRICHLOROTIN | 3091-25-6 | C8H17Cl3Sn | 338.29 | mono-n-octyl-zinn-trichlorid; octyl-titrichloride; octyltrichloro-stannan; octyltrichlorostannane; trichlorooctyl-stannan; trichlorooctyl-Stannane; N-OCTYLTIN-TRICHLORIDE; N-OCTYLTRICHLOROSTANNANE |
Octyldecyl 2-acetamido-2-deoxy-b-D-glucopyranoside | 173725-29-6 | C26H51NO6 | 473.69 | |
octylazanium acetate | 2016-40-2 | C10H23NO2 | 189.295 g/mol | |
Octyl glucose neopentyl glycol | 1257853-32-9 | C27H52O12 | 568.69 | 2,2-Dihexylpropane-1,3-bis b-D-glucopyranoside; Octyl MNG |
NSC348884 | 81624-55-7 | C38H40N10 | 636.79 | N1,N1,N2,N2-Tetrakis[(6-methyl-1H-benzimidazol-2-yl)methyl]-1,2-ethanediamine;1,2-EthanediaMine, N,N,N',N'-tetrakis[(5-Methyl-1H-benziMidazol-2-yl)Methyl]- ;N,N,N',N'-tetrakis[(6-methyl-1H-benzimidazol-2-yl)methyl]ethane-1,2-diamine |
NSC305787 hydrochloride | 53868-26-1 | C25H31Cl3N2O | 481.89 | [2-(Adamantan-1-yl)-6,8-dichloro-4-quinolinyl](2-piperidinyl)methanol hydrochloride; [2-(Adamantan-1-yl)-6,8-dichloro-4-quinolinyl](2-piperidinyl)methanol hydrochloride |
NSC305787 | 785718-37-8 | C25H30Cl2N2O | 445.42 | |
NSC232003 | 1905453-18-0 | C6H7N3O3 | 169.14 | (5Z)-5-[1-(hydroxyamino)ethylidene]pyrimidine-2,4-dione |
Norchelerythrine | 6900-99-8 | C20H15NO4 | 333.343 | 1,2-dimethoxy-[1,3]benzodioxolo[5,6-c]phenanthridine |
NS 6740 | 753499-14-8 | C19H19F3N2O2·HCl | 400.82 | 1,4-Diazabicyclo[3.2.2]non-4-yl[5-[3-(trifluoromethyl)phenyl]-2-furanyl]methanone hydrochloride |
NS 5806 | 426834-69-7 | C16H8Br2F6N6O | 574.07 | N-[3,5-Bis(trifluoromethyl)phenyl]-N'-[2,4-dibromo-6-(2H-tetrazol-5-yl)phenyl]urea |
N-NITROSOSIMAZINE | 6494-81-1 | C7H11ClN6O | 0 | N-NITROSOSIMAZINE; 6-Chloro-N,N'-diethyl-N-nitroso-1,3,5-triazine-2,4-diamine |
N-Nitrosonornicotine-N-b-D-glucuronide - Mixture Of Diastereomers | 864071-82-9 | C15H19N3O7 | 353.33 | NNN-b-D-Glucuronide; 1-b-D-Glucopyranuronosyl-3[(2S)-1-nitroso-2-pyrrolidinyl]-pyridinium; Pyridyl-N-b-D-glucopyranuronosyl-N-Nitrosonornicotine |
N'-Nitrosonornicotine-d4 | 66148-19-4 | C9H7N3OD4 | 181.23 | NNN-D4; (+/-)-5-(1-Nitroso-2-pyrrolidinyl)pyridine-2,3,4,6-d4 |
N'-NITROSONORNICOTINE | 16543-55-8 | C9H11N3O | 177.2 | 1'-demethyl-1'-nitroso-nicotin; 1'-desmethyl-1'-nitrosonicotine; 1'-nitroso-1'-demethyl-nicotin; 1'-nitroso-1'-demethylnicotine; 1'-nitrosonornicotine; 1-nitroso-2-(3-pyridyl)pyrrolidine; nitrosonornicotine; NNN |
Nimesulide Impurity E | 905858-63-1 | C14H15NO5S2 | 341.41 | N-(Methylsulfonyl)-4-(desnitro) Nimesulide; N-(Methylsulfonyl)-N-(2-phenoxyphenyl)methanesulfonamide; |
Nimesulide Impurity D | 5422-92-4 | C12H10N2O3 | 230.23 | 4-Nitro-2-phenoxyaniline; 4-Nitro-2-phenoxybenzenamine; 2-Amino-5-nitrodiphenyl Ether; 2-Phenoxy-4-nitroaniline; |
Nimesulide Impurity B | 51765-51-6 | C13H13NO3S | 263.32 | N-(2-Phenoxyphenyl)methanesulphonamide;N-(2-Phenoxyphenyl)methanesulphonamide; N-(2-phenoxyphenyl)methanesulfonamide; (2-Phenoxy)Methylsulfonylaniline; |
Nimesulide Impurity A | 51765-56-1 | C13H11N3O7S | 353.31 | N-(2,4-Dinitro-6-phenoxyphenyl)methanesulfonamide; N-(2,4-Dinitro-6-phenoxyphenyl)methanesulphonamide; |
Nimesulide | 51803-78-2 | C13H12N2O5S | 308.3 | N-(4-nitro-2-phenoxyphenyl)-methanesulfonamide |
Nimbolide | 25990-37-8 | C27H30O7 | 466.5 | NSC 309909; Methyl 2-[6-(furan-3-yl)-7,9,11,15-tetramethyl-12,16-dioxo-3,17-dioxapentacyclo[9.6.1.02,9.04,8.015,18]octadeca-7,13-dien-10-yl]acetate |
N-Fmoc-4-Amino-2-chlorobenzoic acid | 186320-13-8 | C22H16ClNO4 | 393.82 | N-Fmoc-4-Amino-2-chlorobenzoic acid; Fmoc-4-amino-2-chlorobenzoic acid |
Neurokinin A | 86933-74-6 | C50H80N14O14S | 1133.32 | H-D-His-D-Lys-Thr-Asp-D-Ser-Phe-D-Val-Gly-D-Leu-D-Met-NH2; HKTDSFVGLM; D-histidyl-D-lysyl-L-threonyl-L-alpha-aspartyl-D-seryl-L-phenylalanyl-D-valyl-glycyl-D-leucyl-D-methioninamide; (3S)-3-[[(2S,3R)-2-[[(2R)-6-amino-2-[[(2R)-2-amino-3-(1H-imidazol-5-yl)p |
Neurodazine | 937807-66-4 | C27H21ClN2O3 | 456.92 | 2-[5-(3-Chlorophenyl)-2-furanyl]-4,5-bis(4-methoxyphenyl)-1H-imidazole |
N-Desethyl Amodiaquine-d5 DiHCl | 1216894-33-5 | C18H13ClN3OD5·2HCl | 405.76 | Desethylamodiaquine-D5 Dihydrochloride; 4-[(7-chloroquinolin-4-yl)amino]-2-[(1,1,2,2,2-pentadeuterioethylamino)methyl]phenol dihydrochloride; 4-[(7-Chloroquinolin-4-yl)amino]-2-{[(~2~H_5_)ethylamino]methyl}phenol--hydrogen chloride (1/2) |
N-desethyl amodiaquine hydrochloride | 79049-30-2 | C18H18ClN3O·2HCl | 400.73 | Monodesethylamodiaquine dihydrochloride; 4-[(7-chloroquinolin-4-yl)amino]-2-(ethylaminomethyl)phenol dihydrochloride |
N-Desethyl amodiaquine diHCl | 79352-78-6 | C18H18ClN3O.2HCl | 400.74 | Desethyl amodiaquine |
N-Desethyl Alverine HCl | 93948-19-7 | C18H23N. HCl | 253.39 36.46 | 3(5H)-Indolizinone, 6,7,8,8a-tetrahydro-2-methyl- |
N-Desethyl acetildenafil | 147676-55-9 | C23H30N6O3 | 438.52 | 5-[2-Ethoxy-5-(1-piperazinylacetyl)phenyl]-1,4-dihydro-1-methyl -3-propyl-7H-pyrazolo[4,3-d]pyrimidin-7-one; |
N-Descarboxymethyl N-Ethyl Lacosamide Impurity | 705283-63-2 | C13H20N2O2 | 236.32 | N-Benzyl-2-ethylamino-3-methoxy-propionamide |
N-Descarboxymethyl N-Carboxyethyl Lacosamide Impurity | 1318777-56-8 | C14H20N2O3 | 264.33 | (2R)-3-Methoxy-2-[(1-oxopropyl)amino]-N-(phenylmethyl)propanamide |
Octyl dihydrogen phosphate | 3991-73-9 | C8H19O4P | 210.2078 | octyldihydrogenphosphate; MONOOCTYLPHOSPHATE; Octyldihydrogenphosphate; Monooctylphosphoricacid; Octylphosphate; Phosphoricacid,monooctylester |
Octyl D-glucopyranoside | 54549-23-4 | C14H28O6 | 292.37 | |
Octyl D-galactofuranoside tetraacetate | 223412-29-1 | C22H36O10 | 460.52 | |
Octyl D-galactofuranoside | 202403-49-4 | C14H28O6 | 292.37 | |
Octyl b-D-thiomaltopyranoside | 148616-91-5 | C20H38O10S | 470.58 | n-Octyl b-D-thiomaltoside; Octyl 4-O-a-D-glucopyranosyl-1-thio-b-D-glucopyranoside |
Octyl b-D-thioglucopyranoside | 85618-21-9 | C14H28O5S | 308.44 | n-Octyl b-D-thioglucoside; OTG |
Octyl b-D-thiogalactopyranoside | 42891-16-7 | C14H28O5S | 308.44 | |
Octyl b-D-mannopyranoside | 140147-38-2 | C14H28O6 | 292.37 | |
Octyl b-D-glucopyranoside | 29836-26-8 | C14H28O6 | 292.37 | n-Octylglucoside; 1-O-Octyl b-D-glucopyranoside; OG; Caprylyl glucoside |
Octyl b-D-galactopyranoside | 40427-75-6 | C14H28O6 | 292.37 | n-Octyl b-D-galactoside |
Octyl a-D-mannopyranoside | 124650-29-9 | C14H28O6 | 292.37 | |
Octyl a-D-glucopyranoside | 29781-80-4 | C14H28O6 | 292.37 | N-Octyl a-Glucoside |
Octyl a-D-galactopyranoside | 149342-80-3 | C14H28O6 | 292.37 | |
Octyl 4-O-(b-D-galactopyranosyl)-b-D-glucopyranoside | 74513-17-0 | C20H38O11 | 454.51 | Octyl b-D-lactoside |
octyl 4-aminobenzoate | 14309-41-2 | C15H23NO2 | 249.349 g/mol | octyl4-aminobenzoate; OCTYL4-AMINOBENZOATE; Benzoicacid,4-amino-,octylester; 14309-41-2; ST4025063; AC1L1BJL |
Octyl 3,6-di-O-(a-D-mannopyranosyl)-b-D-mannopyranoside | 140147-36-0 | C26H48O16 | 616.65 | Man-a-1-6-(Man-a-1-3)Man-b-O-octyl |
Octyl 2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-b-D-glucopyranoside | 173725-22-9 | C22H37NO9 | 459.53 | |
Octyl 2-acetamido-2-deoxy-b-D-glucopyranoside | 147126-58-7 | C16H31NO6 | 333.42 | |
Octyl 2-acetamido-2-deoxy-b-D-galactopyranoside | 383417-49-0 | C16H31NO6 | 333.42 | |
Octyl 2-acetamido-2-deoxy-3-O-(b-D-galactopyranosyl)-b-D-glucopyranoside | 197390-85-5 | C22H41NO11 | 495.56 | Gal1-b-3GlcNAc-b-octyl |
Octyl 2-acetamido-2-deoxy-3-O-(b-D-galactopyranosyl)-a-D-glucopyranoside | 607353-49-1 | C22H41NO11 | 495.56 | Galb1,3GlcNAc-a-octyl |
Octyl 2,3,4,6-tetra-O-acetyl-b-D-thioglucopyranoside | 85618-26-4 | C22H36O9S | 476.58 | Octyl 1-thio-b-D-glucopyranoside tetraacetate |
Octyl 2,3,4,6-tetra-O-acetyl-b-D-mannopyranoside | 128299-96-7 | C22H36O10 | 460.52 | |
Octyl 2,3,4,6-tetra-O-acetyl-b-D-glucopyranoside | 38954-67-5 | C22H36O10 | 460.52 | |
Octadecanoyl-L-homoserine lactone | 479050-96-9 | C22H41NO3 | 367.6 | C18-HSl, N-Octadecanoyl-L-homoserine lactone |
Octreotide acetate | 79517-01-4 | C51H70N10O12S2 | 1079.29 | D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-L-cysteinamide Cyclic (2-7)-Disulfide Acetate;SMS 201995 acetate;Sandostatin;H-D-Phe-Cys(1)-Phe-D-Trp-Lys-Thr-Cys(1)-Thr-ol;(4R,7S,10S, |
Octreotide Acetate | 622838-44-2 | C49H66N10O10S2. 2C2H4O2 | 1019.26 2 60.05 | Sandostatin LAR Depot; 19-(2-amino-3-phenylpropanamido)-10-(4-aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxybutan-2-yl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide; bis(aceti |
Octreotide acetate | 760176-26-9 | C49H66N10O10S2·C2H4O2 | 1079.3 | SMS 201-995 |
Octreotide | 83150-76-9 | C49H66N10O10S2 | 1019.247 | Longastatin. Sandostatin. Sandostatin Lar Depot. Longastatina. Samilstin. Sandostatina. Sandostatine. SMS 201-995; SMS-201-995; SMS 201 995 |
Octenidine hydrochloride | 70775-75-6 | C36H62N4.2HCl | 623.836 | N,N'-(decane-1,10-diyldi-1(4H)-pyridyl-4-ylidene)bis(octylammonium) dichloride; Octenidine hydrochloride; OCTENIDINE DIHYDROCHLORIDE; N,N'-(1,10-Decanediyldi-1(4H)-pyridinyl-4-ylidene)bis(1-octanamine) dihydrochloride |
Octenidine | 71251-02-0 | C36H62N4 | 550.90 | OCTENIDINE; N,N'-[1,10-Decanediyldi-1(4H)-pyridinyl-4-ylidene]-bis(1-octanamine); NeoKodan; Octeniderm; Octenisept; Win-41464; Win-41464-2; 1,1'-Decamethylenebis(1,4-dihydro-4-(octylimino)pyridine) |
Octaverine Hydrochloride | 6775-26-4 | C23H27NO5 | 433.93 | 6,7-Dimethoxy-1-(3,4,5-triethoxyphenyl)isoquinoline Hydrochloride; Gastrolena; |
Octaverine | 549-68-8 | C23H27NO5 | 397.464 g/mol | 6,7-dimethoxy-1-(3,4,5-triethoxyphenyl)isoquinoline; Octaverine; Oktaverine; 6,7-Dimethoxy-1-(3,4,5-triethoxyphenyl)isoquinoline; Octaverinum; 549-68-8 |
oCtaphenylsilsesquioxane | 5256-79-1 | C48H40O12Si8 | 1033.51 | OCTAPHENYLSILSESQUIOXANE; OCTAPHENYL-T8-SILSESQUIOXANE; 1,3,5,7,9,11,13,15-OCTAPHENYLPENTACYCLO[9.5.1.13,9.15,15.17,13]OCTASILOXANE; Pentacyclo[9.5.1.13,9.15,15.17,13]octasiloxane, octaphenyl-; Perphenyloctasilsesquioxane; 1,3,5,7,9,11,13,15-OCTAPHENYLPEN |
Octanoyl-N-hydroxyethylglucamide | 869652-63-1 | C16H33NO7 | 351.44 | HEGA-8 |
Octanoyl-L-homoserine lactone | 147852-84-4 | C12H21NO3 | 227.3 | C8-HSL, OHL, N-Octanoyl-L-homoserine lactone |
Octanoyl-L-carnitine chloride | 54377-02-5 | C15H30NO4·Cl | 323.86 | C8 Carnitine; L-Carnitine octanoyl ester; L-Octanoylcarnitine; [(2R)-3-Carboxy-2-octanoyloxypropyl]-trimethylazanium chloride |
Octanoyl-DL-carnitine chloride | 14919-35-8 | C15H30NO4·Cl | 323.9 | C8 Carnitine; DL-Octanoylcarnitine; (±)-Octanoylcarnitine; Octanoyl carnitine hydrochloride; Octanoylcarnitine chloride |
Octanoyl D-glucopyranoside | 60415-65-8 | C14H26O7 | 306.35 | Oxo-octyl-D-glucoside |
Octanoyl carnitine | 3671-77-0 | C15H29NO4 | 0 | octanoylcarnitine; DL-Octanoyl carnitine; 3-Carboxy-N,N,N-trimethyl-2-[(1-oxooctyl)oxy]-1-propanaminium Inner Salt; Carnitine Octanoyl Ester; Octanoyl-DL-carnitine; O-Octanoylcarnitine; rac Octanoyl Carnitine |
Octanoyl b-D-glucosylamine | 134403-86-4 | C14H27NO6 | 305.37 | N-(b-D-Glucopyranosyl)octanamide |
Octahydro-pyrrolo[1,2-a]pyrazin-7-ol | 96563-78-9 | C7H14N2O | 142.19886 | Octahydro-pyrrolo[1,2-a]pyrazin-7-ol |
Octadecanoic acid,2-[(1-oxohexadecyl)oxy]ethyl ester | 26158-81-6 | C36H70 O4 | 566.9386 | |
Octadecanoic acid,12-hydroxy-, 2-ethylhexyl ester | 29710-25-6 | C26H52 O3 | 412.6893 | 2-ethylhexyl 12-hydroxyoctadecanoate; Octadecanoic acid, 12-hydroxy-, 2-ethylhexyl ester; 2-Ethylhexyl-12-hydroxyoctadecanoat; 2-Ethylhexyl 12-hydroxystearate; Einecs 249-793-7 |
octadecane-1-sulfonic acid | 120519-47-3 | C18H38O3S | 334.55752;g/mol | 1-Octadecanesulfonicacid; octadecane-1-sulfonicacid; 120519-47-3; 6140-87-0; Octadecylsulfonicacid; 1-Octadecanesulfonicacid |
Octadecane-1,2-diol | 20294-76-2 | C18H38O2 | 286.4931 | |
Octadecamethyloctasiloxane | 556-69-4 | C18H54O7Si8 | 607.301 g/mol | |
Octacosyl (E)-ferulate | 101959-37-9 | C38H66O4 | 586.9 | Octacosyl 3-(4-hydroxy-3-Methoxyphenyl)acrylate |
Octacosanol | 68580-63-2 | C28H58O | 410.771 | |
Octacos-1-ene | 18835-34-2 | C28H56 | 392.744 g/mol | |
Octachlorocyclopentene | 706-78-5 | C5Cl8 | 343.677 g/mol | |
Octaacetyl Xylotriose | 67226-05-5 | C31H42O21 | 750.65 | |
octa-2,4,6-trienal | 17609-31-3 | C8H10O | 122.164 g/mol | |
OCTA(AMINOPHENYL)-T8-SILESQUIOXANE | 518359-82-5 | C48H48N8O12Si8 | 1153.63 | OCTA(AMINOPHENYL)-T8-SILESQUIOXANE; OCTA(AMINOPHENYL)-T8-SILSESQUIOXANE |
oct-7-enal | 21573-31-9 | C8H14O | 126.196 g/mol | oct-7-enal; Oct-7-enal; 7-octenal; 21573-31-9; octa-7-enal; 7-Octen-1-al |
Oct-4-enedioic acid | 14277-16-8 | C8H12O4 | 172.178 g/mol | oct-4-enedioicacid; Oct-4-enedioicacid; 14277-16-8; (E)-OCT-4-ENE-1,8-DIOICACID; 4-Octenedioicacid,(Z)-; 4-Octenedioicacid,(4E)- |
Ocrilate | 6701-17-3 | C12H19NO2 | 209.285 g/mol | |
o-Cresolphthalein Complexone | 2411-89-4 | C32H32N2O12 | 636.61 | enylene)methylene]]bis[n-(carboxymethyl)-; glycine,n,n'-[(3-oxo-1(3h)-isobenzofuranylidene)bis[(6-hydroxy-5-methyl-3,1-ph; N,N'-[(3-oxo-1(3H)-isobenzofuranylidene]bis[(6-hydroxy-5-methyl-3,1-phenylene)methylene)]bis(n-(cGlycine; XYLENOLPHTHALEIN-BIS(MINOD |
o-Cresol-d3(methyl-d3) | 70837-27-3 | 111.15600 | ||
ocrelizumab | 637334-45-3 | C6494H9978N1718O2014S46 | 148000 | Ocrevus |
o-Carborane | 16872-09-6 | C2H12B10 | 144.22 | |
o-Carbomethoxybenzyl sulfonamide | 112941-26-1 | C9H11NO4S | 229.25 | 2-(METHYL FORMATE) BENZYL SULFONAMIDE; 2-(AMINOSULFONYLMETHYL)BENZOIC ACID METHYL ESTER; 2-CARBOMETHOXYBENZYL SULFONAMIDE; METHYL 2-(AMINOSULFONYLMETHYL)BENZOATE; O-CARBOMETHOXYBENZYL SULFONAMIDE; 2-(Methyl formate)benzyl sulfonamie |
Ocaphane Hydrochloride | 2185-98-0 | C14H22Cl4N2O2 | 392.149 | 2-amino-3-[2-[bis(2-chloroethyl)aminomethyl]phenyl]propanoic acid;hydrochloride; AT-581; ocaphane; ocaphane hydrochloride |
Ocaphane | 3734-80-3 | C14H20Cl2N2O2 | 319.22 | 2-{[bis(2-chloroethyl)amino]methyl}-l-phenylalanine; (2S)-2-amino-3-[2-[bis(2-chloroethyl)aminomethyl]phenyl]propanoic acid; |
O-Butyl hydrogen dithiocarbonate , zinc salt | 150-88-9 | C10H20O2S4Zn | 365.9146 | O-butyl hydrogen dithiocarbonate , zinc salt; zinc butylxanthate; Bis(butoxycarbonothioylthio)zinc; Bis(butoxydithioformic acid)zinc salt; Bis(butoxythioxomethylthio) zinc; Bis[butoxy(thiocarbonyl)thio] zinc; Zinc butylxanthogenate; [S,(-)]-2,4-Bis(benzyl |
Obatoclax mesylate | 803712-79-0 | C20H19N3O.CH4O3S | 413.492 | (2E)-2-[(5Z)-5-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-4-methoxypyrrol-2-ylidene]indole methanesulfonic acid |
Obtusin | 70588-05-5 | C18H16O7 | 344.31 | 1,7-dihydroxy-2,3,8-trimethoxy-6-methylanthracene-9,10-dione |
Obtusifolin | 477-85-0 | C16H12O5 | 284.27 | 2,8-Dihydroxy-1-methoxy-3-methyl-9,10-anthracenedione; 9,10-Anthracenedione, 2,8-dihydroxy-1-methoxy-3-methyl-; Anthraquinone, 2,8-dihydroxy-1-methoxy-3-methyl-; Obtusifolin (anthraquinone); 2,8-Dihydroxy-1-Methoxy-3-Methylanthraquinone |
Obtusafuran methyl ether | 40357-59-3 | C17H18O3 | 270.32 | (2S,3S)-5,6-dimethoxy-3-methyl-2-phenyl-2,3-dihydro-1-benzofuran |
Obtucarbamate B | 20913-18-2 | C11H14N2O4 | 238.2 | 2-Methyl-1,3-phenylenedicarbamic acid methyl ester;Dimethyl toluene-2,6-dicarbamate |
Obtucarbamate A | 6935-99-5 | C11H14N2O4 | 238.2 | Dimethyl 4-methylbenzene-1,3-dicarbamate;Dimethyl toluene-2,4-dicarbamate |
Obscurolide A1 | 144397-99-9 | C15H17NO5 | 291.3 | 4-[[2-[(E)-3-hydroxybut-1-enyl]-5-oxooxolan-3-yl]amino]benzoic acid |
OBP-801 | 328548-11-4 | C20H31N3O6S2 | 473.603 | OBP 801; OBP801; YM-753; YM753; YM 753; Spiruchostatin A |
Obolactone | 712272-88-3 | C19H18O4 | 310.34 | (2R)-2-[[(2R)-6-oxo-2,3-dihydropyran-2-yl]methyl]-6-[(E)-2-phenylethenyl]-2,3-dihydropyran-4-one |
O-BENZYL-DL-SERINE | 5445-44-3 | C10H13NO3 | 195.22 | (+/-)-2-AMINO-3-BENZYLOXYPROPIONIC ACID; DL-SERINE BENZYL ESTER; H-DL-SER(BZL)-OH; BENZYL-DL-SERINE; O-BENZYL-DL-SERINE; 3-benzyloxy-DL-alanine |
O-Benzyldauricine | 2748-99-4 | C45H50N2O6 | 714.89 | |
O-Benzyl-(D)-serine benzyl ester | 21948-10-7 | C17H19 N O3 . Cl H | 285.34 | O-BENZYL-(D)-SERINE BENZYL ESTER; (R)-2-AMINO-3-BENZYLOXY-PROPIONIC ACID BENZYL ESTER; O-Benzyl-(D)-Serine Benzyl Ester HCl; (R)-2-Amino-3-benzyloxy-propionicacidbenzylesterhydrochloride |
o-Benzoic Sulfimide Sodium Salt | 128-44-9 | C7H4NNaO3S | 205.17 | |
Obatoclax | 803712-67-6 | C20H19N3O | 0 | obatoclax |
Obacunone | 751-03-1 | C26H30O7 | 454.5 | Oxireno(4,4A)-2-benzopyrano(6,5-G)(2)benzoxepin-3,5,9(3ah,4bh,6H)-trione, 1-(3-furanyl)-1,6A,7,11A,11B,12,13,13A-octahydro-4B,7,7,11A,13A-pentamethyl-, (1S,3as,4ar,4br,6ar,11ar,11br,11br,13as)- |
OBAA | 221632-26-4 | C28H44O3 | 428.65 | 4-(4-Octadecylphenyl)-4-oxobutenoic acid |
OBA-09 | 856095-68-6 | C10H8O5 | 208.17 | O-Pyruvoylsalicylic acid;2-(1,2-Dioxopropoxy)benzoic acid hydrate;2-((2-Oxopropanoyl)oxy)benzoic acid;2-(2-oxopropanoyloxy)benzoic acid |
OB-1 | 300803-69-4 | C21H17N3O6 | 407.38 | Ethyl 5-(1-methyl-4-nitro-1H-imidazol-5-yloxy)-2-phenylbenzofuran-3-carboxylate |
NSP-DMAE-NHS | 194357-64-7 | C30H26N2O9S | 590.60 | 3-(9-((4-(((2,5-Dioxopyrrolidin-1-yl)oxy)carbonyl)-2,6-dimethylphenoxy)carbonyl)acridin-10-ium-10-yl)propane-1-sulfonate |
O-Acetylserine | 5147-00-2 | C5H9NO4 | 147.13 | (2S)-3-acetyloxy-2-aminopropanoic acid |
O-Acetylsalicylic acid aluminum salt | 23413-80-1 | C18H15AlO9 | 564.43 | O-Acetylsalicylic acid aluminum salt; Hydroxyaluminum bis(o-acetylsalicylate) |
O-Acetyl-L-homoserine hydrochloride | 250736-84-6 | C6H12ClNO4 | 197.62 | L-Homoserine Acetate Hydrochloride |
O-Acetyl-L-carnitine hydrochloride | 5080-50-2 | C9H17NO4.HCl | 239.696 | Acetyl-L-carnitine hydrochloride; O-Acetyl-L-carnitine HCl; [(2R)-2-acetyloxy-3-carboxypropyl]-trimethylazanium chloride |
O-Acetylcyclocalopin A | 486430-93-7 | C17H22O7 | 338.4 | (1S,2'R,3'aR,4'S,6S,7'aS)-rel-(-)- 6-(Acetyloxy)-3'a,4',5',7'a-tetrahydro-2'-hydroxy-2',4,4'-trimethylspiro[3-cyclohexene-1,3'(2'H)-[7H]furo[2,3-c]pyran]-5,7'-dione |
O-Acetyl Salicylhydroxamic Acid | 199854-00-7 | C9H9NO4 | 195.2 | N-(acetyloxy)-2-hydroxy benzamide; AcSHA; O-ASHA |
O-Acetyl N-Benzyloxycarbonyl Valganciclovir | 194159-22-3 | C24H30N6O8 | 530.54 | N-[(PhenylMethoxy)carbonyl]-L-valine 3-(Acetyloxy)-2-[(2-aMino-1,6-dihydro-6-oxo-9H-purin-9-yl)Methoxy]propyl Ester |
OAC3 | 182564-41-6 | C15H11FN2O | 254.3 | 4-fluoro-N-(1H-indol-5-yl)benzamide; N-(4-fluorobenzoyl)-5-amino-1H-indole |
OAC2 | 6019-39-2 | C15H12N2O | 236.27 | N-(1H-indol-5-yl)benzamide; Octamer-binding transcription factor 2; OAC-2; 5-benzoylaminoindole |
OAC1 | 300586-90-7 | C14H11N3O | 237.26 | BAS 00287861; OAC-1; N-1H-pyrrolo[2,3-c]pyridin-5-ylbenzamide |
O8 OGG1 Inhibitor | 350997-39-6 | C9H6Cl2N2OS | 261.13 | 3,4-Dichlorobenzo[b]thiophene-2-carbohydrazide; 3,4-dichloro-1-benzothiophene-2-carbohydrazide |
O-7460 | 1572051-31-0 | C25H48FO5P | 478.6 | [1-[fluoro(methyl)phosphoryl]oxy-3-propan-2-yloxypropan-2-yl] (Z)-octadec-9-enoate |
O6-Phenyl-2'-deoxyinosine | 114485-36-8 | C16H16N4O4 | 328.34 | (2R,3S,5R)-2-(Hydroxymethyl)-5-(6-phenoxy-9H-purin-9-yl)tetrahydrofuran-3-ol; Inosine,2'-deoxy-6-O-phenyl- (9CI) |
O6-Methylguanosine | 7803-88-5 | C11H15N5O5 | 297.27 | |
O6-(2-Hydroxy-1-methylethyl)-2'-deoxyguanosine | 1327339-21-8 | C13H19N5O5 | 325.32 | |
O6-Ethyl-2'-deoxyguanosine | 50704-46-6 | C12H19N5O4 | 297.31 | NSC 240591; O6-Ethyl-2'-deoxyguanosine; O6-Ethyldeoxyguanosine |
O6-Benzyl-N2,3-etheno-2-phenoxythioxomethyl-3,5-O-[tetrakis(isopropyl)-1,3-disiloxanediyl] guanosine | 148437-93-8 | C38H49N5O7SSi2 | 776.06 | 1-[2-O-(Phenoxythioxomethyl)-3,5-O-[1,1,3,3-tetrakis(1-methylethyl)-1,3-disiloxanediyl]-b-D-ribofuranosyl]-4-(phenylmethoxy)-1H-imidazo[2,1-b]purine |
O6-Benzyl-N2,3-etheno-2-deoxy-3,5-O-[tetrakis(isopropyl)-1,3-disiloxanediyl] guanosine | 148437-94-9 | C31H45N5O5Si2 | 623.89 | 1-[2-Deoxy-3,5-O-[1,1,3,3-tetrakis(1-methylethyl)-1,3-disiloxanediyl]-b-D-erythro-pentofuranosyl]-4-(phenylmethoxy)-1H-imidazo[2,1-b]purine |
O6-Benzyl-N2,3-etheno guanosine | 108060-84-0 | C19H19N5O5 | 397.38 | 4-(Phenylmethoxy)-1-b-D-ribofuranosyl-1H-imidazo[2,1-b]purine |
O6-(2-Hydroxypropyl)-2'-deoxyguanosine | 1327339-22-9 | C13H19N5O5 | 325.32 | |
O6-(2-Hydroxyethyl)-2'-deoxyguanosine | 111447-35-9 | C12H17N5O5 | 311.29 | 2'-Deoxy-6-O-(2-hydroxyethyl)guanosine; OHEdG |
O4I2 | 165682-93-9 | C12H11ClN2O2S | 282.74 | ethyl 2-(4-chloroanilino)-1,3-thiazole-4-carboxylate |
O4I1 | 175135-47-4 | C16H15NO2 | 253.3 | 2-[4-[(4-methoxyphenyl)methoxy]phenyl]acetonitrile |
o-3M3FBS | 313981-55-4 | C16H16F3NO2S | 343.36 | 2,4,6-Trimethyl-N-[2-(trifluoromethyl)phenyl]-benzenesulfonamide |
O-304 | 1261289-04-6 | C16H11Cl2N3O2S | 380.25 | 4-Chloro-N-[2-[(4-chlorophenyl)methyl]-3-oxo-1,2,4-thiadiazol-5-yl]benzamide |
O-2-Naphthyl chlorothioformate | 10506-37-3 | C11H7ClOS | 222.69 | CarbonochloridothioicacidO-2-naphthalenylester; 2-NAPHTHYLCHLOROTHIOFORMATE; NCTF; O-2-NAPHTHYL CHLOROTHIOFORMATE; Chloridothiocarbonic acid O-(2-naphtyl) ester; Chlorothioformic acid O-(2-naphtyl) ester |
O-2545 hydrochloride | 874745-43-4 | C26H36N2O2·HCl | 445 | (6aR,10aR)-6a,7,10,10a-Tetrahydro-3-[5-(1H-imidazol-1-yl)-1,1-dimethylpentyl]-6,6,9-trimethyl-6H-dibenzo[b,d]pyran-1-ol hydrochloride |
O-2093 | 439080-01-0 | C34H43Cl2NO3 | 584.62 | N-(bis-3-chloro-4-hydroxybenzyl)-5Z,8Z,11Z,14Z-eicosatetraenamide; (5Z,8Z,11Z,14Z)-N,N-Bis[(3-chloro-4-hydroxyphenyl)methyl]-5,8,11,14-eicosatetraenamide |
O-2050 | 851320-29-1 | C23H31NO4S | 417.56 | rel-N-[6-[(6aR,10aR)-6a,7,10,10a-Tetrahydro-1-hydroxy-6,6,9-trimethyl-6H-dibenzo[b,d]pyran-3-yl]-4-hexyn-1-yl]methanesulfonamide; (6aR,10aR)-1-Hydroxy-3-(1-Methanesulfonylamino-4-hexyn-6-yl)-6a,7,10,10a-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran |
O2,5'-Anhydrothymidine | 15425-09-9 | C10H12N2O4 | 224.21 | |
O1-tert-Butyl O3-methyl (3R)-pyrrolidine-1,3-dicarboxylate | 441717-40-4 | C11H19NO4 | 229.274 | |
O1-tert-Butyl O2-methyl azetidine-1,2-dicarboxylate | 255882-72-5 | C10H17NO4 | 215.247 | |
O-1918 | 536697-79-7 | C19H26O2 | 286.41 | 1,3-Dimethoxy-5-methyl-2-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]benzene |
O-1602 | 317321-41-8 | C17H22O2 | 258.36 | 5-Methyl-4-[(1R,6R)-3-methyl-6-(1-cyclohexen-1-yl]-1,3-benzenediol |
O-[2-Acetamido-4,6-O-benzylidene-2-deoxy-3-O-(2,3,4,6-tetra-O-acetyl-b-D-galactopyranosyl)-a-D-galactopyranosyl]-N-Fmoc-L-threonine allyl ester | 384346-85-4 | C51H58N2O19 | 1003.01 | N-Fmoc-4,6-benzylidene-2346-tetra-O-acetyl T Epitope, Threonyl Allyl Ester |
O-[2-Acetamido-2-deoxy-a-D-galactopyranosyl]-N-Fmoc-L-threonine 2-propen-1-yl ester | 301843-65-2 | C30H36N2O10 | 584.61 | N-Fmoc-O-[2-acetamido-2-deoxy-a-D-galactopyranosyl]-L-threonine allyl ester |
O-[2-(3-Mercaptopropionylamino)ethyl]-O-methylpolyethylene glycol | 401916-61-8 | C7H18O4S | 198.28042;g/mol | ‘ Mercaptopolyethylene glycol monomethyl ether’ , PEG-thiol |
o-[1-(4-Hydroxyphenyl)-1-methylethyl]phenol | 837-08-1 | C15H16O2 | 228.28600 | |
O/PToluenesulfonamide-formuladehyderesinsolutionofButylacetate | 25035-71-6 | C8H11NO3S | 201.24284;g/mol | SantoliteMS; 4-Toluenesulfonamide-formaldehyderesin; Tosylamide/formaldehyderesin; 25035-71-6; Benzenesulfonamide,4-methyl-,polymerwithformaldehyde; 9009-96-5 |
Nystose | 13133-07-8 | C24H42O21 | 666.58 | Fungitetraose; Nistose; 1,1-Kestotetraose |
Nysted Reagent | 41114-59-4 | C6H12Br2OZn3 | 456.14 | |
Nystatin | 1400-61-9 | C47H75NO17 | 926.09 | Stamycin; Nilstat; Mycostatin; Nystavescent; Biofanal; NSC 150817 |
Nyssoside | 182138-70-1 | C22H18O13 | ||
Nymphaea alba, ext. | 84696-27-5 | |||
NYLON 6/9 | 27136-65-8 | C45H84N6O6X2 | 805.19 | NYLON 6/9; POLY(HEXAMETHYLENE AZELAMIDE); POLY(HEXAMETHYLENE NONANEDIAMIDE)) |
N-Valeryl-D-glucosamine | 63223-57-4 | C11H21NO6 | 263.29 | |
NVP 2 | 1263373-43-8 | C27H37ClN6O2 | 513.07 | 4-[[[5'-Chloro-2'-[[trans-4-[[(1R)-2-methoxy-1-methylethyl]amino]cyclohexyl]amino][2,4'-bipyridin]-6-yl]amino]methyl]tetrahydro-2H-pyran-4-carbonitrile |
NVP-QAV680 | 872365-16-7 | C18H18N2O4S | 358.41 | |
NVP-QAV-572 | 957209-68-6 | C17H19F2N7O3S2 | 471.5 | |
NVP-LCQ195 | 902156-99-4 | C17H19Cl2N5O4S | 460.33 | LCQ-195; AT-9311; NVP LCQ195 |
NVP-HDM201 | 1448867-41-1 | C26H24Cl2N6O4 | 555.41 | (4S)-5-(5-chloro-1-methyl-2-oxopyridin-3-yl)-4-(4-chlorophenyl)-2-(2,4-dimethoxypyrimidin-5-yl)-3-propan-2-yl-4H-pyrrolo[3,4-d]imidazol-6-one |
NVP-CGM097 sulfate | 1313367-56-4 | C38H49ClN4O8S | 757.34 | (1S)-1-(4-chlorophenyl)-6-methoxy-2-[4-[methyl-[[4-(4-methyl-3-oxopiperazin-1-yl)cyclohexyl]methyl]amino]phenyl]-7-propan-2-yloxy-1,4-dihydroisoquinolin-3-one;sulfuric acid; NVP-CGM097 (sulfate) |
NVP-BVU972 | 1185763-69-2 | C20H16N6 | 340.38 | N/A |
NVP-BSK805 | 1092499-93-8 | C27H28F2N6O | 490.55 | NVPBSK805; NVP-BSK805; BSK805; BSK 805; 8-(3,5-DIFLUORO-4-(MORPHOLINOMETHYL)PHENYL)-2-(1-(PIPERIDIN-4-YL)-1H-PYRAZOL-4-YL)QUINOXALINE |
NVP-BKM120 Hydrochloride | 1312445-63-8 | C18H22ClF3N6O2 | 446.85 | BKM-120 hydrochloride; BKM120 hydrochloride; BKM 120 hydrochloride |
NVP-BHG712 | 940310-85-0 | C26H20F3N7O | 503.489 | NVP-BHG712; BHG712; BHG-712 |
NVP-BGJ398 phosphate | 1310746-10-1 | C26H34Cl2N7O7P | 658.47 | Infigratinib phosphate; BGJ-398 phosphate |
NVP-BEP800 | 847559-80-2 | C21H23Cl2N5O2S | 480.41 | VER82576; XL184; BMS-907351. |
NVP-BBD130 | 853910-61-9 | C28H21N5O | 443.5 | 2-methyl-2-[4-[3-methyl-2-oxo-8-(2-pyridin-3-ylethynyl)imidazo[4,5-c]quinolin-1-yl]phenyl]propanenitrile |
NVP-BAG956 | 853910-02-8 | C28H21N5 | 427.5 | BAG 956 |
NVP-AEW541 | 475488-34-7 | C27H29N5O | 439.6 | AEW-541; AEW 541; AEW541; 7-[3-(azetidin-1-ylmethyl)cyclobutyl]-5-(3-phenylmethoxyphenyl)pyrrolo[2,3-d]pyrimidin-4-amine |
NVP-ACC789 | 300842-64-2 | C21H17BrN4 | 405.3 | ACC-789; AC1OCFN3; N-(3-bromo-4-methylphenyl)-4-(pyridin-4-ylmethyl)phthalazin-1-amine; |
NVP-ABE-171 | 426268-06-6 | C21H12N4O3 | 368.35 | 4-[8-(2,1,3-benzoxadiazol-5-yl)-1,7-naphthyridin-6-yl]benzoic acid; 4-(8-(benzo[c][1,2,5]oxadiazol-5-yl)-1,7-naphthyridin-6-yl)benzoic acid; |
NVP-231 | 362003-83-6 | C25H25N3O2S | 431.554 | NVP-231; NVP 231; NVP231 |
NVP DPP 728 dihydrochloride | 207556-62-5 | C15H18N6O.2HCl | 371.27 | 6-[[2-[[2-(2S)-2-Cyano-1-pyrrolidinyl]-2-oxoethyl]amino]ethyl]amino-3-pyridinecarbononitrile dihydrochloride |
NVP CXCR2 20 | 1029521-30-9 | C15H11F2N3OS | 319.33 | 4-Cyclopropyl-2-[[(2,3-difluorophenyl)methyl]thio]-1,6-dihydro-6-oxo5-pyrimidinecarbonitrile; NVP-CXCR2 20; NVP CXCR2-20; NVP CXCR220 |
N-Vinyl-N-methylacetamide | 3195-78-6 | C5H9NO | 99.13 | Acetamide, N-methyl-N-vinyl-; n-ethenyl-n-methyl-acetamid; n-ethenyl-n-methylacetamide; N-ethenyl-N-methyl-Acetamide; n-methyl-n-vinyl-acetamid; N-Vinylmethylacetamide; N-VINYL-N-METHYLACETAMIDE; N-METHYL-N-VINYLACETAMIDE |
N-Vinylacetamide | 5202-78-8 | C4H7NO | 85.10448 | N-ethenylacetamide; N-Vinylacetamide; 5202-78-8; Acetamide,N-ethenyl-; N-Ethenylacetamide; N-Vinylacetamidehomopolymer |
N-VINYL-2-PIPERIDONE | 4370-23-4 | C7H11NO | 125.17 | N-VINYL-2-PIPERIDONE |
N-Vanillyldecanamide | 31078-36-1 | C18H29NO3 | 307.43 | Decylic acid vanillylamide |
NV-128 | 1210335-22-0 | |||
Nuzhenide | 39011-92-2 | C31H42O17 | 686.7 | 2-(4-hydroxyphenyl)ethyl,6-(3-ethylidene-2-(beta-D-glucopyrano; |
Nuvenzepine | 96487-37-5 | C19H20N4O2 | 336.39 | 11-(1-methylpiperidine-4-carbonyl)-6H-pyrido[3,2-c][1,5]benzodiazepin-5-one; 11-(N-methylisonipecotyl)-6,11-dihydro-5H-pyrido(2,3-b)(1,5)benzodiazepin-5-one; DF 545; DF-545; nuvenzepine |
Nutlin-3b | 675576-97-3 | C30H30Cl2N4O4 | 581.49 | |
Nutlin-3a | 675576-98-4 | C30H30Cl2N4O4 | 581.494 | Nutlin-3a; Nutlin 3a; Nutlin3a; |
Nutlin-3 | 548472-68-0 | C30H30Cl2N4O4 | 581.49 | (±)-4-[4,5-Bis(4-chlorophenyl)-2-(2-isopropoxy-4-methoxy-phenyl)-4,5-dihydro-imidazole-1-carbonyl]-piperazin-2-one; 4-[4,5-bis(4-chlorophenyl)-2-(4-methoxy-2-propan-2-yloxyphenyl)-4,5-dihydroimidazole-1-carbonyl]piperazin-2-one |
Nutlin-3 | 890090-75-2 | C30H30Cl2N4O4 | 581.49 | |
Nullscript | 300816-11-9 | C16H14N2O4 | 298.3 | 4-(1,3-dioxo-1H-benzo[de]isoquinolin-2(3H)-yl)-N-hydroxybutanamide |
Nuezhenidic acid | 183238-67-7 | C17H24O14 | 452.36 | |
Nudiposide | 62058-46-2 | C27H36O12 | 552.57 | (2R,3R,4S,5R)-2-[[(1R,2S,3S)-7-hydroxy-1-(4-hydroxy-3,5-dimethoxyphenyl)-3-(hydroxymethyl)-6,8-dimethoxy-1,2,3,4-tetrahydronaphthalen-2-yl]methoxy]oxane-3,4,5-triol |
Nudifloside D | 454212-54-5 | C27H42O13 | 574.62 | |
Nudifloside C | 297740-99-9 | C26H38O12 | 542.57 | |
Nudifloside B | 297740-98-8 | C43H60O22 | 928.92 | |
Nudifloramide-d3 | 1207384-48-2 | C7H5D3N2O2 | 155.17 | N-(Methyl-d3)-2-pyridoxone-5-carboxamide; N-(Methyl-d3)-2-pyridinone- 5-carboxamide; 1,6-Dihydro-1-(methyl-d3)-6-oxo-3-pyridinecarboxamide; 1,6-Dihydro-1-(methyl-d3)-6-oxonicotinamide; 3-Carbamoyl-1-(methyl-d3)-6-pyridone; N1-(Methyl-d3)-2-pyridone-5-carb |
Nudifloramide | 701-44-0 | C7H8N2O2 | 152.15 | N-Methyl-2-pyridoxone-5-carboxamide; N-Methyl-2-pyridinone-5-carboxamide; 1,6-Dihydro-1-methyl-6-oxo-3-pyridinecarboxamide; 1,6-Dihydro-1-methyl-6 -oxonicotinamide; |
Nudicaucin B | 211557-36-7 | C47H76O17 | 913.11 | (3beta)-3-[(3-O-beta-D-Galactopyranosyl-alpha-L-arabinopyranosyl)oxy]-olean-12-en-28-oic acid beta-D-glucopyranosyl ester |
Nudicaucin A | 211815-97-3 | C46H72O17 | 897.07 | (3beta)-3-[(3-O-beta-D-Galactopyranosyl-alpha-L-arabinopyranosyl)oxy]-30-noroleana-12,20(29)-dien-28-oic acid beta-D-glucopyranosyl ester |
Nucleozin | 341001-38-5 | C21H19ClN4O4 | 426.85 | 1-(2-Chloro-4-nitrophenyl)-4-[(5-methyl-3-phenyl-4-isoxazolyl)carbonyl]-piperazine, Nucleozin, [4-(2-Chloro-4-nitro-phenyl)-piperazin-1-yl]-(5-methyl-3-phenyl-isoxazol-4-yl)-methanone |
NU7441 | 503468-95-9 | C25H19NO3S | 413.491 | NU7441; NU-7441; NU 7441. |
NU-7200 | 842122-14-9 | C17H17NO4 | 299.326 | NU-7200; NU 7200; NU7200. |
NU-7199 | 69541-04-4 | C17H17NO4 | 299.326 | NU-7199; NU 7199; NU7199. |
NU-7107 | 503465-21-2 | C18H19N3O2 | 309.362 | NU-7107; NU 7107; NU7107. |
NU-7031 | 79105-88-7 | C14H15NO4 | 261.277 | NU-7031; NU7031; NU 7031. |
NU7026 | 154447-35-5 | C17H15NO3 | 281.311 | DNA-PK Inhibitor II; 2-(Morpholin-4-yl)-benzo[h]chromen-4-one; 2-morpholin-4-ylbenzo[h]chromen-4-one |
NU6140 | 444723-13-1 | C23H30N6O2 | 422.533 | NU6140; NU-6140; NU 6140. |
NU6027 | 220036-08-8 | C11H17N5O2 | 251.29 | NU6027; NU-6027; NU 6027. |
NU2058 | 161058-83-9 | C12H17N5O | 247.3 | NU2058; NU 2058; NU-2058; O(6)-Cyclohexylmethylguanine. |
NU1085 | 188106-83-4 | C14H11N3O2 | 253.261 | NU1085; NU-1085; NU 1085. |
NU1064 | 63916-38-1 | C9H9N3O | 175.19 | NU1064; NU-1064; NU 1064. |
NU1025 | 90417-38-2 | C9H8N2O2 | 176.175 | NU1025; NU-1025; NU 1025. |
NU 9056 | 1450644-28-6 | C6H4N2S4 | 232.37 | 5-(1,2-Thiazol-5-yldisulfanyl)-1,2-thiazole |
NU 6102 | 444722-95-6 | C18H22N6O3S | 402.5 | NU-6102; NU6102; 4-[[6-(cyclohexylmethoxy)-7H-purin-2-yl]amino]benzenesulfonamide |
N-Trityl Candesartan | 139481-72-4 | C43H34N6O3 | 682.79 | |
n-Tritriacontan-16,18-dione | 24514-86-1 | C33H64O2 | 492.873 | 16,18-Tritriacontanedione; tritriacontane-16,18-dione |
N-Trithyl Losartan | 124751-00-4 | C41H37ClN6O | 665.24 | 2-Butyl-4-chloro-5-hydroxymethyl-1-[[2'-(1H-2-triphenylmethyl-tetrazol-5-yl)biphenyl-4-yl]methyl]imidazole |
N-TRIMETHYLSILYLANILINE | 3768-55-6 | C9H15NSi | 165.31 | 1,1,1-Trimethyl-N-phenylsilamine; 1,1,1-trimethyl-n-phenyl-silanamin; 1,1,1-trimethyl-N-phenyl-Silanamine; N-Phenyl-N-(trimethylsilyl)amine; N-Phenyltrimethylsilylamine; Phenyl(trimethylsilyl)amine |
N-TRIMETHOXYSILYLPROPYL-N,N,N-TRIMETHYLAMMONIUM CHLORIDE | 35141-36-7 | C9H24ClNO3Si | 257.83 | N-TRIMETHOXYSILYLPROPYL-N,N,N-TRIMETHYLAMMONIUM CHLORIDE; n,n,n-trimethyl-3-(trimethoxysilyl)-1-propanaminiuchloride; trimethyl-3-(trimethoxysilyl)propylammonium chloride; N-(3-(TRIMETHOXYSILYL)PROPYL)-N,N,N-TRI- ME.AMMONIUM CHLORIDE; N-Trimethoxysilylpro |
N-Tri-boc Tobramycin | 502610-97-1 | C33H61N5O15 | 767.86 | |
NTRC 824 | 1623002-61-8 | C25H26F3N3O6S | 553.55 | N-[2-[5-[[(4-Methylphenyl)sulfonyl]amino]-3-(2,2,2-trifluoroacetyl)-1H-indol-1-yl]acetyl]-L-leucine; NTRC-824; NTRC 824; NTRC824 |
N-trans-Sinapoyltyramine | 200125-11-7 | C19H21NO5 | 343.379 | N-Sinapoyltyramine |
NPEC-caged-(S)-3,4-DCPG | 1257323-85-5 | C19H16N2O10 | 432.34 | (N)-1-(2-Nitrophenyl)ethylcarboxy-(S)-3,4-Dicarboxyphenylglycine |
NPEC-caged-(1S,3R)-ACPD | 1315379-60-2 | C16H18N2O8 | 366.32 | (1S,3R)-1-(2-Nitrophenyl)ethylcarboxyaminocyclopentane-1,3-dicarboxylic acid |
NPEC-caged serotonin | 1257326-22-9 | C19H19N3O5 | 369.37 | 3-((N)-1-(2-Nitrophenyl)ethylcarboxy)-(2-Aminoethyl)-1H-indol-5-ol |
NPE-caged-proton | 1186195-63-0 | C8H8NNaO6S | 269.21 | 1-(2-Nitrophenyl)ethyl sulfate sodium salt |
NPE-caged-GTP | 124830-99-5 | C18H23N6O16P3(free acid) | 672.33 (free acid) | Guanosine-5'-triphosphate, P3-(1-(2-nitrophenyl)-ethyl)-ester |
NPE-caged-ATP | 67030-27-7 | C18H23N6O15P3(free acid) | 656.33 (free acid) | Adenosine-5'-triphosphate, P3-(1-(2-nitrophenyl)-ethyl)-ester |
Nisin Z | 137061-46-2 | C141H229N41O38S7 | 3331.05 | |
Nisin | 1414-45-5 | C143H230N42O37S7 | 3354.07 | |
Niraparib | 1038915-60-4 | C19H20N4O | 320.396 | MK-4827; (S)-2-(4-(piperidin-3-yl)phenyl)-2H-indazole-7-carboxamide; ZEJULA; 2-[4-[(3S)-piperidin-3-yl]phenyl]indazole-7-carboxamide |
Niranthin | 50656-77-4 | C24H32O7 | 432.5 | 3',4',5,9,9'-PentaMethoxy-3,4-Methylenedioxylignan |
Neonuezhenide | 96382-91-1 | C31H42O18 | 702.65 | |
Neomycin Sulfate EP Impurity A (Neamine) | 3947-65-7 | C12H26N4O6 | 322.36 | Negamicin; Dekamycin V; Neomycin A; 4-O-(2,6-Diamino-2,6-dideoxy-alpha-D-glucopyranosyl)-2-deoxy-D-streptamine; 2-Desoxy-4-O-(2,6-diamino-2,6-didesoxy-alpha-D-glucopyranosyl)-D-streptamin; BRN 0026714 |
Neomycin sulfate | 1405-10-3 | C23H46N6O13.H2SO4 | 712.72 | |
Neomycin C sulfate | 66-86-4 | C23H46N6O13.xH2SO4 (lot specific) | 614.64 (Free base) | |
Neomycin B sulfate | 119-04-0 | C23H46N6O13.xH2SO4 (lot specific) | 614.64 (Free base) | |
Neomycin | 1404-04-2 | C23H46N6O13 | 614.66 | o-2,6-diamino-2,6-dideoxy-.beta.-l-idopyranosyl-(1.->3)-o-.beta.-d-ribofuranosyl-(1->5)]-o-[2,6-diamino-2,6-dideoxy-.alpha.-d-glucopyranosyl-(1->4)]-2-deoxy sulfate; |
Neomangiferin | 64809-67-2 | C25H28O16 | 584.48 | 2-(b-D-Glucopyranosyl)-7-(b-D-glucopyranosyloxy)-1,3,6-trihydroxy-9H-xanthen-9-one |
Neolitsine | 2466-42-4 | C19H17NO4 | 323.4 | [7S,(+)]-6,7,7a,8-Tetrahydro-7-methyl-5H-bis[1,3]benzodioxolo[6,5,4-de:5',6'-g]quinoline |
Neoliquiritin | 5088-75-5 | C21H22O9 | Ergoline-8-carboxamide,9,10-didehydro-N-[(1S)-1-[[(3S,8aR)-hexahydro-1,4-dioxo-3-(phenylmethyl)pyrrolo[1,2-a]pyrazin-2(3H)-yl]carbonyl]-2-methylpropyl]-6-methyl-,(8b)- | |
Neolinine | 112515-37-4 | C23H37NO6 | 423.54 | (1alpha,6alpha,14alpha,16beta)-20-Ethyl-4-(hydroxymethyl)-6,16-dimethoxyaconitane-1,8,14-triol |
N-Deshydroxyethyl Dasatinib | 910297-51-7 | C20H22ClN7OS | 443.95 | N-(2-Chloro-6-methylphenyl)-2-[[2-methyl-6-(1-piperazinyl)-4-pyrimidinyl]amino]-5-thiazolecarboxamide; Dasatinib metabolite M4 |
N-Desethyloxybutynin | 80976-67-9 | |||
N-Desethyl-N-Methyl Vardenafil | 224785-87-9 | C22H30N6O4S | 474.59 | UNII-U1J85UZ69Z; CHEMBL168949; U1J85UZ69Z; N-Desmethylvardenafil; SCHEMBL5537; AIVNVMRJLJHFCU-UHFFFAOYSA-N; 2-[2-ethoxy-5-(4-methylpiperazin-1-yl)sulfonylphenyl]-5-methyl-7-propyl-1H-imidazo[5,1-f][1,2,4]triazin-4-one |
NTR 368 | 197230-90-3 | C69H124N22O19 | 1565.87 | (3S)-3-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-acetamidopropanoyl]amino]-3-hydroxybutanoyl]amino]-4-methylpentanoyl]amino]-4-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-1,5-diamino-1,5-dioxopentan-2-yl]amino]-3-methyl- |
NTNCB hydrochloride | 191931-56-3 | C25H33N3O4S.HCl | 508.07 | 2-Nitro-N-[[trans-4-[[[(1,2,3,4-tetrahydro-2-naphthalenyl)methyl]amino]methyl]cyclohexyl]methyl]benzenesulfonamide hydrochloride |
N-Tigloylglycine-2,2-d2 | 1219806-44-6 | CH3CH=C(CH3)CONHCD2COOH | 159.18 | N-trans-2-Methyl-2-butenoylglycine-d2; Tigloylaminoacetic Acid-d2; Tiglylglycine-d2; 2,2-dideuterio-2-(2-methylbut-2-enoylamino)acetic acid |
N-Thioglycolyl-D-galactosamine | 1334320-74-9 | C8H15NO6S | 253.27 | GalNTGc |
N-TETRADECYL-D29 ALCOHOL | 284474-78-8 | C14HD29O | 243.57 | N-TETRADECYL-D29 ALCOHOL; 1-TETRADECAN-D29-OL |
N-TETRADECYL-1,1-D2 ALCOHOL | 169398-02-1 | C14H28D2O | 216.4 | N-TETRADECYL-1,1-D2 ALCOHOL |
N-STEAROYL-D-SPHINGOMYELIN | 58909-84-5 | C41H84N2O6P | 732.0892 | |
NSP-SA-NHS | 199293-83-9 | C32H31N3O10S2 | 681.731 | 3-(9-((4-((2,5-Dioxopyrrolidin-1-yl)oxy)-4-oxobutyl)(tosyl)carbamoyl)acridin-10-ium-10-yl)propane-1-sulfonate |
N-sodiohexamethyldisilazane | 1070-89-9 | C6H18NNaSi2 | 183.37 | 1,1,1-trimethyl-n-(trimethylsilyl)-silanaminsodiumsalt; sodium-bis-(trimethylsilyl)-amide(solutioninthf); sodiumhexamethyldisilazane,nahmds,in; sodiumhexamethyldisilazane,nahmds,intetrahydrofuran; SODIUM HEXAMETHYLDISILAZANE; SODIUM HEXAMETHYLDISILAZIDE |
NSI-189 | 1270138-40-3 | C22H30N4O | 366.5 | NSI-189; NSI 189; NSI189 |
Norlichexanthone | 20716-98-7 | C14H10O5 | 258.2 | 3,6,8-Trihydroxy-1-methylxanthone; 1,3,6-Trihydroxy-8-methyl-9H-xanthen-9-one; |
Norkurarinone | 34981-24-3 | C25H28O6 | Kushenol F; 2',4',5,7-Tetrahydroxy-6-lavandulylflavanone; | |
Norkhellol | 4439-68-3 | C12H8O5 | 232.2 | 4-Hydroxy-7-(hydroxymethyl)-5H-furo[3,2-g]chromen-5-one |
Norisoboldine | 23599-69-1 | C18H19NO4 | 313.35 | norisoboldine; (+)-Laurelliptine; (+)-N-Norisoboldine; (6aS)-5,6,6a,7-Tetrahydro-2,10-dimethoxy-4H-dibenzo[de,g]quinoline-1,9-diol; (S)-(+)-Laurelliptine |
N-Nonyldeoxygalactonojirimycin | 223771-83-3 | C15H31NO4 | 289.41 | |
N-Nonanoyl-N-methylglucamine | 85261-19-4 | C16H33NO6 | 335.44 | Mega-9 |
N-Nonanoylmorpholine | 5299-64-9 | C13H25NO2 | 227.34 | 1-(4-morpholino)-1-nonanon; 1-Nonanone, 1-(4-morpholino)-; 4-(1-oxononyl)-morpholin; 4-(1-oxononyl)morpholine; 4-nonanoyl-morpholin; 4-Nonanoylmorpholine |
N-Methylcalycinine | 86537-66-8 | C19H19NO4 | 325.4 | (7aR)-10-Methoxy-7-methyl-6,7,7a,8-tetrahydro-5H-[1,3]benzodioxol o[6,5,4-de]benzo[g]quinolin-12-ol |
N-Methylbenzohydrazide hydrochloride | 1660-25-9 | C8H10N2O.HCl | 186.64 | |
N-Methylbenzohydrazide | 1483-24-5 | C8H10N2O | 150.18 | |
NF 449 | 627034-85-9 | C41H24N6Na8O29S8 | 1505.06 | 4,4',4'',4'''-[Carbonylbis(imino-5,1,3-benzenetriyl-bis(carbonylimino))]tetrakis-1,3-benzenedisulfonic acid, octasodium salt |
NF 340 | 202982-98-7 | C37H26N4Na4O15S4 | 986.84 | 4,4'-(Carbonylbis(imino-3,1-(4-methyl-phenylene)carbonylimino))bis(naphthalene-2,6-disulfonic acid) tetrasodium salt |
NF 279 | 202983-32-2 | C49H30N6Na6O23S6 | 1401.1 | 8,8'-[Carbonylbis(imino-4,1-phenylenecarbonylimino-4,1-phenylenecarbonylimino)]bis-1,3,5-naphthalenetrisulfonic acid hexasodium salt |
NF 1819 | 1881244-28-5 | C24H22FN5O4 | 463.46 | (3R,4S)-rel-4-(1,3-Benzodioxol-5-yl)-3-(4-fluorophenyl)-1-[1-(1H)-1,2,4-triazol-1-carbonyl)-4-piperidinyl]-2-azetidinone |
NF 157 | 104869-26-3 | C49H28F2N6Na6O23S6 | 1437.08 | 8,8'-[Carbonylbis[imino-3,1-phenylenecarbonylimino(4-fluoro-3,1-phenylene)carbonylimino]]bis-1,3,5-naphthalenetrisulfonic acid hexasodium salt |
NF 110 | 111150-22-2 | C41H28N6Na4O17S4 | 1096.9 | 4,4',4'',4'''-[Carbonylbis[imino-5,1,3-benzenetriylbis(carbonylimino)]]tetrakisbenzenesulfonic acid tetrasodium salt |
NF 023 | 104869-31-0 | C35H20N4Na6O21S6 | 1162.86 | 8,8'-[carbonylbis(imino-3,1-phenylenecarbonylimino)]bis-1,3,5-naphthalene-trisulphonic acid, hexasodium salt |
Nexturastat A | 1403783-31-2 | C19H23N3O3 | 341.411 | Nexturastat A |
N-Chloroethylmorpholine | 3240-94-6 | C6H12ClNO | 149.61858;g/mol | 4-(2-Chloroethyl)morpholine; 3240-94-6; Morpholine,4-(2-chloroethyl)-; 4-(2-Chloro-ethyl)-morpholine; N-(2-Chloroethyl)morpholine; Morpholinoethylchloride |
N-CHLOROACETYLSUCCINIMIDE | 38766-10-8 | C6H6ClNO3 | 175.57 | N-CHLOROACETYLSUCCINIMIDE |
N-Chloroacetyl-L-tyrosine | 1145-56-8 | C11H12ClNO4 | 257.67 | |
N-Chloroacetyl DL-Homocysteine Thiolactone | 84611-22-3 | C6H8ClNO2S | 193.65 | 2-Chloro-N-(tetrahydro-2-oxo-3-thienyl)acetamide |
N-Benzyl-D-glucamine | 74410-48-3 | |||
N-BENZYL-BISPIDINE | 69407-32-5 | C14H20N2 | 216.32 | N-BENZYL-BISPIDINE |
N-Benzoyl-d5-glycine | 53518-98-2 | C6D5CONHCH2COOH | 184.21 | Hippuric Acid-d5; Benzoylaminoacetic Acid-d5; Bz-Gly-OH-d5; 2-[(2,3,4,5,6-pentadeuteriobenzoyl)amino]acetic acid |
NSC93690 | 3166-88-9 | C10H16ClN | 0 | NSC93690; 4-EthylphenethylamineHCl |
NSC87877 | 56990-57-9 | C19H13N3O7S2 | 459.45 | 5-Quinolinesulfonic acid, 8-hydroxy-7-(6-sulfo-2-naphthylazo)-;8-Hydroxy-7-[(6-sulfo-2-naphthyl)azo]-5-quinolinesulfonic acid;NSC-87877;(E)-8-hydroxy-7-((6-sulfonaphthalen-2-yl)diazenyl)quinoline-5-sulfonic acid;(7E)-8-oxo-7-[(6-sulfonaphthalen-2-yl)hydra |
NSC781406 | 1676893-24-5 | C29H27F2N5O5S2 | 627.68 | 2,4-difluoro-N-[2-methoxy-5-[4-[3-(4-methylsulfonylpiperazin-1-yl)prop-1-ynyl]quinolin-6-yl]pyridin-3-yl]benzenesulfonamide; CHEMBL3763244; BDBM50145412 |
NSC697923 | 343351-67-7 | C11H9NO5S | 267.26 | |
NSC659000 | 139449-81-3 | C20H13Cl2N3O2 | 398.24 | (E)-7-chloro-2-(4-chlorostyryl)-3-(3-methylisoxazol-5-yl)quinazolin-4(3H)-one |
NSC-601980 analog | 91757-46-9 | C15H14N4 | 250.30 | NSC601980 analog |
NSC59984 | 803647-40-7 | C12H15N3O4 | 265.27 | NSC-59984; NSC 59984. |
NSC5844 | 140926-75-6 | C20H16Cl2N4 | 383.27 | N,N'-bis(7-chloroquinolin-4-yl)ethane-1,2-diamine; NSC5844; NSC-5844; NSC 5844; RE640; RE-640; R E640 |
NSC-41589 | 6310-41-4 | C9H11NOS | 181.25 | |
NS 398 | 123653-11-2 | C13H18N2O5S | 314.36 | N-[2-Cyclohexyloxy-4-nitrophenyl]methanesulfonamide |
NS 3861 | 216853-60-0 | C12H14BrNS.C4H4O4 | 400.29 | 3-(3-Bromo-2-thienyl)-8-methyl-8-azabicyclo[3.2.1]oct-2-ene fumarate |
NS 3763 | 70553-45-6 | C22H16N2O6 | 404.37 | |
NS 3694 | 426834-38-0 | C15H10ClF3N2O3 | 358.7 | Apoptosis Inhibitor II; 4-chloro-2-[[3-(trifluoromethyl)phenyl]carbamoylamino]benzoic acid |
NS 3623 | 343630-41-1 | C15H10BrF3N6O | 427.18 | N-[4-Bromo-2-(1H-tetrazol-5-yl-phenyl]-N'-[3-(trifluoromethyl)phenyl]-urea |
NS 30678 hydrochloride | 1193707-19-5 | C12H16ClNO4S.HCl | 342.24 | |
NS 2028 | 204326-43-2 | C9H5BrN2O3 | 269.05 | 8-Bromo-1H,4H-[1,2,4]oxadiazolo[3,4-c][1,4]benzoxazin-1-one |
NS 19504 | 327062-46-4 | C10H9BrN2S | 269.16 | 5-[(4-Bromophenyl)methyl]-2-thiazolamine |
NS 1738 | 501684-93-1 | C14H9Cl2F3N2O2 | 365.13 | N-(5-Chloro-2-hydroxyphenyl)-N'-[2-chloro-5-(trifluoromethyl)phenyl]urea |
NS 1643 | 448895-37-2 | C15H10F6N2O3 | 380.06 | 1,3-Bis(2-hydroxy-5-trifluoromethylphenyl)urea; N,N'-Bis[2-hydroxy-5-(trifluoromethyl)phenyl]urea; |
NS 1619 | 153587-01-0 | C15H8F6N2O2 | 362.23 | 3-[2-hydroxy-5-(trifluoromethyl)phenyl]-6-(trifluoromethyl)-1H-benzimidazol-2-one NS 1619 153587-01-0 NS-1619 1-(2-hydroxy-5-(trifluoromethyl)phenyl)-5-(trifluoromethyl)-1H-benzo[d]imidazol-2(3H)-one CHEMBL384903 |
NS 11394 | 951650-22-9 | C23H19N3O | 353.42 | 2-[3-[5-(2-hydroxypropan-2-yl)benzimidazol-1-yl]phenyl]benzonitrile;NS-11394;3'-[5-(1-Hydroxy-1-methylethyl)-1H-benzimidazol-1-yl]-[1,1'-biphenyl]-2-carbonitrile |
NS 11021 | 956014-19-0 | C16H9BrF6N6S | 511.24 | N'-[3,5-Bis(trifluoromethyl)phenyl]-N-[4-bromo-2-(2H-tetrazol-5-yl-phenyl]thiourea |
NRX-4204 | 220619-73-8 | C24H32O2 | 352.518 | NRX4204; NRX 4204; NRX194204; NRX 194204; NRX-194204; AGN-194204; VTP 194204 |
NRX-204647 | 1351452-80-6 | C24H27NO3 | 377.78 | 4-((1E,3Z)-3-(hydroxyimino)-3-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)prop-1-en-1-yl)benzoic acid |
NRC-2694 | 936446-61-6 | C24H26N4O3 | 418.49 | N-(3-ethynylphenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amine; NRC-2694; NRC 2694; NRC2694; 4-Quinazolinamine, N-(3-ethynylphenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)- |
NQTrp | 185351-19-3 | C21H16N2O4 | 360.36 | (2S)-2-[(1,4-dioxonaphthalen-2-yl)amino]-3-(1H-indol-3-yl)propanoic acid; 185351-19-3; nqtrp; TRY001; DTXSID30717912; ZINC100222454; KB-274843; N-(1,4-Dioxo-1,4-dihydronaphthalen-2-yl)-L-tryptophan; L-Tryptophan, N-(1,4-dihydro-1,4-dioxo-2-naphthalenyl)-; |
NQDI-1 | 175026-96-7 | C19H13NO4 | 319.31 | NQDI1; NQDI-1; NQDI 1. CAS#175026-96-7 |
NQ 301 | 130089-98-4 | C18H12ClNO3 | 325.75 | 2-[(4-Acetylphenyl)amino]-3-chloro-1,4-naphthalenedione |
N-Pyrrolidin-3-amino-3-(2'-chlorophenyl)propionamide | 886362-98-7 | C13H17ClN2O | 252.73 | |
N-Pyridin-2-yl-Oxalamic Acid Ethyl Ester | 41374-72-5 | C9H10N2O3 | 194.19 | EdoxaBan impurity K |
N-Pyridin-2-yl[1,1'-biphenyl]-4-acetamide | 51484-40-3 | C19H16N2O | 288.34314 | N-pyridin-2-yl[1,1'-biphenyl]-4-acetamide; difenpiramide; Difenpyramide; N-(2-Pyridinyl)-1,1'-biphenyl-4-acetamide |
NPY 5RA972 | 439861-56-0 | C21H25N3O2 | 351.44 | N-[4-Methyl-9-(1-methylethyl)-9H-carbazol-3-yl]-4-morpholinecarboxamide |
N-p-Tolyl-guanidine | 54015-04-2 | C8H11N3 | 149.19 | N-P-TOLYL-GUANIDINE |
NPS-2143 hydrochloride | 324523-20-8 | C24H26Cl2N2O2 | 445.38 | NPS2143 hydrochloride; NPS 2143 hydrochloride |
NPS-2143 | 284035-33-2 | C24H25ClN2O2 | 408.92 | SB262470 |
NPS-1034 | 1221713-92-3 | C31H23F2N5O3 | 551.554 | NPS-1034; NPS1034; NPS 1034 |
NPS ALX Compound 4a dihydrochloride | 299433-10-6 | C25H25N3O2S.2HCl | 504.47 | 6-(Hexahydropyrrolo[1,2-a]pyrazin-2(1H)-yl)-1-(1-naphthalenylsulfonyl)-1H-indole dihydrochloride |
NPS 2390 | 226878-01-9 | C19H21N3O | 307.39 | N-tricyclo[3.3.1.13,7]dec-1-yl-2-quinoxalinecarboxamide |
n-Propyltrimethoxysilane | 1067-25-0 | C6H16O3Si | 164.28 | N-PROPYLTRIMETHOXYSILANE; n-Propyltrimethoxysilane(Trimethoxypropylsilane); PROPYLTRIMETHOXYSILANE; CP0810; Dynasylan PTMO; trimethoxypropyl-silan |
n-Propyltriethoxysilane | 2550-02-9 | |||
NPEC-caged-dopamine | 1257326-23-0 | C17H18N2O6 | 346.33 | (N)-1-(2-Nitrophenyl)ethylcarboxy-3,4-dihydroxyphenethylamine |
NPEC-caged-D-AP5 | 1416943-27-5 | C14H19N2O9P | 390.28 | D-[[1-(2-Nitrophenyl)ethyl]carbamoyl]-2-amino]-5-phosphonopentanoic acid |
N-p-Coumaroyltyramine | 36417-86-4 | C17H17NO3 | 283.3 | (2E)-3-(4-Hydroxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]acrylamide |
N-p-Coumaroyloctopamine | 66648-45-1 | C17H17NO4 | 299.32 | trans-N-(p-Coumaroyl)octopamine;OctopaMine, N-p-couMaroyl- |
N-p-Coumaroyl-N'-caffeoylputrescine | 1138156-77-0 | C22H24N2O5 | 396.443 | 3-(3,4-Dihydroxyphenyl)-N-(4-(3-(4-hydroxyphenyl)acrylamido)butyl)acrylamide; (E)-N-[4-[[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]amino]butyl]-3-(4-hydroxyphenyl)prop-2-enamide |
NPC-15437 hydrochloride | 141774-20-1 | C25H50N4O2·2HCl | 511.6 | NPC 15437 dihydrochloride; (S)-2,6-Diamino-N-[(1-(1-oxotridecyl)-2-piperidinyl)methyl]hexanamide dihydrochloride |
N-Palmitoyl-L-aspartate | 1782-17-8 | C20H37NO5 | 371.5 | BRN 2295471; Palmitoyl-L-aspartic acid; L-N-Palmitoylaspartic acid; N-Palmitoyl-L-aspartic acid; (2S)-2-(hexadecanoylamino)butanedioic acid |
N-Palmitoyl-D-sphingomyelin | 6254-89-3 | C39H79N2O6P | 703.043 | P-SM18; N-Palmitoylsphingomyelin; C16 Sphingomyelin; Palmitoyl Sphingomyelin; Hexadecanoyl Sphingomyelin; [(E,2S,3R)-2-(hexadecanoylamino)-3-hydroxyoctadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate |
NP-118809 | 41332-24-5 | C32H32N2O | 460.61 | 1-(4-benzhydrylpiperazin-1-yl)-3,3-diphenylpropan-1-one; 1-(Diphenylmethyl)-4-(1-oxo-3,3-diphenylpropyl)piperazine; |
N-Oxide nicotine dichlorhydrate | 23155-03-5 | C10H14N2O.2HCl | 251.151 | 3-[(2S)-1-methylpyrrolidin-2-yl]-1-oxidopyridin-1-ium dihydrochloride |
N-oxalylglycine | 5262-39-5 | |||
NoxA1ds | 1435893-78-9 | C50H88N14O15 | 1125.33 | Glu-Pro-Val-Asp-Ala-Leu-Gly-Lys-Ala-Lys-Val-NH2 |
Novokinin | 358738-77-9 | C39H61N11O7 | 795.98 | Novokinin; L-arginyl-L-prolyl-L-leucyl-L-lysyl-L-prolyl-L-tryptophan |
Norscopolamine | 4684-28-0 | C16H19NO4 | 289.3 | 3-Oxa-9-azatricyclo[3.3.1.02,4]non-7-yl tropate; [7(S)-(1alpha,.2beta,4beta,5alpha,7beta)]-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl (hydroxymethyl)phenylacetate |
Nortriptyline-d3 Hydrochloride | 203784-52-5 | C19D3H19C1N | 302.86 | 3-(10,11-Dihydro-5H-dibenzo[a,d]cyclohepten-5-ylidene)-N-(methyl-d3)-1- propanamine Hydrochloride; Acetexa-d3; Allegron-d3; Nortrilen-d3; Norzepine-d3; Pamelor-d3; Sensival-d3; Vividyl-d3; |
Norsanguinarine | 522-30-5 | C19H11NO4 | 317.3 | Sanguinarine, 13-demethyl-; (1,3)Benzodioxolo(5,6-c)-1,3-dioxolo(4,5-i)phenanthridine; 1,3-Dioxolo(i)(1,3)dioxolo(4,5)benzo(1,2-c)phenanthridine; 1,3-Dioxolo[i][1,3]dioxolo[4,5]benzo[1,2-c]phenanthridine |
Norpterosin B glucoside | 1226785-88-1 | C19H26O7 | 366.41 | 2alpha,5,7-Trimethyl-6-(beta-D-glucopyranosyloxymethyl)-2,3-dihydro-1H-indene-1-one |
Norpterosin B | 1226892-20-1 | C13H16O2 | 204.26 | (2R)-2,3-Dihydro-6-(hydroxymethyl)-2,5,7-trimethyl-1H-inden-1-one;(2R)-Norpterosin B |
Noribogaine HCl | 110514-35-7 | C19H25N2OCl | 332.88 | |
Norphenylephrine Hydrochloride | 15308-34-6 | C8H11NO2.HCl;C8H12ClNO2 | 189.64 | Norphenylephrine Hydrochloride |
Nornidulin | 33403-37-1 | C19H15Cl3O5 | 429.7 | Ustin |
Nornicotine-d4 | 66148-18-3 | C9H8N2D4 | 152.23 | (R,S)-Nornicotine-d4;3-(2-Pyrrolidinyl)pyridine-d4; (±)-1'-Demethylnicotine-d4; (±)-3-(2-Pyrrolidinyl)pyridine-d4; (±)-1'-Demethylnicotine-d4 |
Nornicotine (3-(2-pyrrolidinyl)pyridine) | 494-97-3 | C9H12N2 | 148.21 | 3-[(2S)-2-Pyrrolidinyl]pyridine; |
Norneovardenafil | 358390-39-3 | C18H20N4O4 | 356.38 | 3-(1,4-Dihydro-5-methyl-4-oxo-7-propylimidazo[5,1-f][1,2,4]triazin-2-yl)-4-ethoxybenzoic Acid |
Norneo sildenafil | 371959-09-0 | C22H29N5O4S | 459.56 | 5-[2-Ethoxy-5-(1-piperidinylsulfonyl)phenyl]-1,6-dihydro-1-methyl-3-propyl-7H-pyrazolo[4,3-d]pyrimidin-7-one; 1-[[3-(4,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxyphenyl]sulfonyl]piperidine; |
Nornalmefene | 42971-33-5 | C17H19NO3 | ||
Noricaritin | 5240-95-9 | C20H20O7 | 372.37 | 3,4',5,7-Tetrahydroxy-8-(3-hydroxy-3-methylbutyl)flavone; 3,5,7-Trihydroxy-8-(3-hydroxy-3-methylbutyl)-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one |
Norharmane | 244-63-3 | C11H8N2 | 168.19 | 9H-Pyrido[3,4-b]indole |
Norglaucine hydrochloride | 39945-41-0 | C20H24ClNO4 | 377.86 | 5,6,6a,7-Tetrahydro-1,2,9,10-tetramethoxy-4H-dibenzo[de,g]quinoline hydrochloride |
Norgestimate-2,2,4,6,6,10-D6 | 1263194-12-2 | C23H25NO3D6 | 375.54 | Norgestimate-2,2,4,6,6,10-D6, Norgestimate-D6, (17 - alpha;)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one-D6 3-Oxime; Dexnorgestrel Acetime-D6; D-138-D6; ORF-10131-D6 |
Norethindrone Related Compound | 142154-46-9 | C28H36O6 | 468.6 | [(3S,8R,9S,10R,13S,14S,17R)-3-acetyloxy-17-ethynyl-13-methyl-2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl] (Z)-3-acetyloxybut-2-enoate; |
norethindrone acetate | 51-98-9 | C22H28O3 | 340.46 | |
Norethindrone (Norethisterone) | 68-22-4 | C20H26O2 | 298.42 | |
Norepinephrine-d6 HCl | 1219803-04-9 | C8H5NO3D6.HCl | 211.68 | DL-Norepinephrine-d6 Hydrochloride; 4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol-d6; (+/-)-Noradrenaline-d6 Hydrochloride; DL-Arterenol-d6 Hydrochloride; |
Norepinephrine Tartrate Impurity G | 13062-58-3 | C22H21NO3 | 347.42 | 2-(Dibenzylamino)-3',4'-dihydroxy-acetophenone Hydrochloride |
Norepinephrine Tartrate Impurity D | 1932110-67-2 | C9H13NO3 | 183.21 | (R)-4-(2-amino-1-methoxyethyl)benzene-1,2-diol |
Norepinephrine Tartrate Impurity 3 | 35538-87-5 | C8H11NO6S | 249.24 | This is a controlled substance:Next for Status |
Norepinephrine Tartrate Impurity 2 | 24159-36-2 | C8H11NO5S | 233.24 | |
Norepinephrine Tartrate (Noradrenaline Tartrate) | 339091-66-6 | C8H11NO3. C4H6O6 | 319.26 | Noradrenaline Tartrate; 1,2-Benzenediol, 4-[(1R)-2-amino-1-hydroxyethyl]-, 2,3-dihydroxybutanedioate |
Norepinephrine Impurity (2-Amino-1-(3,4-dihydroxyphenyl)ethan-1-one HCl) | 5090-29-9 | C8H9NO3. HCl | 203.62 | 2-Amino-1-(3,4-dihydroxyphenyl)ethan-1-one HCl |
Norepinephrine hydrochloride | 329-56-6 | C8H12ClNO3 | 205.64 | L-Arterenol hydrochloride, L-Noradrenaline hydrochloride |
Nordihydro Capsaicin | 28789-35-7 | C17H27NO3 | 293.41 | N-[(4-Hydroxy-3-methoxyphenyl)methyl]-7-methyl-octanamide; Norhydrocapsaicin; Octanamide, N-((4-hydroxy-3-methoxyphenyl)methyl)-7-methyl- |
Norcepharadione B | 57576-41-7 | C18H13NO4 | 307.305 | Norcepharadione; 1,2-dimethoxy-4h-dibenzo[de,g]quinoline-4,5(6h)-dione |
norcarane | 286-08-8 | C7H12 | 96.17 | Bicyclo[4.1.0]heptane; Norcarane |
Norcantharidin | 5442-12-6 | C8H8O4 | 168.15 | 3,6-ENDOXOHEXAHYDROPHTHALIC ANHYDRIDE; 7-OXABICYCLO[2.2.1]HEPTANE-2,3-DICARBOXYLIC ANHYDRIDE; EXO-7-OXABICYCLO[2.2.1]HEPTANE-2,3-DICARBOXYLIC ANHYDRIDE; TIMTEC-BB SBB008464; TIMTEC-BB SBB005955; NORCANTHARIDIN; 4,7-Epoxyisobenzofuran-1,3-dione, hexahydro- |
Norcantharidin | 29745-04-8 | C8H8O4 | 168.15 | |
Norcaesalpinin E | 854038-96-3 | C21H28O6 | 376.44 | 17-Norbonducellpin C |
Norbraylin | 60796-64-7 | C14H12O4 | 244.2 | 6-Hydroxy-8,8-dimethyl-2H,8H-benzo[1,2-b:3,4-b']dipyran-2-one; rbraylin |
nor-Binaltorphimine dihydrochloride | 113158-34-2 | C40H43N3O6.2HCl | 734.72 | Nor-BNI dihydrochloride; 17,17'-(Dicyclopropylmethyl)-6,6',7,7'-6,6'-imino- 7,7'-binorphinan-3,4',14,14'-tetrol dihydrochloride |
Nor-Binaltorphimine dihydrochloride | 113158-35-3 | C40H43N3O6.2HCl | 734.71 | |
Norathyriol | 3542-72-1 | C13H8O6 | 260.2 | 1,3,6,7-Tetrahydroxy-9H-xanthen-9-one;1,3,6,7-Tetrahydroxyxanthone; |
norastemizole | 75970-99-9 | C19H21FN4 | 324.401 | |
Norarmepavine | 3195-01-5 | C18H21NO3 | 299.364 | L-(-)-N-Norarmepavine |
Noradrenaline bitartrate monohydrate | 108341-18-0 | C8H11NO3.C4H6O6.H2O | 337.28 | Levophed |
Nor-acetildenafil | 949091-38-7 | C24H32N6O3 | 452.55 | 5-[2-Ethoxy-5-[2-(4-methyl-1-piperazinyl)acetyl]phenyl]-1,6-dihydro-1-methyl-3-propyl-7H-pyrazolo[4,3-d]pyrimidin-7-one; |
n-Octyl polyethyleneglycol ether phosphate | 39464-69-2 | C20H43O6P | 410.5256 | n-Octyl polyethyleneglycol ether phosphate; Oleyl alcohol ethoxylate phosphate |
n-Octyl b-D-maltoside | 82494-08-4 | C20H38O11 | 454.51 | Octyl 4-O-(a-D-glucopyranosyl)-b-D-glucopyranoside; OM; n-Octyl b-D-maltopyranoside |
n-Octyl acrylate | 2499-59-4 | C11H20O2 | 184.27 | ENT 3827; Octyl2-propenoate; OCTYL ACRYLATE; N-OCTYL ACRYLATE; Octylacrylate,n-; ACRYLICACID,N-OCTYLESTER; Octylacrylat |
N-Octanoylglycine-2,2-d2 | 1219805-51-2 | CH3(CH2)6CONHCD2COOH | 203.28 | N-Capryloylglycine-d2; N-Octanoylamino acetic acid-d2; 2,2-dideuterio-2-(octanoylamino)acetic acid |
n-Octanamide | 629-01-6 | C8H17NO | 143.23 | OCTANAMIDE; CAPRYLAMIDE; N-OCTANAMIDE; Caprylic acid amide |
N-OCTADECYLPHOSPHONIC ACID | 4724-47-4 | C18H39O3P | 334.47 | ODPA; N-OCTADECYLPHOSPHONIC ACID; octadecylphosphonic acid; N-OCTADECYLPHOSPHONIC ACID, 93+%; n-Octadecylphosphonicacid,min.97%; n-Octadecylphosphonic acid, 98 %; Octadecanephosphonic acid; n-Octadecylphosphonic acid,min. 97% |
N-Octadecyl-N'-propyl-sulfamide | 925891-74-3 | C21H46N2O2S | 390.7 | N-(propylsulfamoyl)octadecan-1-amine |
N-Octadecylfluorescein-5-thiourea | 65603-18-1 | C39H50N2O5S | 658.89 | N-(Fluorescein-5-thiocarbamoyl)octadecylamine |
N-Octadecylbenzylamine | 20198-87-2 | C25H45N | 359.6315;g/mol | N-Octadecylbenzylamine; N-Benzyloctadecylamine; N-Stearylbenzylamine; 20198-87-2; Benzenemethanamine,N-octadecyl-; N-benzyl-octadecylamine |
n-Octadecyl sulfide | 1844-09-3 | C36H74S2 | 539.04 | DIOCTADECYL SULFIDE; DI-N-OCTADECYLSULPIDE; DISTEARYL SULFIDE; N-OCTADECYL SULFIDE; OCTADECYL SULFIDE; STEARYL SULFIDE |
n-Octadecyl disodium sulfosuccinate | 14481-60-8 | 493.613 | DISODIUM N-OCTADECYL SULFOSUCCINAMATE; N-OCTADECYL DISODIUM SULFOSUCCINATE; 4-(octadecylamino)-4-oxo-2-sulfo-butanoicacidisodiumsalt; Butanoicacid,4-(octadecylamino)-4-oxo-2-sulfo-,disodiumsalt; disodium 4-(octadecylamino)-4-oxo-2-sulphonatobutyrate; DISO | |
Nocodazole | 31430-18-9 | C14H11N3O3S | 301.32 | methyl N-[6-(thiophene-2-carbonyl)-1H-benzimidazol-2-yl]carbamate; nocodazole; Oncodazole; 31430-18-9; R 17934; Nocodazolum; Nocidazole; Nocodazol; NSC 238159; Methyl N-(5-thenoyl-2-benzimidazolyl)carbamate; Methyl [5-(2-thienylcarbonyl)-1H-benzimidazol-2 |
Nocloprost | 79360-43-3 | C22H37ClO4 | 400.983 | |
Nocistatin (human) | 212609-11-5 | C149H238N42O53S3 | 3561.93 | Glu-Gln-Lys-Gln-Leu-Gln |
Nocistatin (bovine) | 208253-85-4 | C82H135N21O32 | 1927.07 | |
NocII | 188119-47-3 | C92H141N23O28S2 | 2081.4 | |
Nociceptin (1-7) | 178249-42-8 | C31H41N7O9 | 655.7 | L-Phenylalanylglycylglycyl-L-phenylalanyl-L-threonylglycyl-L-alanine; 1-7-Orphanin FQ (pig); (2S)-2-[[2-[[(2S,3R)-2-[[(2S)-2-[[2-[[2-[[(2S)-2-amino-3-phenylpropanoyl]amino]acetyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-3-hydroxybutanoyl]amino]acetyl] |
Nobiletin | 478-01-3 | C21H22O8 | 402.39 | Hexamethoxyflavone |
NO-1886 | 133208-93-2 | C19H20BrN2O4P | 451.3 | Ibrolipim; Lipoprotein Lipase Activator; LPL Activator; OPF 009; N-(4-bromo-2-cyanophenyl)-4-(diethoxyphosphorylmethyl)benzamide |
nNOS Inhibitor I | 357965-99-2 | C8H21N7O2·3CF3COOH | 589.4 | NOS I; ncNOS; N-[(4S)-4-Amino-5-[(2-aminoethyl]amino]P; N-[(4S)-4-amino-5-[(2-aminoethyl)amino]pentyl]-N'-nitroguanidine tris(trifluoroacetate) salt |
N-Nornuciferine | 4846-19-9 | C18H19NO2 | 281.355 | Daechualkaloid E; (6aR)-1,2-dimethoxy-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline |
N-Nonyldeoxynojirimycin | 81117-35-3 | C15H31NO4 | 289.41 | NN-DNJ |
N-Methyl-3-chloropropylamine hydrochloride | 97145-88-5 | C4H11Cl2N | 144.04 | N-METHYL-3-CHLOROPROPYLAMINE HYDROCHLORIDE; 3-(METHYLAMINO)PROPYL CHLORIDE HYDROCHLORIDE; n-methyl-3-chloropropylamineHCl |
N-Methyl-3-(trifluoromethyl)aniline | 2026-70-2 | C8H8F3N | 175.15 | METHYL-(3-TRIFLUOROMETHYL-PHENYL)-AMINE; N-METHYL-3-(TRIFLUOROMETHYL)ANILINE |
N-methyl-2-bromo-4-fluorobenzamide | 923138-87-8 | C8H7BrFNO | 0 | N-methyl-2-bromo-4-fluorobenzamide |
N'-Methyl-2,2'-diaminodiethylamine | 4097-88-5 | C5H15N3 | 117.19 | N-Methyl-2,2'-diaminodiethylamine; HYSQEYLBJYFNMH-UHFFFAOYSA-N; N'-methyl-2,2'-diaminodiethylamine; 4097-88-5; N-(2-Aminoethyl)-N-methyl-1,2-ethanediamine; bis(2-aminoethyl)(methyl)amine |
N-Methyl-1-(tetrahydro-2H-pyran-2-yl)methanamine | 7179-96-6 | C7H15NO | 129.2 | N-Methyl-1-(tetrahydro-2H-pyran-2-yl)methanamine; Methyl-(tetrahydro-pyran-2-ylmethyl)amine |
N-Methyl-1-(2-phenyl-1,3-thiazol-4-yl)methanamine dihydrochloride | 921101-66-8 | C11H14Cl2N2S | 277.22 | |
N-Methyl-1-(1-morpholin-4-ylcyclohexyl)methanamine | 938458-83-4 | C12H24N2O | 212.33 | |
N-methyl(3-(pyridin-4-yl)phenyl)methanamine | 852180-67-7 | C13H14N2 | 198.26 | N-METHYL-N-(3-PYRIDIN-4-YLBENZYL)AMINE; N-methyl(3-(pyridin-4-yl)phenyl)methanamine |
N-METHOXY-N-METHYLCARBAMOYL CHLORIDE | 30289-28-2 | C3H6ClNO2 | 123.54 | N-METHOXY-N-METHYLCARBAMOYL CHLORIDE; N-Methoxy-N-methylcarbamic acid chloride; N-Methoxy-N-methylcarbamoyl chloride,95% |
N-METHOXY-N-METHYL-2-THIOPHENECARBOXAMIDE | 229970-94-9 | C7H9NO2S | 171.22 | N-METHOXY-N-METHYL-THIOPHENE-2-CARBOXAMIDE; N-METHOXY-N-METHYL-2-THIOPHENECARBOXAMIDE |
N-Methoxy-N-methyl-2,3-dihydro-benzo[1,4]dioxine-2-carboxamide | 848170-22-9 | C11H13NO4 | 0 | N-METHOXY-N-METHYL-2,3-DIHYDROBENZO[B][1,4]DIOXINE-2-CARBOXAMIDE |
N-Methoxyanhydrovobasinediol | 125180-42-9 | C21H26N2O2 | 338.5 | |
N-Methoxy-2-pyrazinecarboxamide | 115110-16-2 | C6H7N3O2 | 153.13868;g/mol | N-methoxypyrazine-2-carboxamide; N-Methoxy-2-pyrazinecarboxamide; 115110-16-2; ZINC39064861; AKOS009129083; N-METHOXYPYRAZINE-2-CARBOXAMIDE |
NLG-919 | 1402836-58-1 | C18H22N2O | 282.38 | GDC0919; GDC-0919; GDC 0919; NLG919; NLG 919; NLG-919; RG6078; RG-6078; RG 6078. |
NLCQ-1 | 221292-08-6 | C15H15Cl2N5O2 | 368.218 | NLCQ-1; NSC 709257 |
n-Lauryl acrylate | 57472-68-1 | C12H18O5 | 242.3 | DIPROPYLENE GLYCOL DIACRYLATE (STABILIZED WITH MEHQ); Dodecylacrylate,n-; Dipropylenglykoldiacrylat; 2-Propenoic acid oxybis(methyl-2,1-ethanediyl) ester; Dipropylene glycol diacrylate; Oxybis(methyl-2,1-ethanediyl) diacrylate |
N-LAUROYL-L-GLUTAMIC ACID | 3397-65-7 | C17H31NO5 | 329.43 | N-LAUROYL-L-GLUTAMIC ACID; L-Glutamicacid,N-(1-oxododecyl)-(9CI); N-(1-oxododecyl)-L-glutamic acid; LAUROYL GLUTAMIC ACID; N-(1-OXODODECYL)GLUTAMICACID; N-Dodecanoyl-L-glutamic acid |
N-LAUROYL-L-ALANINE | 52558-74-4 | C15H29NO3 | 271.4 | N-LAUROYL-L-ALANINE |
NL-103 | 1788896-33-2 | C71H108N18O14 | 1437.76 | NL-103; NL 103; NL103; N-(4-chloro-3-(3-chlorobenzamido)phenyl)-6-((7-(hydroxyamino)-7-oxoheptyl)amino)nicotinamide |
NKY 80 | 299442-43-6 | C12H11N3O2 | 229.23 | 2-Amino-7-(2-furanyl)-7,8-dihydro-5(6H)-quinazolinone |
NKP-608 | 177707-12-9 | C31H24ClF6N3O2 | 620.00 | |
Nimotuzumab | 780758-10-3 | |||
Nitrodenafil | 147676-99-1 | C17H19N5O4 | 357.36 | 5-(2-Ethoxy-5-nitrophenyl)-1,6-dihydro-1-methyl-3-propyl-7H-pyrazolo[4,3-d]pyrimidin-7-one; |
Nitrocefin | 41906-86-9 | C21H16N4O8S2 | 516.51 | |
Nitrocaramiphen hydrochloride | 98636-73-8 | C18H26N2O4.HCl | 370.88 | 2-(Diethylamino)ethyl Ester 1-(4-Nitrophenyl)cyclopentanecarboxylic Acid Hydrochloride; 1-(p-Nitrophenyl)-2-(diethylamino)ethylester Cyclopentanecarboxylic Acid Hydrochloride |
Nitrocaphane | 54940-95-3 | C14H19Cl2N3O4 | 364.22 | 3-[2-[[Bis(2-chloroethyl)amino]methyl]-5-nitrophenyl]-2-aminopropionic acid;2-((Bis(2-chloroethyl)amino)methyl)-5-nitrophenylalanine;At-1258;Phenylalanine, 2-((bis(2-chloroethyl)amino)methyl)-5-nitro-;(S)-2-Amino-3-(2-((bis(2-chloroethyl)amino)methyl)-5-n |
Nitroacetonitrile | 13218-13-8 | C2H2N2O2 | 86.05 | Nitroacetonitrile; DWBOSISZPCOPFS-UHFFFAOYSA-N; 2-nitroacetonitrile; AC1LBV0U; C2H2N2O2; ZINC100085645 |
Nitroacetaldehyde diethyl acetal | 34560-16-2 | C6H13NO4 | 163.17 | NITROACETALDEHYDE DIETHYLACETAL; 1,1-DIETHOXY-2-NITROETHANE; Ethane, 1,1-diethoxy-2-nitro-; NITROACETALDEHYDE DIETHYL; 1,1-DIETHOXY-2-NITROETHANE 96+% |
NITRO RED | 56431-61-9 | C16H10N4Na2O9S2 | 512.38 | disodium; (3Z)-4-amino-3-[(4-nitrophenyl)hydrazinylidene]-5-oxonaphthalene-2,7-disulfonate; 56431-61-9; 4-Amino-5-hydroxy-3-(4-nitrophenylazo)-2,7-naphthalenedisulfonicaciddisodiumsalt; NitroRed; NITRORED |
Nitrilotriacetic Acid-d9 | 807630-34-8 | 191.13900 | ||
Nitrile hydratase | 82391-37-5 | |||
Nitrilase | 9024-90-2 | 0 | NITRILASE ARABIDOPSIS THALIANA RECOM.; NITRILASE AUS ALCALIGENES FAECALIS, ~15 U/MG*; NITRILASE AUS RHODOCOCCUS SP., >0.1 U/MG*; NITRILASE AUS RHODOCOCCUS RHODOCHROUS, ~10 U/G*; NITRILASE, ARABIDOPSIS THALIANA, RECOM.FROM E. COLI*; NITRILA | |
Nitric acid, cerium(3+)salt, hexahydrate (8CI,9CI) | 10294-41-4 | Ce. 6 H2 O . 3 H N O3 | 434.27 | |
Nitrendipine Propyl Ester | 225785-54-6 | C19H22N2O6 | 374.4 | 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic Acid 3-Methyl 5-Propyl Ester; 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic Acid Methyl Propyl Ester; |
Nitrendipine | 39562-70-4 | C18H20N2O6 | 360.3699 | Bayotensin |
Nitrate Reductase (NAD[P]H) from Aspergillus niger | 9029-27-0 | NAD(P)H:Nitrate oxidoreductase | ||
Nitenpyram | 150824-47-8 | C11H15ClN4O2 | 270.72 | (E)-Nitenpyram; (E)-N-((6-Chloropyridin-3-yl)methyl)-N-ethyl-N'-methyl-2-nitroethene-1,1-diamine; Capstar; TI 304 |
Nitecapone | 116313-94-1 | C12H11NO6 | 265.2 | OR-462; 3-(3,4-dihydroxy-5-nitrobenzylidene)pentane-2,4-dione |
NITD609 | 1193314-23-6 | C19H14Cl2FN3O | 390.24 | (3R,3'S)-5,7'-dichloro-6'-fluoro-3'-methylspiro[1H-indole-3,1'-2,3,4,9-tetrahydropyrido[3,4-b]indole]-2-one; cipargamin; KAE609; NITD 609; NITD-609; NITD609 |
NITD-304 | 1473450-60-0 | C17H20Cl2N2O | 339.26 | NITD-304; NITD 304; NITD304; 4,6-dichloro-N-(4,4-dimethylcyclohexyl)-1H-indole-2-carboxamide |
Nitazoxanide-D4 | 1246819-17-9 | C12H5D4N3O5S | 311.28 | NTZ D4; Alinia D4; NSC-697855 D4 |
Nitazoxanide Impurity 2 | 952686-58-7 | C19H13N3O7S | 427.40 | 2-[[(5-Nitro-2-thiazolyl)amino]carbonyl]phenyl 2-(acetyloxy)benzoate |
Nitazoxanide Impurity 1 | 402848-76-4 | C12H10N2O3S | 262.29 | 2-Acetoxy-N-(2-thiazolyl)benzamide; Denitronitazoxanide |
Nitazoxanide | 55981-09-4 | C12H9N3O5S | 307.28 | 2-(Acetyloxy)-N-(5-nitro-2-thiazolyl)benzamide; N-(5-Nitro-2-thiazolyl)salicylamide Acetate Ester; Nizonide |
NISTC4170803 | 4170-80-3 | C8H10OS | 0 | NISTC4170803; ETHYL PHENYL SULFOXIDE, TECH.; (Ethylsulfinyl)benzene; Ethyl phenyl sulfoxide; Phenyl (ethyl) sulfoxide; Phenyl ethyl sulfoxide |
Nisoxetine | 53179-07-0 | C17H21NO2 | 271.35414;g/mol | Nisoxetine;Nisoxetina;Nisoxetinum;3-(2-methoxyphenoxy)-N-methyl-3-phenylpropan-1-amine;3-(2-Methoxyphenoxy)-N-methyl-3-phenylpropylamine;Compound89218 |
N-isopropyl-N'-phenyl-p-phenylenediamine | 101-72-4 | C15H18N2 | 226.32 | 1,4-Benzenediamine, N-(1-methylethyl)-N'-phenyl-; 1,4-Benzenediamine,N-(1-methylethyl)-N'-phenyl-; 4010 NA; 4010na; 4-Anilino-N-isopropylaniline; 4-Benzenediamine,N-(1-methylethyl)-N'-phenyl-1; Akrochem antioxidant pd1; Antigen 3c |
N-Isopropyl Carvedilol | 1246819-01-1 | C27H32N2O4 | 448.57 | 1-(9H-Carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)ethyl](1-methylethyl)amino]-2-propanol |
Nisoldipine D6 | 1189718-34-0 | C20H13D6N2O6 | 394.46 | 3-methyl 5-(2-(methyl-d3)propyl-3,3,3-d3) 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate |
Nisoldipine | 63675-72-9 | C20H24N2O6 | 388.41 | Sulphanilamide |
Nipradilol | 81486-22-8 | C15H22N2O6 | 326.347 | NIPRADILOL; K 351; 3,4-Dihydro-8-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]-2H-1-benzopyran-3-ol 3-nitrate; Hypadil; Nipradolol; Nipranol; 2H-1-Benzopyran-3-ol, 3,4-dihydro-8-(2-hydroxy-3-((1-methylethyl)amino)propoxy)-, 3-nitrate; 3,4-Dihydro-8-(2-hydro |
Niphimycin | 11056-18-1 | C59H103N3O18 | 1142.476 | Scopafungin; 3-oxo-3-(((10E,12Z,20E)-5,7,9,19,23,25,27,31,33,34,35-undecahydroxy-8,14,18,22,26,30-hexamethyl-15-((E)-4-methyl-12-(3-methylguanidino)dodec-8-en-2-yl)-17-oxo-16,37-dioxabicyclo[31.3.1]heptatriaconta-10,12,20-trien-3-yl)oxy)propanoic acid |
Nintedanib Impurity D | 1987887-92-2 | C24H21N3O3 | 399.45 | |
Nintedanib Impurity 6 (Intedanib Impurity 6) | 894783-71-2 | C30H31N5O4 | 525.60 | BIBF-1202; BIBF 1202; BIBF1202. (3Z)-2,3-Dihydro-3-[[[4-[methyl[(4-methyl-1-piperazinyl)acetyl]amino]phenyl]amino]phenylmethylene]-2-oxo-1H-indole-6-carboxylic acid;(Z)-3-(((4-(N-methyl-2-(4-methylpiperazin-1 -yl)acetamido)phenyl)amino)(phenyl)methylene)- |
Nintedanib Impurity 2 (Intedanib Impurity 2) | 1174335-83-1 | C20H16ClNO5 | 385.81 | methyl (3E)-1-(2-chloroacetyl)-3-[methoxy(phenyl)methylidene]-2-oxo-2,3-dihydro-1H-indole-6-carboxylate; |
Nintedanib Ethanesulfonate (Intedanib Ethanesulfonate) | 656247-18-6 | C33H39N5O7S | 649.76 | Methyl (3Z)-3-(((4-(N-methyl-2-(4-methylpiperazin-1-yl)acetamido)phenyl)amino) (phenyl)methylidene)-2-oxo-2,3-dihydro-1H-indole-6-carboxylate ethanesulfonate; BIBF1120; BIBF 1120 BIBF-1120; Nintedanib esylate Nintedanib ethanesulfonate salt; Intedanib; Br |
Nintedanib (Intedanib) | 656247-17-5 | C31H33N5O4 | 539.62 | Vargatef; BIBF-1120; BIBF 1120; BIBF1120; Intedanib |
Ningetinib | 1394820-69-9 | C31H29FN4O5 | 728.79 | N-[3-Fluoro-4-[[7-(2-hydroxy-2-methylpropoxy)quinolin-4-yl]oxy]phenyl]-1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazole-4-carboxamide; N-[3-Fluoro-4-[[7-(2-hydroxy-2-methylpropoxy)-4-quinolinyl]oxy]phenyl]-2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyr |
Nimustine hydrochloride | 55661-38-6 | C9H13ClN6O2·HCl | 309.15 | Nidran hydrochloride; Nimustine HCl; 3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride |
Nimustine | 42471-28-3 | C9H13ClN6O2 | 309.15 | Nimustine Hydrochloride; pimustine hydrochloride. ACNU 50 Nidran. ACNU. N'-[4-amino-2-methyl-5-pyrimidinyl)methyl]-N-(2-chloroethyl)-N-nitrosourea |
Nimorazole | 6506-37-2 | C9H14N4O3 | 226.23 | Nitrimidazine; Naxogin |
Nimodipine-d7 | 1246815-36-0 | C21H19N2O7D7 | 425.49 | 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic Acid 3-(2-Methoxyethyl) 5-(1-Methylethyl-d7) Ester; (+/-)-Nimodipine-d7; Admon-d7; BAY-e 9736-d7 |
Nimodipine Impurity A | 85677-93-6 | C21H24N2O7 | 416.43 | Dehydro Nimodipine; 2,6-Dimethyl-4-(3-nitrophenyl)-,3,5-pyridinedicarboxylic Acid 3-(2-Methoxyethyl) 5-(1-Methylethyl) Ester; 2,6-Dimethyl-4-(3-nitrophenyl)- 3,5-pyridinedicarboxylic Acid 2-Methoxyethyl 1-Methylethyl Ester; USP Nimodipine Related Compound |
Nimodipine | 66085-59-4 | C21H26N2O7 | 418.44 | LY127809; LY 127809; LY-127809; Nimodipine, Nimotop, Periplum, BAY E 9736, BAY-E-9736, BAYE9736 |
Nimesulide-d5 | 1330180-22-7 | C13H7N2O5SD5 | 313.35 | N-(4-Nitro-2-(phenoxy-d5)phenyl)methanesulfonamide; 4-Nitro-2-(phenoxy-d5) methanesulfonamide-d5; 4'-Nitro-2'-(phenoxy-d5)methanesulfonanilide; Aulin-d5; Flogovital-d5; Lizepat-d5; Mesulid-d5 |
Nimesulide Impurity G | 70995-08-3 | C12H9NO4 | 231.21 | 4-Nitro-2-phenoxyphenol; Phenyl-(5-nitro-2-hydroxy-phenyl)-aether; |
Nimesulide Impurity F | 51765-72-1 | C14H14N2O7S2 | 386.4 | N-Methylsulfonyl Nimesulide; N-(Methylsulfonyl)-N-(4-nitro-2-phenoxyphenyl)methanesulfonamide; N-(Methylsulfonyl)-4'-nitro-2'-phenoxymethanesulfonanilide; |
NIM811 | 143205-42-9 | C62H111N11O12 | 1202.61 | (Melle-4)cyclosporin; Sdz-nim-811; NIM-811; NIM 811 |
Nilvadipine-d3 | 95326-14-0 | C19H15N3O6D4 | 389.4 | 2-Cyano-1,4-dihydro-6-methyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic Acid 3-(Methyl-d3) 5-(1-methylethyl) Ester |
Nilvadipine | 75530-68-6 | C19H19N3O6 | 385.37 | F-ara-A (NSC 312887) Phosphate; FR-34235, FK 235; FR 34235, FK-235; FR34235, FK235 |
Nilutamide-d6 | 1189477-66-4 | C12H4F3N3O4D6 | 323.26 | 5,5-(Dimethyl-d6)-3-[4-nitro-3-(trifluoromethyl)phenyl]-2,4-imidazolidinedion; 1-(3-Trifluoromethyl-4-nitrophenyl)-4,4-(dimethyl-d6)imidazoline-2,5-dione; Anandron-d6 |
Nilutamide | 63612-50-0 | C12H10F3N3O4 | 317.224 | NILANDRON, 5,5-dimethyl-3-[4-nitro-3-(trifluoromethyl)phenyl]-2,4-imidazolidinedione |
Niludipine | 22609-73-0 | C25H34N2O8 | 490.55 | NILUDIPINE;(2-propoxyethyl)ester; 5-pyridinedicarboxylicacid,1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-bis; bay-a7168; bis(2-propoxyethyl)1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedi;niludipin; Bis(2-propoxyethyl) 2,6-dimethyl-4-(3-nitrophen |
Nilotinib-d6 | 1268356-17-7 | C28H16F3N7OD6 | 535.58 | 4-Methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzamide-d6; AMN 107-d6; |
Nilotinib N-Oxide | 1246817-85-5 | C28H22F3N7O2 | 545.53 | 4-Methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridinyl-N-oxide)-2-pyrimidinyl]amino]benzamide; |
Nilotinib monohydrochloride monohydrate | 923288-90-8 | C28H25ClF3N7O2 | 583.99 | AMN-107; Tasigna |
Nilotinib Impurity 9 | 641571-15-5 | C28H22F3N7O | 529.53 | 4-Methyl-N-(3-(5-Methyl-1H-iMidazol-1-yl)-5-(trifluoroMethyl)phenyl)-3-((4-(pyridin-3-yl)pyriMidin-2-yl)aMino)benzaMide; |
Nilotinib Impurity 3 | 943320-48-7 | C10H8F3N3 | 227.19 | 3-(1H-Imidazol-1-yl)-5-(trifluoromethyl)-aniline; |
Nilotinib Impurity 2 | 641571-06-4 | C11H10F3N3 | 241.22 | 3-(2-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline; |
Nilotinib Impurity 13 | 917391-28-7 | C12H10F3N3O | 269.23 | 3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)benzamide; |
Nilotinib Impurity 12 | 641571-12-2 | C12H8F3N3 | 251.21 | 3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)benzonitrile; 3-(4-Methyl-imidazol-1-yl)-5-trifluoromethyl-benzonitrile; |
Nifurtimox | 23256-30-6 | C10H13N3O5S | 287.29 | BAY 2502; BAY2502; BAY-2502; Bayer 2502; Bayer2502; Bayer-2502; Lampit |
Nifursol | 16915-70-1 | C12H7N5O9 | 365.21 | 2-hydroxy-3,5-dinitro-N-[(E)-(5-nitrofuran-2-yl)methylideneamino]benzamide NIFURSOL Histomon Salfuride 16915-70-1 Sulfuride Nifursolo [DCIT] Nifursolum [INN-Latin] UNII-TG99GOU55Z EINECS 240-963-6 NCGC00160555-01 DSSTox_CID_26226 DSSTox_RID_81 |
Nifurprazine | 1614-20-6 | C10H8N4O3 | 232.2 | (E)-6-(3-(5-Nitro-2-furyl)vinyl)-3-pyridazinylamin; 3-Amino-6-((5-nitro-2-furil)-vinil)-1,2-diazina; 3-Amino-6-((5-nitro-2-furil)-vinil)-1,2-diazina [Italian]; 3-Amino-6-(2-(5-nitro-2-furyl)vinyl)pyradizine; 3-Amino-6-(2-(5-nitro-2-furyl)vinyl)pyridazine; |
Nifuroxazide-d4 | 1188487-83-3 | C12H5N3O5D4 | 279.25 | 4-Hydroxybenzoic Acid-d4 2-[(5-Nitro-2-furanyl)methylene]hydrazide; (5-Nitro-2-furfurylidene)(4-hydroxybenzoyl-d4)hydrazine |
Nifuroxazide EP Impurity D | 112537-96-9 | C10H6N4O6 | 278.18 | 5-Nitro-2-furfuraldazine; 5-Nitro-2-furancarboxaldehyde (E,E)-(5-Nitro-2-furanyl)methylene]hydrazone; USP Nitrofurazone Related Compound A; |
Nifuroxazide | 965-52-6 | C12H9N3O5 | 275.22 | Nifuroxazid; Dicoferin; Diarlidan; Nifuroxazida; 4-hydroxy-N-[(E)-(5-nitrofuran-2-yl)methylideneamino]benzamide |
Nifuratel Impurity B | 736-53-8 | C10H6N4O6 | 278.18 | 5-Nitrofuraldazine; 5-nitro-2-furaldehyde (5-nitrofurfurylene)hydrazone |
Nifuratel Impurity A | 92-55-7 | C9H9NO7 | 243.17 | Nitrofurfural Diacetate;5-Nitro-2-furaldehyde Diacetate; |
Nifuratel | 4936-47-4 | C10H11N3O5S | 285.28 | NF 113; SAP 113; NF113; SAP113; NF-113; SAP-113; Methylmercadone |
Nifuraldezone | 3270-71-1 | C7H6N4O5 | 226.14 | |
Niflumic acid-13C6 | 1325559-33-8 | 2-(3-Trifluoromethyl- phenyl-13C -amino)-6nicotinic acid | ||
Niflumic Acid | 4394-00-7 | C13H9F3N2O2 | 282.2 | 2-[[3-(trifluoromethyl)phenyl]amino]-3-pyridinecarboxylic acid; Actol; Donalgin; Nifluril; UP83 |
Nifenalol HCl | 5704-60-9 | C11H17ClN2O3 | 260.71 | 2-(Isopropylamino)-1-(p-nitrophenyl)ethanol hydrochloride; Nifenalol; Nifenalol HCl; INPEA. |
Nifekalant HCl | 130656-51-8 | C19H27N5O5 . HCl | 441.91 | Nifekalant hydrochloride; 6-[[2-[(2-Hydroxyethyl)[3-(4-nitrophenyl)propyl]amino]ethyl]amino]-1,3-dimethyl-2,4(1H,3H)-pyrimidinedione Hydrochloride; |
Nifedipine-d6 | 1188266-14-9 | C17H12D6N2O6 | 352.38 | 1,4-Dihydro-2,6-dimethyl-4-(2-nitrophenyl)-3,5-pyridinedicarboxylic Acid Dimethyl Ester-d6; |
Nifedipine-d4(2-nitrophenyl-d4) | 1219798-99-8 | C17H12D4N2O6 | 350.36 | 1,4-Dihydro-2,6-dimethyl-4-(2-nitrophenyl)-3,5-pyridinedicarboxylic Acid Dimethyl Ester |
Nifedipine Pyrimidine Impurity | 80742-11-6 | C19H18N4O6 | 398.38 | (2R,4R)-rel-1,2,3,4-Tetrahydro-6-methyl-2,4-bis(2-nitrophenyl)-5-pyrimidine carboxylic acid methyl ester; |
Nifedipine metabolite | 34783-31-8 | C16H14N2O7 | 346.3 | Hydroxydehydro Nifedipine Carboxylate; 2-(Hydroxymethyl)-6-methyl-4-(2-nitrophenyl)-3,5-pyridinedicarboxylic Acid 5-Methyl Ester;4-(2-Nitrophenyl)-2-hydroxymethyl-5-methoxycarbonyl -6-methylpyridine-3-carboxylic Acid; |
Nifedipine Impurity C | 111304-31-5 | C12H11NO5 | 249.23 | Butanoic acid, 2-[(2-nitrophenyl)methylene]-3-oxo-, methyl ester, (2Z)-; |
Nifedipine Impurity 2 (Nicardipine Carboxylic Acid Derivative ) | 74936-72-4 | C16H16N2O6 | 332.32 | 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid 3-methyl ester; |
Nifedipine Impurity 1 | 161838-99-9 | C17H18N2O6 | 346.34 | 2,6-Dimethyl-3,5-dicarbomethoxy-4-(4-nitrophenyl)-1,4-dihydropyridine; |
Nifedipine HCl | 60299-11-8 | C17H18N2O6.HCl | 346.34 36.46 | 1,4-Dihydro-2,6-dimethyl-4-(2-nitrophenyl)-3,5-pyridinedicarboxylic Acid Dimethyl Ester; |
Nifedipine Amide Impurity | 114709-68-1 | C16H17N3O5 | 331.33 | 5-(Aminocarbonyl)-1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-3-pyridinecarboxylic Acid Methyl Ester,; |
Nidulin | 10089-10-8 | C20H17Cl3O5 | 443.7 | Methylustin |
NIDA 41020 | 502486-89-7 | C23H24Cl2N4O2 | 459.37 | N-(Piperidin-1-yl)-5-(4-methoxyphenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide |
Nicotinuric Acid-d4 | 1216737-36-8 | C8H4N2O3D4 | 184.18 | N-[(3-Pyridinyl-d4)carbonyl]glycine; N-(Nicotinoyl)-d4-glycine; 2-(Nicotinylamino-d4)acetic Acid; (Nicotinoyl-d4)glycine; (Nicotinyl-d4)glycine; |
Nicotinuric Acid | 583-08-4 | C8H8N2O3 | 180.16 | N-(3-Pyridinylcarbonyl)glycine; N-Nicotinoylglycine; 2-(Nicotinylamino)acetic Acid |
nicotinoyl chloride | 10400-19-8 | C6H4ClNO | 141.5551 | Nicotinic acid chloride; Nicotinyl chloride; 3-Pyridinecarbonyl chloride |
NGI 1 | 790702-57-7 | C17H22N4O3S2 | 394.51 | NGI-1; NGI1; ML414; ML 414; ML-414; 5-[(Dimethylamino)sulfonyl]-N-(5-methyl-2-thiazolyl)-2-(1-pyrrolidinyl)benzamide |
Nicotine-d7 HCl | 1219805-86-3 | C10H7N2D7·HCl | 169.28 | (-)-1-Methyl-2-[3-pyridyl]pyrrolidine-d7 |
Nicotine-d4 | 350818-69-8 | C10H10N2D4 | 166.26 | 3-(1-Methyl-2-pyrrolidinyl)pyridine-2,4,5,6-d4; (±)-Nicotine-d4; (±)-3-(1-Methyl-2-pyrrolidinyl)pyridine-d4; (R,S)-Nicotine-d4; (±)-Nicotine-d4; 1-Methyl-2-(3-pyridyl)pyrrolidine-d4; DL-Nicotine-d4 |
Nicotine-d3 | 69980-24-1 | C10H11N2D3 | 165.25 | rac-Nicotine-d3; 3-[1-(Methyl-d3)-2-pyrrolidinyl]pyridine; (±)-Nicotine-d3; (±)-3-[1-(Methyl-d3)-2-pyrrolidinyl)pyridine; (R,S)-Nicotine-d3; (±)-Nicotine-d3; 1-(Methyl-d3)-2-(3-pyridyl)pyrrolidine; DL-Nicotine-d3 |
Nicotine N-Oxide | 63551-14-4 | C10H14N2O | 178.24 | 3-(1-methyl-1-oxidopyrrolidin-1-ium-2-yl)pyridine; |
Nicotine Impurity C | 486-56-6 | C10H12N2O | 176.22 | S-(-)-Cotinine; NIH 10498, NIH10498, NIH-10498, (-)-Cotinine(5S)-1-Methyl-5-(3-pyridinyl)-2-pyrrolidinone; (S)-(-)-1-Methyl-5-(3-pyridiyl)-2- pyrrolidinone; |
NICOTINE DITARTRATE DIHYDRATE | 6019-06-3 | C18H30N2O14 | 498.44 | NICOTINE TARTRATE DIHYDRATE; NICOTINE DITARTRATE DIHYDRATE; (-)-NICOTINE DI-(+)-HYDROGEN TARTRATE; (-)-NICOTINE DI-(+)-HYDROGEN TARTRATE, DIHYDRATE; (-)-Nicotinedi-(+)-hydrogenetartrate; (-)-NICOTINDITARTRAT(+)-DIHYDRAT; (-)-NICOTINE D-(+)-HYDROGEN TARTRA |
Nicotine bis-L-(+)-tartrate | 2624-48-8 | C18H26N2O12 | 462.41 | Nicotine bis-L-(+)-tartrate; Nicotine bi-L-(+)-tartrate 2-hydrate |
Nicotine | 22083-74-5 | C10H14N2 | 162.23 | 1-METHYL-2-(3-PYRIDYL)PYRROLIDINE; BLACK LEAF 40; (+/-)-NICOTINE; NICOTINE; (+-)-nicotin; (+-)-pyridin; (r,s)-nicotine; 3-(1-methyl-2-pyrrolidinyl)-pyridin |
Nicotinamide-N-oxide | 1986-81-8 | C6H6N2O2 | 138.12 | 1-oxidopyridin-1-ium-3-carboxamide; nicotinamide N-oxide |
Nicotinamide-d4 | 347841-88-7 | C6H2N2OD4 | 126.15 | 3-Pyridinecarboxamide-d4; 3-(Aminocarbonyl)pyridine-d4; 3-Amidopyridine-d4; 3-Carbamoylpyridine-d4; 3-Pyridinecarboxylic acid amide-d4 |
Niclosamide-13C6 hydrate | 1325808-64-7 | 5-Chloro-N-(2-chloro-4- nitro-phenyl-13C )-2-6 hydroxy-benzamide hydrate | ||
Nicotinamide riboside | 1341-23-7 | C11H15N2O5 | 255.3 | Nicotinamide-beta-riboside; Nicotinamide ribonucleoside; N-Ribosylnicotinamide; 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyridin-1-ium-3-carboxamide |
Nicotianamine | 34441-14-0 | C12H21N3O6 | 303.3 | (S,S,S)-nicotianamine; (2S)-1-[(3S)-3-{[(3S)-3-amino-3-carboxypropyl]amino}-3-carboxypropyl]azetidine-2-carboxylic acid |
Nicotelline | 494-04-2 | C15H11N3 | 233.27 | 3,2':4',3''-Terpyridine; Nicotellin |
Nicosulfuron | 111991-09-4 | C15H18N6O6S | 410.41 | 2-[[(4,6-DIMETHOXYPYRIMIDIN-2-YL) AMINO-CARBONYL]AMINO SULFONYL]-N,N-DIMETHYL-3-PYRIDINE CARBOXAMIDE; 2-[(4,6-dimethoxypyrimidin-2-ylcarbamoyl)sulfamoyl]-n,n-dimethylnicotinamide; 1-(4,6-dimethoxypyrimidin-2-yl)-3-(3-dimethylcarbamoyl-2-pyridylsulfonyl)ur |
Nic-OSu | 78348-28-4 | C10H8N2O4 | 220.18 | Nic-OSu; Nicotinic acid N-hydroxysuccinimide ester; Nicotinic acid hydroxysuccinimidyl ester |
Nicorandil-d4 | 1132681-23-2 | C8H5D4N3O4 | 215.2 | N-[2-(Nitrooxy)ethyl]-3-pyridinecarboxamide-d4; SG-75-d4; Adancor-d4; Ikorel-d4 |
Nicorandil Impurity 5 | 896133-95-2 | C8H10N2O3 | 182.18 | |
Nicorandil Impurity 4 | 1798026-96-6 | C16H17N5O5 | 359.34 | 2-[(Pyridin-3-ylcarbonyl)-2-[(pyridin-3-ylcarbonyl)ethyl]amino]ethyl Nitrate; |
Nicorandil Impurity 3 | 40055-37-6 | C8H8N2O | 148.17 | 2-(3-Pyridyl)-2-oxazoline; 3-(4,5-Dihydrooxazol-2-yl)pyridine; 3-(2-Oxazolin-2-yl)pyridine; |
Nicorandil Impurity 2 Nitrate | 88598-33-8 | C8H10N2O2. HNO3 | 229.19 | |
Nicorandil Impurity 1 | 6265-73-2 | C8H10N2O2 | 166.18 | N-(2-Hydroxyethyl)nitotinamide; 3-(2-Hydroxyethyl)carbamoylpyridine; N-(2-Hydroxyethyl)-3-pyridinecarboxamide; N-(2-Hydroxyethyl)nicotinamide; N-Nicotinoyl-2-aminoethanol; N-Nicotinoylethanolamine; |
Nicorandil | 65141-46-0 | C8H9N3O4 | 211.17 | Antagonil |
Nicofuranose | 15351-13-0 | C30H24N4O10 | 600.53 | NICOFURANOSE; BETA-D-FRUCTOFURANOSE TETRANICOTINATE; 1,3,4,6-Tetrakis-O-(3-pyridinylcarbonyl)hex-2-ulofuranose; beta-D-Fructofuranose, 1,3,4,6-tetra-3-pyridinecarboxylate; Bradilan; D-Fructofuranose 1,3,4,6-tetranicotinate |
Nicodicosapent | 1269181-69-2 | C28H39N3O2 | 449.64 | N-(2-((5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenamido)ethyl)nicotinamide |
Nicoboxil | 13912-80-6 | C12H17NO3 | 223.27 | Nicoboxil; Nicotinic acid butoxy ester |
Niclosamide-13C6 | 1325559-12-3 | C13H8Cl2N2O4 | 333.16 | 5-Chloro-N-(2-chloro-4-nitrophenyl)-2-hydroxybenzamide-13C6 Hydrate; 2',5-D733ichloro-4'-nitrosalicylanilide-13C6 |
Niclosamide piperazine salt | 34892-17-6 | C17H18Cl2N4O4 | ||
Niclosamide monohydrate | 73360-56-2 | C13H10Cl2N2O5 | 345.13 | Niclocide monohydrate; BAY2353 monohydrate; Cestocid monohydrate; Sagimid monohydrate; Yomesan monohydrate |
Niclosamide ethanolamine salt | 1420-04-8 | C13H8Cl2N2O4·C2H7NO | 388.2 | BAY-73; BAY-6076; Bayluscide; HL 2448; Clonitralid; Niclosamide-olamine; Niclosamidel |
Niclosamide | 50-65-7 | C13H8Cl2N2O4 | 327.12 | Niclocide; 5-Chloro-N-(2-chloro-4-nitrophenyl)-2-hydroxybenzamide; Bayluscid |
Niclofolan | 10331-57-4 | C12H6Cl2N2O6 | 345.09 | 4,4'-Dichloro-6,6'-dinitro-o,o'-biphenol;5,5'-Dichloro-2,2'-dihydroxy-3,3'-dinitrobiphenyl;5,5'-Dichloro-3,3'-dinitro(1,1'-biphenyl)-2,2'-diol;Menichlopholan;Bilevon M;ME-3625;ME3625;BAY9015;BAY-9015;6,6'-Dichloro-4,4'-dinitro-[1,1'-biphenyl]-2,2'-diol;4- |
Nicergoline | 27848-84-6 | C24H26BrN3O3 | 484.39 | [(6aR,9R,10aS)-10a-methoxy-4,7-dimethyl-6a,8,9,10-tetrahydro-6H-indolo[4,3-fg]quinoline-9-yl]methyl 5-bromopyridine-3-carboxylate Aventis Brand of Nicergoline betapharm Brand of Nicergoline Circo Maren Circo-Maren ct Arzneimittel Brand of Nicergoline |
Nicardipine Related Compound 4 | 123973-71-7 | C25H27N3O6 HCl | 465.51 36.46 | 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid, 3-(2-(methyl(phenylmethyl)amino)ethyl) ester; |
Nicardipine Related Compound 2 | 64603-72-1 | C16H14N2O6 | 330.3 | 5-(Methoxycarbonyl)-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3-carboxylic acid ; Nicardipine Dehydro Carboxylic Acid Impurity ; |
Nicardipine Methyl Amino Derivative | 58368-87-9 | C19H23N3O6 | 389.41 | 3-Methyl 5-(2-(methylamino)ethyl) 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; |
Nicarbazin | 330-95-0 | C19H18N6O6 | 426.38 | N,N'-bis(4-nitrophenyl)urea compd. with 4,6-Dimethyl-2(1H)-pyrimidinone; 4,4'-Dinitrocarbanilide compd. with 4,6-Dimethyl-2-pyrimidinol; |
Nicaraven | 79455-30-4 | C15H16N4O2 | 284.31 | CP-51974-1 HCl |
Nicainoprol | 76252-06-7 | C21H27N3O3 | 369.465 | CAS-924; RU-42924; CAS924; RU42924; 1,2,3,4-Tetrahydro-8-(2-hydroxy-3-(isopropylamino)propoxy)-1-nicotinoylquinoline |
NIBR189 | 1599432-08-2 | C21H21BrN2O3 | 429.31 | NIBR-189; NIBR189 |
NIBR0213 | 1233332-14-3 | C27H29ClN2O3 | 465 | NIBR-0213; NIBR 0213; GTPL6997; (2S)-2-[[4-[3-[[(1R)-1-(4-chloro-3-methylphenyl)ethyl]amino]phenyl]-2,6-dimethylbenzoyl]amino]propanoic acid |
Niazirin | 122001-32-5 | C14H17NO5 | 279.292 | 4-(Rhamnosyloxy)phenylacetonitrile |
Niazinin | 147821-57-6 | C15H21NO6S | 343.39 | |
Niazimicin | 147821-49-6 | C16H23NO6S | 357.421 | Niazimicin A; O-ethyl N-[[4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyphenyl]methyl]carbamothioate |
N-HYDROXYMETHYLTRICHLOROACETAMIDE | 34891-76-4 | C3H4Cl3NO2 | 192.43 | |
N-Glycolylneuraminic acid | 1113-83-3 | C11H19NO10 | 325.27 | Neu5Gc |
N-GlcNAc-Biotin | 1272755-69-7 | C18H30N4O7S | 446.52 | 2-Acetamido-N-biotinyl-2-deoxy-b-D-glucopyranosylamine; 2-Acetamido-2-deoxy-b-D-glucopyranosylaminobiotin |
NG-Hydroxy-L-arginine acetate salt | 53598-01-9 | C8H18N4O5 | 250.25 | NOHA acetate salt |
NG-amino-L-arginine hydrochloride | 1031799-40-2 | C6H15N5O2·HCl | 225.7 | L-NAA; Nomega-amino-L-arginine hydrochloride; (2S)-2-amino-5-[[amino(hydrazinyl)methylidene]amino]pentanoic acid hydrochloride |
NGD 94-1 | 178928-68-2 | C18H20N6 | 320.39 | 2-[4-[(2-Phenyl-1H-imidazol-5-yl)methyl]-1-piperazinyl]-pyrimidine |
NGB 2904 | 189061-11-8 | C28H29Cl2N3O.HCl | 530.92 | N-[4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butyl]-9H-fluorene-2-carboxamide |
NGA5B N-Glycan | 172906-79-5 | C82H136N8O56 | 2129.98 | Asialo, agalacto, bisected pentaanennary |
NGA4F N-Glycan | 321142-61-4 | C72H120N6O50 | 1869.73 | Asialo, agalacto, fucosylated, tetraantenary N-linked glycan |
N-Desmethyl Enzalutamide | 1242137-16-1 | C20H14F4N4O2S | 450.412 | N-desmethylenzalutamide; 1242137-16-1; 4-{3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl}-2-fluorobenzamide; 4-(3-(4-cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl)-2-fluorobenzamide; Enza |
N-Desmethyl Ivabradine HCl | 1246638-08-3 | C26H34N2O5. HCl | 491.02 | 3-[3-[[[(7S)-3,4-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl]amino]propyl]-1,3,4,5-tetrahydro-7,8-dimethoxy-3-benzazepin-2-one Hydrochloride; N-Demethylivabradine Hydrochloride |
N-Desmethyl Ivabradine D6 HCl | 1346600-74-5 | C26H28D6N2O5·ClH | 497.02 | 3-[3-[[[(7S)-3,4-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl]amino]propyl]-1,3,4,5-tetrahydro-7,8-dimethoxy-3-benzazepin-2-one-d4 Hydrochloride; N-Demethylivabradine-d4 Hydrochloride |
N-Desmethyl Imatinib-d8 | 1185103-28-9 | C28H21N7OD8 | 487.64 | N-Desmethyl Gleevec-d8 |
N-Desmethyl Imatinib | 404844-02-6 | C28H29N7O | 479.59 | N-[4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-4-(1-piperazinylmethyl)-benzamide; N-Desmethyl Gleevec |
N-Desmethyl galantamine | 41303-74-6 | C16H19NO3 | 273.33 | (8aS,10R,12aS)-1,2,3,4,8a,9-Hexahydro-7-methoxy-10H-benzofuro[3a,3,2-ef][2]benzazepin-10-ol; (-)-N-Demethylgalanthamine; N-Norgalanthamine; Norgalantamine; (4As,6R,8As)-4A,5,9,10,11,12-Hexahydro-3-Methoxy-6H-Benzofuro[3A,3,2-Ef][2]Benzazepin-6-Ol; Galanta |
NAPTALAM | 132-66-1 | C18H13NO3 | 291.3 | 2-((1-naphthalenylamino)carbonyl)-benzoicaci; 2-((1-naphthalenylamino)carbonyl)benzoicacid; 6q8; acp322; alanap1; alanap10g |
Naproxen Sodium | 26159-34-2 | C14H13NaO3 | 252.24 | Naproxen sodium; RS 3650; RS-3650; RS3650; Sodium naproxen; Naproxen natrium |
Naproxen EP Impurity J | 21388-17-0 | C13H14O | 186.26 | 2-Methoxy-6-ethylnapthalene; |
N-Alkyl dimethyl ethylbenzyl ammonium chloride | 68956-79-6 | C25H46ClN | 0 | N-Alkyl dimethyl ethylbenzyl ammonium chloride; C12-18-alkyl[(ethylphenyl)methyl]dimethylammonium chlorides |
Nalidixic acid-D5 | 1189467-36-4 | 1,4-Dihydro-1-ethyl-D5-7-methyl-1,8-naphthy- ridine-4-on-3-carboxylic acid |
||
Nalidixic acid sodium salt | 3374-05-8 | C12H11N2NaO3 | 254.22 | |
Nalidixic acid | 389-08-2 | C12H12N2O3 | 232.24 | NSC-82174 |
NAI-N3 | 1612756-29-2 | C10H8N6O | 228.21 | [2-(azidomethyl)pyridin-3-yl]-imidazol-1-ylmethanone |
Naginata ketone | 6138-88-1 | C10H12O2 | 164.204 | Dehydroelsholtzione; 3-methyl-1-(3-methylfuran-2-yl)but-2-en-1-one |
N-Hydroxymaleimide | 4814-74-8 | C4H3NO3 | 113.07 | N-HYDROXYMALEAMINE; N-HYDROXYMALEIMIDE; 1-HYDROXY-2,5-DIHYDRO-1H-PYRROLE-2,5-DIONE; 1-hydroxy-1H-pyrrole-2,5-dione; N-Hydroxymaleimide 95%; 1-Hydroxypyrrole-2,5-dione |
N-Hydroxyguanidine | 13115-21-4 | CH5N3O | 124.11 | N-Hydroxyguanidine; Hydroxyguanidine sulfate |
N-hydroxydodecanamide | 10335-68-9 | C12H25NO2 | 215.332 g/mol | |
N-Hydroxyacetoimidoyl chloride | 683-58-9 | C2H4ClNO | 93.512260 | |
N-Hydroxy-4-methylbenzenesulfonamide | 1593-60-8 | C7H9NO3S | 187.21626;g/mol | N-hydroxy-4-methylbenzenesulfonamide; N-HYDROXY-4-METHYLBENZENESULFONAMIDE; 1593-60-8; N-Tosylhydroxylamine; Hydroxysulfonamide58; ACMC-209djs |
N-Hydroxy-3-nitro-benzamidine | 5023-94-9 | C7H7N3O3 | 181.15 | 3-NITRO-BENZAMIDOXIME; N-HYDROXY-3-NITRO-BENZAMIDINE; N'-HYDROXY-3-NITROBENZENECARBOXIMIDAMIDE; N-HYDROXY-3-NITRO-BENZENECARBOXIMIDAMIDE; m-nitrobenzamide oxime; N-Hydroxy-3-nitrobenzimidamide |
N-Hydroxy Riluzole | 179070-90-7 | C8H5F3N2O2S | 250.2 | N-Hydroxy-6-(trifluoromethoxy)-2-benzothiazolamine; 6-(Trifluoromethoxy)-2(3H)- benzothiazolone Oxime; 2-Hydroxyamino-6-(trifluoromethoxy)benzothiazole; |
N-Hydroxy-2-aminofluorene | 53-94-1 | C13H11NO | 197.23254 | N-Hydroxy-2-aminofluorene; 7-Hydroxyaminofluorene; HSDB2113; N-Hydroxy-aminofluorene; 2-Fluorenylhydroxylamine; 2-(Hydroxyamino)fluorene |
N-Hydroxy-1H-adenine | 5667-20-9 | C5H5N5O | 151.13 | 6-hydroxyaminopurine; 6-hydroxylaminopurine; n-hydroxy-1h-purin-6-amin; n-hydroxy-adenin; 6-N-HYDROXYLAMINOPURINE; AURORA KA-540; N-hydroxy-1H-adenine; 6-(Hydroxyamino)-9H-purine |
N-Hydroxy-1,8-naphthalimide sodium salt | 6207-89-2 | C12H6NNaO3 | 235.17 | N-Hydroxy-1,8-naphthalimide sodium salt; N-Hydroxynaphthalimide sodium salt; N,N-(1,8-Naphthalyl)hydroxylamine sodium salt |
N-Hydroxy Sulfamethoxazole | 114438-33-4 | C10H11N3O4S | 269.28 | 4-(Hydroxyamino)-N-(5-methyl-3-isoxazolyl)-benzenesulfonamide; Sulfamethoxazole N4-Hydroxylamine; Sulfamethoxazole Hydroxylamine; NSC 665547; |
N-Hydroxy Ropinirole HCl | 1542267-72-0 | C16H24N2O2 HCl | 312.84 | N-Hydroxy Ropinirole Hydrochloride |
N-Hydroxy Pentamidine Acetate (salt) | 130349-07-4 | C19H24N4O3.2/3.C2H4O2 | 446.505 | |
N-Hydrogenated tallow-1,3-diaminopropane | 68603-64-5 | |||
NHS-FLUORESCEIN | 135795-62-9 | C24H15NO7 | 429.38 | NHS-FLUORESCEIN |
NHI 2 | 1269802-97-2 | C17H12F3NO3 | 335.28 | Methyl 1-hydroxy-6-phenyl-4-(trifluoromethyl)-1H-indole-2-carboxylate |
N-HEXADECANE-D34 | 15716-08-2 | C16D34 | 260.65 | N-HEXADECANE-D34; HEXADECANE-D34; HEXADECANE-D34, 98 ATOM % D |
n-Heptyl Chloroformate | 33758-34-8 | C8H15O2Cl | 178.66 | Chloroformic acid n-heptyl ester; n-Heptyl chloroformate |
N-heptanthiol | 1639-09-4 | C7H16S | 132.27 | 1-HEPTANETHIOL; 1-HEPTYL MERCAPTAN; HEPTYL MERCAPTAN; MERCAPTAN C7; N-HEPTYL MERCAPTAN; 1-heptanthiol; heptane-1-thiol; heptanethiol(non-specificname) |
N-HEPTANE | 33838-52-7 | C7D16 | 116.30100 | |
NH125 | 278603-08-0 | C27H45IN2 | 524.56 | NH125 |
NGP-555 | 1304630-27-0 | C23H23FN4S | 406.523 | NGP 555; N-(5-ethyl-2,4-dimethylphenyl)-4-[3-fluoro-4-(4-methylimidazol-1-yl)phenyl]-1,3-thiazol-2-amine |
NGA4B N-Glycan | 115403-70-8 | C74H123N7O51 | 1926.79 | Asialo, agalacto, bisected tetraantenary N-linked glycan |
NGA4 N-Glycan | 385767-06-6 | Asialo, agalacto, tetra-antennary N-linked glycan; A4 N-Glycan | ||
NGA3F N-Glycan | 1513691-26-3 | C64H107N5O45 | 1666.54 | Asialo, agalacto, fucosylated triantennary N-linked glycan |
NGA3B N-Glycan | 1620146-04-4 | C66H110N6O46 | 1723.59 | Asialo, agalacto, bisected, tri-antennary N-linked glycan |
NGA3 N-Glycan | 110387-63-8 | C58H97N5O41 | 1520.40 | A3 N-Glycan; Asialo, agalacto, tri-antennary N-linked glycan; (GlcNAc)3Man3GlcNAc2; Mannotriose-di-(N-acetyl-D-glucosamine), tris(N-acetyl-D-glucosaminyl) |
NGA2FB N-Glycan | 79726-49-1 | C64H107N5O45 | 1666.54 | Asialo, agalacto, bisected, fucosylated bi-antennary N-linked glycan; Mannotriose-[fucosyl-di-(N-acetylglucosamine)]; (GlcNAc)Man3(Fuc)(GlcNAc)2 |
NGA2 N-Glycan | 84808-02-6 | C50H84N4O36 | 1317.21 | A2 N-Glycan; Asialo,agalacto,bi-antennary N-linked glycan; (GlcNAc)2Man3(GlcNAc)2; Mannotriose-di-(N-acetylglucosamine) bis(N-acetylglucosaminyl) |
NG25 | 1315355-93-1 | C29H30F3N5O2 | 537.58 | NG 25; NG-25 |
NG,NG-dimethyl-L-arginine hydrochloride | 220805-22-1 | C8H18N4O2·2HCl | 275.2 | ADMA; ADMA 2HCl; NG,NG-Dimethylarginine dihydrochloride; NG,NG-Dimethyl-L-arginine dihydrochloride; (2S)-2-amino-5-[[amino(dimethylamino)methylidene]amino]pentanoic acid dihydrochloride |
NG 52 | 212779-48-1 | C16H19ClN6O | 346.81 | Compound 52; NG-52; NG52 |
NG 25 trihydrochloride | 2108554-00-1 | C29H30F3N5O2.3HCl | 646.96 | |
NFPS | 405225-21-0 | C24H24FNO3 | 393.45 | N-[3-([1,1-Biphenyl]-4-yloxy)-3-(4-fluorophenyl)propyl]-N-methylglycine |
N-Formyl-O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-l-tyrosine | 671235-41-9 | C16H11I4NO5 | 804.89 | N-Formyl Thyroxine |
N-Formyl-Met-Leu-Phe | 59880-97-6 | C21H31N3O5S | 437.55 | (2S)-2-[[(2S)-2-[[(2S)-2-formamido-4-methylsulfanylbutanoyl]amino]-4-methylpentanoyl]amino]-3-phenylpropanoic acid; For-Met-Leu-Phe-OH; N-formyl-L-methionyl-L-leucyl-L-phenylalanine |
N-Formyl-L-kynurenine | 3978-11-8 | C11H12N2O4 | 236.22 | (S)-2-Amino-4-(2-formamidophenyl)-4-oxobutanoic acid |
N-Fluoropyridinium pyridine heptafluorodiborate | 131307-35-2 | C10H10B2F8N2 | 331.81 | |
N-Fluorobenzenesulfonamide | 145490-75-1 | C6H6FNO2S | 175.180743;g/mol | n-fluorobenzenesulfonamide; 145490-75-1; N-fluorobenzenesulphonamide; N-fluorobenzenesulfonamide; ACMC-20n4k0; N-fluorobenzenesulfonamide |
N-Feruloyltyramine | 66648-43-9 | C18H19NO4 | 313.4 | 2-Propenamide, 3-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]-, (E)-; (2E)-3-(4-Hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]-2-propenamide; (E)-Feruloyltyramine; (E)-N-Feruloyltyramine; Alfrutamide |
N-Feruloyloctopamine | 66648-44-0 | C18H19NO5 | 329.35 | trans-N-Feruloyl octopamine;OctopaMine, N-feruloyl- |
N-Feruloyl-3-methoxytyramine | 78510-19-7 | C19H21NO5 | 343.4 | N-trans-Feruloyl-3-O-methyldopamine |
NFAT inhibitor, Cell Permeable | 592517-80-1 | C147H259N67O36S | 3573.15 | RRRRRRRRRRRGGGMAGPHPVIVITGPHEE |
NF 546 | 1006028-37-0 | C47H44N6Na4O17P4 | 1180.74 | 4,4'-(Carbonylbis(imino-3,1-phenylene-carbonylimino-3,1-(4-methyl-phenylene)carbonylimino))-bis(1,3-xylene-alpha,alpha'-diphosphonic acid tetrasodium salt |
Nexinhib20 | 331949-35-0 | C15H16N4O3 | 300.31 | Neutrophil exocytosis inhibitor 20; 4,4-Dimethyl-1-(3-nitrophenyl)-2-(1H-1,2,4-triazol-1-yl)-1-penten-3-one |
Nevirapine-d5 | 1189717-29-0 | C15H9N4OD5 | 271.34 | 11-Cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one-d5 |
Nevirapine-d4 | 1051418-95-1 | C15H10N4OD4 | 270.33 | 11-Cyclopropyl-5,11-dihydro-4-methyl-6H-dipyridyo[3,2-b;2',3'-e][1,4]diazepin-6-one |
Nevirapine-d3 | 1051419-24-9 | C15H11D3N4O | 269.32 | 11-Cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one-d3; BI-RG 587-d3; NSC 641530-d3; Nevarapine-d3; Viramune-d3; |
Nevirapine Impurity D | 1391054-30-0 | C30H26N8O2 | 530.59 | 11,11'-Dicyclopropyl-4,4'-dimethyl-5,5',11,11'-tetrahydro-6H,6'H-9,9'-bidipyrido[3,2-b:2',3'-e][1,4]diazepin-6,6'-dione; Nevirapine Impurity D; Nevirapine EP Impurity D; |
Nevirapine Impurity C | 287980-58-2 | C15H16N4O | 268.32 | 5,11-Dihydro-4-methyl-11-propyl-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one; Nevirapine EP Impurity C; |
Nevirapine Impurity B | 287980-84-1 | C12H10N4O | 226.24 | 5,11-Dihydro-4-methyl-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one; Nevirapine EP Impurity B; |
Nevirapine Impurity A | 133627-17-5 | C14H14N4O | 254.29 | 11-Ethyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one; BIRH 414 BS; USP Nevirapine Related Compound A; Nevirapine EP Impurity A; |
Nevirapine Butenyl Analogue | 284686-27-7 | C18H18N4O | 306.37 | 4-(But-1-en-1-yl)-11-cyclopropyl-5H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6(11H)-one; 4-(1-Buten-1-yl)-11-cyclopropyl-5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one; |
Nevirapine | 129618-40-2 | C15H14N4O | 266.3 | BI-RG-587; BIRG 0587; BIRG587; HSDB 7164; Nevirapine; NSC 641530; NVP; Brand name: Viramune Viramune XR. |
Neuchromenin | 180964-26-5 | C13H12O5 | 248.23 | (-)-2,3-Dihydrocitromycin |
Neuropeptide Y (porcine) | 83589-17-7 | C190H287N55O57 | 4254 | |
Neuropeptide Y (human, rat) | 90880-35-6 | C189H285N55O57S | 4271.7 | NPY, Human; YPSKPDNPGEDAPAEDMARYYSALRHYINLITRQRY-NH2 |
Neuropeptide W-23 (human) | 383415-79-0 | C119H183N35O28S | 2584.03 | NPW-23 (HUMAN); NEUROPEPTIDE W-23 (HUMAN); TRP-TYR-LYS-HIS-VAL-ALA-SER-PRO-ARG-TYR-HIS-THR-VAL-GLY-ARG-ALA-ALA-GLY-LEU-LEU-MET-GLY-LEU; H-TRP-TYR-LYS-HIS-VAL-ALA-SER-PRO-ARG-TYR-HIS-THR-VAL-GLY-ARG-ALA-ALA-GLY-LEU-LEU-MET-GLY-LEU-OH |
Neuropeptide SF (mouse, rat) | 230960-31-3 | C40H65N13O10 | 888.03 | Ser-Leu-Ala-Ala-Pro-Gln-Arg-Phe-NH2 |
Neuropeptide S (Rat) | 412938-75-1 | C95H160N34O27 | 2210.52 | Ser-Phe-Arg-Asn-Gly-Val-Gly-Ser-Gly-Val-Lys-Lys-Thr-Ser-Phe-Arg-Arg-Ala-Lys-Gln; L-seryl-L-phenylalanyl-L-arginyl-L-asparaginylglycyl-L-valylglycyl-L-serylglycyl-L-valyl-L-lysyl-L-lysyl-L-threonyl-L-seryl-L-phenylalanyl-L-arginyl-L-arginyl-L-alanyl-L-lysy |
Neuropeptide S (Mouse) | 412938-74-0 | C93H156N34O27 | 2182.47 | H-Ser-Phe-Arg-Asn-Gly-Val-Gly-Ser-Gly-Ala-Lys-Lys-Thr-Ser-Phe-Arg-Arg-Ala-Lys-Gln-OH |
Neuropeptide S (human) | 412938-67-1 | C93H155N31O28S | 2187.5 | SFRNGVGTGMKKTSFQRAKS; SER-PHE-ARG-ASN-GLY-VAL-GLY-THR-GLY-MET-LYS-LYS-THR-SER-PHE-GLN-ARG-ALA-LYS-SER; NPS (HUMAN); NEUROPEPTIDE S (HUMAN); H-SER-PHE-ARG-ASN-GLY-VAL-GLY-THR-GLY-MET-LYS-LYS-THR-SER-PHE-GLN-ARG-ALA-LYS-SER-OH; REF DUPL: H-Ser-Phe-Arg-Asn-G |
Neuropeptide FF | 99566-27-5 | C54H76N14O10 | 1081.28 | L-phenylalanyl-L-leucyl-L-phenylalanyl-L-glutaminyl-L-prolyl-L-glutaminyl-L-arginyl-L-phenylalaninamide, trifluoroacetate salt; Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe amide; F-8-F-NH2 |
Neuropeptide AF (human) | 192387-38-5 | C90H132N26O25 | 1978.19 | H-ALA-GLY-GLU-GLY-LEU-ASN-SER-GLN-PHE-TRP-SER-LEU-ALA-ALA-PRO-GLN-ARG-PHE-NH2; NEUROPEPTIDE AF (HUMAN) |
Neuropathiazol | 880090-88-0 | C19H18N2O2S | 338.42 | Ethyl 4-(methyl(2-phenylthiazol-4-yl)amino)benzoate; KHS2 |
Neuromedin U-25 (human) | 312306-89-1 | C141H203N41O38 | 3080.4 | NMU-25 |
Neuromedin U (rat) | 117505-80-3 | C124H180N34O31 | 2643 | (2S,3Z,5S,6Z,8S,9Z,11S,12Z,14S)-2-amino-14-((Z)-(((S,Z)-1-(((S,Z)-1-((2-((S)-2-((Z)-(((S,Z)-1-(((S)-1-((S)-2-((1Z,3S,4Z,7Z,10Z,12S,13Z,15S,16Z,18S,19Z,21S,22Z,24S)-29-amino-12,15,21-tribenzyl-24-((S)-2-((Z)-(((S,Z)-1-(((S)-1,4-dihydroxy-1,4-diiminobu |
Neuromedin N | 92169-45-4 | C38H63N7O8 | 745.95 | H-Lys-Ile-Pro-Tyr-Ile-Leu-OH;L-Lys-L-Ile-L-Pro-L-Tyr-L-Ile-L-Leu-OH;Lys-Ile-Pro-Tyr-Ile-Leu;Lysyl-isoleucyl-prolyl-tyrosyl-isoleucyl-leucine;(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-1-[(2S,3S)-2-[[(2S)-2,6-diaminohexanoyl]amino]-3-methylpentanoyl]pyrrolidine-2- |
Neuromedin B | 87096-84-2 | C52H73N15O12S | 1132.29 | H-Gly-Asn-Leu-Trp-Ala-Thr-Gly-His-Phe-Met-NH2; glycyl-L-asparagyl-L-leucyl-L-tryptophyl-L-alanyl-L-threonyl-glycyl-L-histidyl-L-phenylalanyl-L-methioninamide; (2S)-2-[(2-aminoacetyl)amino]-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S,3R)-1-[[2-[[(2S)-1-[[(2S)-1-[[(2 |
Neurokinin B | 86933-75-7 | C55H79N13O14S2 | 1210.42 | H-Asp-Met-His-Asp-Phe-Phe-Val-Gly-Leu-Met-NH2; L-alpha-aspartyl-L-methionyl-L-histidyl-L-alpha-aspartyl-L-phenylalanyl-L-phenylalanyl-L-valyl-glycyl-L-leucyl-L-methioninamide; (3S)-3-amino-4-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S) |
NeuAc-a-2,3-Gal-b-1,4-Glc-NHCO-(CH2)5NH-biotin | 168636-53-1 | C39H65N5O21S | 972.02 | |
NeuAc a2-3Gal b1-3(NeuAc a2-6)GalNAc | 71764-07-3 | C36H59N3O27 | 965.86 | |
Neu5Troc[1Me,4789Ac]a(2-3)Gal[26Bn]-b-MP | 610763-72-9 | C48H56Cl3NO20 | 1073.31 | |
Neu5Ac(a2-6)Gal(b1-4)GalNAc | 383365-43-3 | C25H42N2O19 | 674.60 | |
Netupitant N-Oxide | 910808-11-6 | C30H32F6N4O2 | 594.59 | Netupitant metabolite Netupitant N-oxide;2-[3,5-bis(trifluoromethyl)phenyl]-3,3,3-trideuterio-N-methyl-N-[6-(4-methyl-4-oxidopiperazin-4-ium-1-yl)-4-(2-methylphenyl)pyridin-3-yl]-2-(trideuteriomethyl)propanamide |
Netupitant Impurity 8 | 290297-24-4 | C17H22N4 | 282.39 | |
Netupitant | 290297-26-6 | C30H32F6N4O | 578.603 | AGE94200; AGE-94200; AGE 94200;Ro 67-3189; Ro-67-3189; Ro67-3189; CHEBI441603; CID6451149; D05152; UNII-7732P08TIR, CHEMBL206253, AG-E-94200, Netupitant |
Netobimin | 88255-01-0 | C14H20N4O7S2 | 420.4546 | amino)methylene)amino)-; ethanesulfonicacid,2-(((methoxycarbonyl)amino)((2-nitro-5-(propylthio)phenyl); hapasil; NETOBIMIN; Neviyapine; Ethanesulfonic acid, 2-(methoxycarbonyl)amino2-nitro-5-(propylthio)phenylaminomethyleneamino-; 2-[3-Methoxycarbonyl-2-[ |
Netivudine | 84558-93-0 | C12H14N2O6 | 282.24900 | |
Netilmicin sulfate | 56391-57-2 | C21H41N5O7.2.5H2O4S | 1441.55 | |
Netilmicin | 56391-56-1 | C21H41N5O7 | 475.583 | )-o-(2,6-diamino-2,3,4,6-tetradeoxy-alpha-d-glycero-hex-4-enopyranosyl(1-4))-2; 1-n-aethylsisomicin; certomycin; -deoxy-n(sup1)-ethyl-; d-streptamine,o-3-deoxy-4-c-methyl-3-(methylamino)-beta-l-arabinopyranosyl(1-6; netillin; netilyn; netroymcin |
Neticonazole hydrochloride | 130773-02-3 | C17H22N2OS·HCl | 338.9 | Neticonazole HCl; 1-[(E)-2-methylsulfanyl-1-(2-pentoxyphenyl)ethenyl]imidazole hydrochloride |
N-ethyltoluene-2-sulphonamide | 1077-56-1 | C9H13NO2S | 199.27 | n-ethyl-2-methyl-benzenesulfonamid; n-ethyl-o-toluenesulfonamid; n-ethyltoluene-2-sulphonamide; RIT-CIZER NO 8; N-E-O/PTSA; n-ethyl-o-toluenesulfonamide |
N-Ethyl-p-toluenesulfonamide | 80-39-7 | C9H13NO2S | 199.27 | Benzenesulfonamide, N-ethyl-4-methyl-; Ethyl toluenesulfonamide; Ethylp-toluenesulfonamide; n-ethyl-4-methyl-benzenesulfonamid; n-ethyl-4-methylbenzenesulfonamide; N-Ethyl-4-methyl-benzenesulfonamide; n-ethyl-4-toluenesulfonamide; N-Ethyl-p-methylbenzenes |
N-ethyl-N-methylaniline | 613-97-8 | C9H13N | 135.20 | N-ETHYL-N-METHYLANILINE; (C2H5)N(CH3)-C6H5; Aniline, N-ethyl-N-methyl-; Benzenamine, N-ethyl-N-methyl-; Ethylmethylaniline; Methylethyl aniline; n-ethyl-n-methyl-benzenamin; N-Ethyl-N-methylbenzenamine |
Nepodin | 3785-24-8 | C13H12O3 | 216.236 | Musizin; Dianellidin |
Neramexane | 219810-59-0 | C11H23N | 169.31 | KRP-209; 1,3,3,5,5-Pentamethylcyclohexanamine |
Nequinate-D7 | 1584701-10-9 | 7-Benzyloxy-D7-6-butyl- 4-oxo-1,4-dihydro- quinoline-3-carboxylic acid methyl ester | ||
Nequinate | 13997-19-8 | 7-Benzyloxy-6-butyl-4- oxo-1,4-dihydro- quinoline-3-carboxylic acid methyl ester | ||
Nepicastat HCl | 170151-24-3 | C14H16ClF2N3S | 331.81 | N6022; Nepicastat hydrochloride; (S)-5-(aminomethyl)-1-(5,7-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)-1H-imidazole-2(3H)-thione hydrochloride; Nepicastat (hydrochloride); UNII-3WK068D17I |
Nepheline syenite | 37244-96-5 | 2AlO4Si.K.Na | 300.216 | potassium; sodium; oxido-oxo-oxoalumanyloxysilane; NEPHELINESYENITE; 37244-96-5; Nephelinesyenite |
Nepetoidin B | 55486-06-1 | C17H14O6 | 314.293 | [(Z)-2-(3,4-dihydroxyphenyl)ethenyl] (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate |
Nepetin-7-glucoside | 569-90-4 | C22H22O12 | 478.4 | Nepitrin; Eupatolin 7-glucoside |
Nepetin | 520-11-6 | C16H12O7 | 316.3 | 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-6-methoxychromen-4-one |